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SANCHEZ-LUGO, LIZETTE, Ph. D. The Effects cf a Diet-Exercise 
Program on Blood Lipids, Blood Pressure, and Diabetes Indices 
in Relation to Body Fat and Body Fat Distribution. (1992) 
Directed by Dr. Terry L. Bazzarre. 268 pp. 
The purpose of this dissertation research was to evaluate 
the relationship of obesity measured as the sum of skinfolds 
(SSF) and body mass index (BMI) and body fat distribution 
measured as waist-hip ratio (WHR) to risk factors for 
cardiovascular heart disease (CHD), hypertension, and 
diabetes, and to evaluate the effects of a 12-week diet-
exercise program on fasting insulin, glucose, glycohemoglobin 
(Hb A,), systolic (SBP) and diastolic blood pressure (DBP), 
total cholesterol (TC), high density lipoprotein cholesterol 
(HDL-C), high density lipoprotein cholesterol subfraction 2 
(HDL2-C), subfraction 3 (HDL3-C), diet, body weight (BW), body 
fat (%BF), waist (WC) and hip circumference (HC) 
cardiovascular fitness and stress. 
Fifty-five subjects (20 males and 35 females) were 
evaluated for the cross-sectional component of this research, 
and 36 subjects (15 males and 21 females) were evaluated for 
the longitudinal study. The exercise program consisted of 
"fast" walking sessions 3 times/week. Lifestyle workshops on 
topics such as nutrition, stress management, and the benefits 
of physical activity and a healthy diet were conducted weekly. 
Statistical analysis conducted included Pearson's 
correlation coefficients, multiple regression analysis, and 
analysis of covariance. The paired-difference t-test was used 
to estimate differences between weeks 0 and 12 for each 
vari able. 
TC was the only dependent variable positively associated 
with WHR independent of age and SSF. Insulin, glucose, SBP, 
and DBP were positively associated with SSF independent of age 
and WHR. Hb A, was positively associated with SSF independent 
of age and WHR in females. HDLZ-C and HDL3-C were negatively 
associated with SSF independent of age and WHR in females and 
males, respectively. Increases in WHR tertiles were not 
associated with increases in any of the diabetes or 
hypertension risk factors, TC, or with decreases in HDL-C, 
HDLZ-C, or HDL3-C in females. HDL3-C levels decreased with 
increments in WHR in males. 
At week 12, BW, SSF, BMI, 5KBF, WC, and HC decreased 
significantly while WHR did not. Fasting insulin, glucose, 
Hb A1s SBP, and TC were reduced significantly while HDL-C, 
HDLZ-C, and HDL3-C were not altered. Cardiovascular fitness 
improved significantly while stress levels decreased. Fat and 
calorie intake decreased significantly in males. Decreased 
SSF was correlated with decreased insulin and DBP in males and 
with increased HDL2-C in females. Decreased WHR was 
correlated with decreased TC in males while decreased BW was 
correlated with decreased TC in females. Overall, the most 
important findings of this dissertation were that TC was 
positively associated with body fat distribution independent 
of general obesity. 
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CHAPTER I 
INTRODUCTION 
Obesity is a major public health problem in developed 
countries (Larsson, Svardsudd, Welin, Wilhelmsen, Bjorntorp, 
and Tibblin, 1984; Van Gaal, Vansant, and Leeuw, 1989). The 
prevalence of obesity ranges from 25% to 50% or more in 
adults. Excess body fat or obesity is a risk factor 
associated with increased susceptibility to a variety of 
disorders and a higher mortality rate (Bray, 1985). 
However, a considerable period of observation is required 
before the associations between obesity and disease can be 
seen (Bjorntorp, 1985). 
Several studies (Van Gaal et al., 1989; Lundgren, 
Bengtsson, Blohme, Lapidus, and Sjostrom, 1989; Ohlson et 
al., 1985) suggest that fat distribution, especially the 
android (abdominal) pattern, is a risk factor for 
cardiovascular heart disease (CHD), non insulin dependent 
diabetes mellitus (NIDDM), systolic blood pressure (SBP), 
and diastolic blood pressure (DBP). The effect of fat 
distribution on these conditions seems to be independent of 
the effect of obesity. Utilizing the waist/hip circumference 
ratio (WHR), as a measurement of abdominal obesity, Larsson 
et al. (1984) found that a relative excess of abdominal 
2 
tissue increased the risk of myocardial infarction or death. 
Appendix A includes a diagram explaining the relationships 
between abdominal obesity, diabetes, hypertension, and 
coronary heart disease risk factors. 
Purpose of the Study 
The overall purpose of this dissertation research was 
to examine the effects of a 12-week multidiscipiinary 
nutrition education, physical fitness, and lifestyle 
management program (RESHAPE), on the dependent variables 
fasting insulin, glucose, hemoglobin A, (Hb A,), total 
cholesterol (TC), high density lipoprotein cholesterol 
(HDL-C), high density lipoprotein cholesterol subfraction 2 
(HDL2-C), high density lipoprotein cholesterol subfraction 3 
(HDLg-C), SBP, and DBP according to measurements of body fat 
(sum of four skinfolds), and body mass index (BMI) and 
measurements of body fat distribution (measured as the WHR). 
Overall Goals and Objectives: 
The overall purpose of this dissertation research was 
to evaluate the relationship of obesity to risk factors for 
CHD, hypertension, and diabetes. The particular focus of 
this research was to determine if body fat distribution 
(android obesity vs. gynoid obesity) was more highly 
correlated to each of these groups of chronic disease risk 
factors than an estimate of overall measure of obesity such 
as sum of skinfolds (SSF) or the BMI. 
The specific objectives of this research were directed 
at the measurement of diet, body fat, cardiovascular 
fitness, and stress as well as selected risk factors for 
CHD, hypertension, and diabetes in a group of 
overweight/obese males and females. The selected nutrient 
variables of interest were: energy intake (kcal), fat, 
protein, and carbohydrate (total grams per day), 
cholesterol, dietary fiber, sodium, potassium, calcium, 
zinc, and copper. Measures of body fat included body 
weight, the Quetelet or Body Mass Index (BMI=wt/ht2), sum of 
four skinfolds (SSF=triceps, biceps, subscapular, and 
suprailiac), estimated % body fat (%BF), and the WHR. 
Cardiovascular fitness was measured by the amount of time 
required to walk one mile. Measures of stress included the 
Current Self-Appraisal Questionnaire (CSA) developed by 
Bazzarre (unpublished) and the State-Trait Anxiety Inventory 
(STAI) developed by Spielberger, Gorsuch, and Lushene 
(1970). 
The relative risk of developing CHD was based on the 
measurement of TC, HDL-C, and the HDL2 and HDL3 cholesterol 
subfractions (i.e., HDLZ-C and HDL3-C, respectively). The 
relative risk of developing hypertension was based on the 
measurement of both SBP and DBP. The relative risk of 
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developing diabetes was based on measuring fasting glucose, 
insulin, and Hb A,. 
Other objectives of this research were based on an 
evaluation of the effect of an intervention, the RESHAPE 
Program, on the selected chronic disease risk factors. The 
goal of the RESHAPE program is to reduce obesity/adiposity 
through effective lifestyle management programs, and 
simultaneously to reduce one's risk factors for these 
chronic diseases. Thus, a cross-sectional study as well as 
a longitudinal/intervention study were developed in order to 
test specific hypotheses that would demonstrate whether 
abdominal or android obesity (i.e., a high WHR) was more 
highly correlated to the regulation of the selected chronic 
disease risk factors than general obesity. 
Specific Hypotheses: 
Because gender and age have consistently been shown to 
account for a considerable amount of variation in the 
prevalence of chronic diseases, and in dietary intake, 
obesity (including body fat distribution) and cardiovascular 
fitness, all of the hypotheses have been tested separately 
for both males and females. The hypotheses have been 
grouped according to the two study designs used in this 
dissertation research: the cross-sectional study which is 
represented by data collected at week 0 (baseline); and the 
intervention study which included data collected at both 
5 
weeks 0 and 12 of the RESHAPE program. Since these 
hypotheses were developed a priori. statistical tests were 
considered significant at the p<0.05 level even though a 
large number of hypotheses were tested and even though the 
sample size was predetermined by the limitations of the 
RESHAPE Program to be relatively small. Changes in social 
variables such as the Current Self Appraisal and the State-
Trait Anxiety Inventory were considered significant if the 
p-value was lower than 0.10 (Skipper, Guenther, & Nass, 
1967). 
Cross-sectional study research hypotheses: 
For the first hypothesis, the Pearson product moment 
correlation coefficient test was used to assess the 
correlations between the dependent variables and the WHR, 
SSF, and BMI. 
Hypotheses 1: There are positive correlations between the 
WHR, SSF, and BMI and: 
a. diabetes risk factors: fasting insulin, glucose, and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; and, 
d. negative correlations with selected CHD risk 
factors: HDL-C, HDL2-C, and HDL3-C. 
Multiple regression analysis was used to evaluate the 
associations between the dependent variables and the SSF 
(hypothesis 2), or the WHR (hypothesis 3). When the 
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association between the dependent variables and SSF were 
assessed, age and WHR were included in the model to adjust 
for any confounding effect. Age and SSF were controlled 
for, when the associations between the dependent variables 
and WHR were evaluated. 
Hypotheses 2: After controlling for the effects of the 
variables age and WHR, the regression coefficient for SSF is 
greater than zero for: 
a. diabetes risk factors: fasting insulin, glucose and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; and, 
d. less than zero for CHD risk factors: HDL-C, HDLZ-C, 
and HDLg-C. 
Hypotheses 3: After controlling for the effects of age and 
SSF, the regression coefficient for WHR is greater than zero 
for: 
a. diabetes risk factors: fasting insulin, glucose, and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; and, 
d. less than zero for CHD risk factors: HDL-C, HDL2-C, 
and HDLg-C. 
For hypotheses 4, the relationships between the 
dependent variables and the categorical WHR variable were 
7 
evaluated using Analysis of Covariance. Age and SSF were 
used as covariates. 
Hypotheses 4: After adjusting for SSF and age, an increase 
in WHR tertile from low to medium to high is associated 
with: 
a. an increase in the estimated means of the following 
diabetes risk factor variables: fasting insulin, glucose, 
and Hb A,; 
b. an increase in the estimated means of the following 
hypertension risk factors: SBP and DBP; 
c. an increase in the estimated mean of TC as a CHD 
risk factor; and, 
d. a decrease in the estimated means of the following 
CHD risk factors: HDL-C, HDLZ-C, and HDL3-C. 
Intervention study research hypothesis: 
For the longitudinal component of this dissertation 
research, a paired-difference t-test was used to test 
hypotheses 5 through 9. Hypothesis 5 assessed the changes 
in the levels of the dependent variables (fasting insulin, 
glucose, Hb A,, SBP, DBP, TC, HDL-C, HDL2-C, and HDL3-C) 
after the 12-week exercise-nutrition program. Hypotheses 6 
through 9 assessed changes after the 12-week intervention 
program for the following independent variables: body 
weight, BMI, SSF, 5KBF, waist circumference, hip 
circumference, WHR, calories, fat, dietary fiber, and 
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cholesterol intake, time to walk a mile, as well as the 
current self appraisal and the STAI as indices of stress. 
Hypotheses 5: At the end of the 12-week RESHAPE Program, 
the following dependent variables will decrease: 
a. diabetes risk factors: fasting insulin, glucose, and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; and, 
d. the CHD risk factors: HDL-C, HDL2-C, and HDL3-C will 
i ncrease. 
Hypotheses 6: At the end of the 12-week RESHAPE Program, 
measures of obesity such as body weight, BMI, SSF, %BF, 
waist circumference, hip circumference, and WHR will 
decrease. 
Hypotheses 7: Participants in the RESHAPE Program will have 
higher CSA scale scores and lower STAI scale scores at the 
end of the 12-week program. 
Hypotheses 8: Participants in the RESHAPE Program will have 
a lower calorie, fat, and cholesterol intake, and a higher 
dietary fiber intake. 
Hypothesis 9: The cardiovascular fitness of the 
participants in the RESHAPE Program will improve at the end 
of the 12-week as measured by a decrease in the time taken 
to walk a mile. 
Hypotheses 10 through 12 assessed the associations 
between changes in SSF, WHR, and body weight with changes in 
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each of the dependent variables. The Pearson product moment 
correlation coefficient was used to test these hypotheses. 
Hypotheses 10: Favorable reductions in SSF are positively 
correlated with changes in: 
a. diabetes risk factors: fasting insulin, glucose, and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; 
d. and negatively correlated with changes in CHD risk 
factors: HDL-C, HDL2-C, and HDL3-C. 
Hypotheses 11: Favorable reductions in WHR are positively 
correlated with changes in: 
a. diabetes risk factors: fasting insulin, glucose, and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; 
d. and negatively correlated with changes in CHD risk 
factors: HDL-C, HDL2-C, and HDL3-C. 
Hypotheses 12: Favorable reductions in body weight are 
positively correlated with changes in: 
a. diabetes risk factors: fasting insulin, glucose, and 
Hb A,; 
b. hypertension risk factors: SBP and DBP; 
c. CHD risk factors: TC; 
d. and negatively correlated with changes in CHD risk 
factors: HDL-C, HDLZ-C, and HDL3-C. 
10 
Definitions: 
Sum of Skinfolds (SSF): The sum of tricep, bicep, 
subscapular, and suprailiac skinfolds. SSF is an estimate 
of total subcutaneous body fat. 
Body mass index (BMI): weight/height2. BMI is an estimate 
of percent body fat (XBF). However, it may reflect both 
lean and fat tissue. 
Waist to hip ratio (WHR): WHR is an indirect measure of the 
relative amount of visceral or intra-abdominal adipose 
tissue. Abdominal obesity (AO) or android pattern is 
characterized by a high WHR and is more common in males than 
females. G1uteo-femoral obesity (GFO) or gynoid pattern is 
characterized by a low WHR and is usually observed in 
females. Increased body fat deposition is generally 
associated with increased AO in males and increased GFO in 
females; however, increased abdominal fat distribution can 
increase with increased body fat in females. The difference 
between male and female fat distribution patterns is 
governed by hormonal influences. Android obesity either in 
males or females is associated with an increased risk of 
developing NIDDM, hypertension, and CHD. Gynoid obesity 
does not appear to be associated with these metabolic 
compli cat i ons. 
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List of Acronyms: 
AI atherogenic index (TC/HDL-C) 
AO abdominal obesity 
XBF percent body fat 
BMI body mass index or Quetelet Index (weight/height2) 
CHD cardiovascular heart disease 
BW body weight 
CSA current self appraisal 
CT computed tomography 
DAF deep abdominal fat 
DBP diastolic blood pressure 
FFA free fatty acids 
FT free testosterone 
GFO gluteofemoral obesity 
HB A1 glycosylated hemoglobin 
HDL-C high density lipoprotein cholesterol 
HL hepatic lipase 
HSL hormone sensitive lipase 
LBM lean body mass 
LPL lipoprotein lipase 
NIDDM non-insulin dependent diabetes mellitus 
OGTT oral glucose tolerance test 
SBP systolic blood pressure 
SF ski nfold 
SSF sum of four skinfolds (tricep, bicep, subscapular, 
and suprailiac) 
SHBG sex hormone binding globulin 
STAI State-Trait Anxiety Inventory 
STR subscapular/tricep skinfold ratio 
TC total cholesterol 
TG triglycerides 
VLCD very low calorie diet 
VLDL very low density lipoprotein 
WHR waist to hip circumference ratio 
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CHAPTER II 
REVIEW OF THE LITERATURE 
The purpose of this chapter was to review and analyze 
research on the relationships of body fat and body fat 
distribution to each of the following dependent variables: 
fasting insulin, glucose, HbA.,, SBP, DBP, TC, HDL-C, HDLZ-
C, and HDL3-C. The effects of exercise on body fat and each 
of the chronic disease risk factors are also included in 
this review of the literature. 
Introduct ion:  
Fat distribution differs according to gender (Van Gaal 
et al . 1989). Fat tends to be either predominantly in the 
abdominal region or in the upper trunk in males. In 
females, fat is more commonly distributed in the gluteal-
femoral regions. 
The major clinical findings regarding the effects on 
health of the central type of fat distribution which also 
apply to the grossly obese include: elevated glucose 
intolerance, non insulin dependent diabetes mellitus 
(NIDDM), hyperinsulinemia (Hartz, Rupley, Kalkhoff, & Rimm, 
1983; Larsson et al. 1984); high blood pressure (Modan et 
al., 1985; Van Gaal et al., 1989); increased occurrence of 
strokes and heart diseases (Modan et al., 1985); increased 
total cholesterol and low HDL-C levels (Larsson et al., 
1984; Van Gaal et al., 1989); and, increased HbA., levels 
(Van Gaal et al. , 1989). 
Using the WHR as a measurement of abdominal obesity, 
Larsson et al. (1984) found that a relative excess of 
abdominal tissue increased the risk of myocardial infarction 
or death. Kissebah et al. (1982) noted that 
hyperinsulinemia is characteristic of subjects with upper 
segment body mass distribution. Kissebah et al. (1982) 
subsequently proposed that upper trunk obesity be used as a 
diagnostic marker for glucose intolerance, fasting hyper-
insulinemia, and fasting hypertriglyceridemia. Hartz et al. 
(1983) noted a sharp increase in the prevalence of diabetes 
as the WHR increased in 15,532 females. After controlling 
for the effect of general obesity, they found that the 
relative risk of diabetes in females with upper body obesity 
was 3.17 times (p<0.001) higher than for females with lower 
body obesity. 
Measurements of body fat and body fat distribution 
Anthropometric measurements can be useful tools for 
evaluating the health of individuals in clinical diagnostic 
situations, as well as in populations as part of public 
health screenings. According to Hass and Flegal (1981), 
anthropometry is based on the concept that appropriate 
measurements reflect morphological changes that occur in 
response to functionally significant physiological changes. 
Nutrition science relies heavily on anthropometric 
techniques as a first-order indicator for detection and 
treatment of some nutritional problems, especially those 
involving energy and protein (e.g. obesity and 
malnut ri t ion). 
The development of indirect methods of determining 
human body composition began during the 1940's (Lukaski, 
1987). Most body composition methods are based on the two-
compartment model (a fat one and a fat-free one). 
Unfortunately, this model does not account for the 
differential effects of water, protein-muscle tissue, and 
skeletal-bone tissue. 
Densitometry 
Densitometry is used to estimate body fat by 
determining body density which is measured by comparing the 
weight of a body in air to the weight of the body in water 
(hydrostatic weighing). The chemical composition of the 
fat-free body is assumed to be relatively constant with a 
density of 1.100 g/cc at 37°C. The density of fat is 0.900 
g/cc at 37°C. (Behnke, et al., 1942 cited in Lukaski, 
1987). Residual lung volume and the volume of gas in the 
gastrointestinal tract affect body density. Therefore, the 
residual lung volume is measured based on the determination 
of vital capacity. The volume of gas in the 
gastrointestinal tract is estimated as 100 ml for adults. 
Other assumptions in using the densitometric approach 
include: the concept that the chemical composition of the 
fat-free body is relatively constant; and, the concept that 
hydration status and the proportion of bone mineral to 
muscle in the fat free body are constant (Lukaski, 1987). 
The application of this formula used for adults and for 
children may result in artificially elevated values since 
differences in hydration and bone density are not accounted 
for. According to Lohman (1981), body densities of the fat-
free body and lean body mass change from population to 
population depending on age, racial background, gender, and 
one's level of physical activity. 
Skinfold Thicknesses 
The measurement of skinfold (SF) thickness has 
basically two assumptions (Lukaski, 1987): the concept that 
the thickness of subcutaneous adipose tissue reflects a 
constant proportion of total body fat; and, the concept that 
the sites selected for measurement represent the average 
thickness of subcutaneous adipose tissue. 
The anatomic locations of the five most commonly 
measured SF sites are: triceps, subscapular, suprailiac, 
abdomen, and thigh. There are basically two ways to use SF 
(McArdle, F. I. Katch, & V. L. Katch, 1986). The first 
method is based on using the sum of the values for different 
SF as an indication of the relative degree of fatness among 
individuals which can be used to reflect changes in fatness 
after an intervention program. The second method is based 
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on using the SF in conjunction with mathematical equations 
designed to predict body density or percent body fat. These 
equations are population specific, and predict fatness 
fairly accurately in samples of subjects similar in age, 
gender, state of training, and fatness to those from which 
the equations were derived (Lohnman, 1981). According to 
Hass and Flegal (1981), there is more error in measuring SF 
in females than in males which reflects greater variability 
in the amount of adipose tissue at any site in females 
compared to males. Skin elasticity, different subcutaneous 
tissue mobility, different compression times, and individual 
skills also influence the results. 
Various ratios of SF thickness measurements have been 
used to assess body fat distribution and its relationship to 
disease. Haffner, Stern, Hazuda, Pugh, and Patterson (1987) 
found that the subscapular:triceps skinfold ratio (STR) was 
associated with NIDDM in females. In a prospective study, 
Haffner, Stern, Mitchell, Hazuda, and Patterson (1990) found 
that BMI, the STR, fasting insulin, and glucose 
concentration were all predictors of the incidence of 
diabetes in a group of Mexican Americans. 
Body Mass Index 
Body mass index (BMI) or Quetelet index (QI), is the 
body weight in kilograms divided by the height squared in 
meters, weight/(height )2. The BMI is more highly correlated 
with body fat than with other indices of height and weight 
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(National Research Council [NRC], 1989). According to the 
NRC, definition of obesity can be based on either SF 
measurements or BMI as follow: a BMI above 30 kg/m2, a 
tricep plus subscapular SF above 45mm in males and 65mm in 
females, or XBF more than 25% of body weight in males or 30% 
in females. Roche, Siervogel, Chumlea, and Webb (1981) 
found a positive correlation between BMI and %BF of 0.77 for 
males and 0.76 for females (p<0.01). 
Ci rcumferences 
Fat distribution can also be determined by waist to hip 
circumference ratios (WHR), or waist to thigh circumference 
ratios (NRC, 1989). Waist or the narrowest region between 
bottom of the rib cage and superior iliac spine, abdomen at 
the level of the umbilicus, pelvis at pubic symphysis, 
thigh, and arm have been used most widely. The use by 
different investigators of various anatomic landmarks for 
measuring hip and waist circumferences accounts for some of 
the differences in reported measurements (Leibel, Edens, and 
Fried, 1989). Obesity located in the abdominal areas 
(android obesity) is the subgroup of obesity with 
complications endangering health and life. The simplest 
method for measuring this form of obesity is to record the 
waist circumference and to divide it by the hip 
circumference in order to compensate for variation in frame 
size. 
According to Bjorntorp (1985) the WHR is at least as 
effective as other measurements of abdominal obesity such as 
skinfolds, ultrasound, or fat cell size. Ashwell et al. 
(1985) cited in Leibel (1989) found a significant 
correlation (r=0.61, p<0.001) between WHR and intra­
abdominal :subcutaneous fat ratio measured by computed 
tomography (CT). Therefore, the WHR appears to be a useful 
indirect measure of the relative amount of visceral adipose 
tissue, and this ratio in turn correlates well with many 
morbidities associated with obesity (Leibel et al., 1989). 
Houmard et al. (1991) found that the predictive 
strength of WHR on non-obese, middle to older aged males 
varies depending upon the measurement method used. They 
found that the WHR obtained from circumference measures at 
the level of umbilicus/maximal hip, level of umbilicus/level 
of greater trochanter, and minimal waist/maximal hip 
achieved the strongest relationships with indices of 
carbohydrate and lipid metabolism, body composition, and 
fitness level. The WHR measured at the level of the 
umbilicus/level of superior iliac spine was intermediate in 
terms of the strength of the associations. The WHR measured 
at the level of 1/3 of the distance between the xiphoid 
process and umbilicus/level of 4 cm below the superior iliac 
spine was not related to any metabolic or physiological 
variable. Ostlund, Staten, Kohrt, Schultz, and Malley 
(1990) found that WHR measured at the minimal waist/maximal 
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hip was more useful than the WHR measured at the level of 
the umbilicus/maximal hip in predicting the HDL2-C levels. 
Peiris et al. (1987) cited in Kissebah and Peiris (1989) 
found that WHR correlated highly with the intra-abdominal 
visceral fat mass even after controlling for the effects of 
age and degree of overweight. The simplicity of this method 
is an advantage for epidemiologic studies. 
Ultrasound and Radiography 
Muscle, bone, and fat cross-sectional areas can be 
assessed using ultrasound and radiographic analysis (McArdle 
et al., 1986). In the ultrasound method, the distance 
between the skin and the fat-muscle layer, and the distance 
between the fat-muscle layer and the bone are measured 
indicating thickness of fat and muscle at different sites. 
Lukaski (1987) reported a correlation of 0.80 (p<0.05) 
between ultrasonic measurements and skinfold thickness. 
Computed Tomography 
The computed tomography (CT) allows for radiographic 
images of different body sections.giving information on 
total tissue-fat area and intra-abdominal fat area. Using 
CT, Sjostrom (1988) found that the 4th or 5th lumbar 
vertebra separates males and females according adipose 
tissue distribution estimating the amount of visceral fat 
and the relative distribution of fat between the intra­
abdominal and extra-abdominal compartments. He found that 
adult males have 53% of their fat in the upper body, while 
females have 46% of their fat in the upper body. 
Limitat ions 
There are several scientific, theoretical as well as 
practical limitations associated with the procedures 
available for the determination of body fat. 
1. It is questionable whether any of the formulas 
represent sufficiently accurate predictions to be useful in 
practical applications (Hass et al., 1981). 
2. The generalized density values for lean and fat 
tissues of 1.10 and 0.90 g/cc, respectively, are average 
values for young and middle age adults. The assumptions 
that these values are constant, may not be entirely valid. 
3. The use of these formulas to estimate body fat in 
children and aging adults is questionable. For example, th 
density of the skeleton is probably in continual change 
during the growth period as well as during bone 
demineralization with aging. These facts would make the 
actual density of the lean tissue of young children and the 
elderly lower than the assumed values. As a result, an 
overestimation of relative body fat would occur with 
densitometry for children and the elderly (Durnin and 
Womersley, 1974). The variability in the protein:mineral 
ratio could lead to a variation in percent body fat of 2.1% 
(0.005 g/cc) in healthy subjects (Lukaski, 1987). 
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4. The measurement of body density by hydrostatic 
weighing requires complex laboratory equipment and very 
cooperative subjects. The technique is also more time 
consuming than the measurements of body density by SF 
measurements. The subjects cooperation is necessary for the 
under-water weighing technique, and it is unsuitable for 
most young children and elderly people. On the other hand, 
the use of SF as a measure of subcutaneous fat thickness is 
widespread because the technique is relatively easy, 
inexpensive and requires little equipment. SF measurements 
are suitable for nutrition surveillance and clinical 
evaluation (Himes, Roche & Webb, 1980). 
5. Lohman (1981) has pointed out that changes in the 
thickness of the subcutaneous fat from the elbow toward the 
shoulder are fairly large. If the point of application of 
the caliper is displaced by 2.5cm proximal, distal, medial, 
or lateral to the midpoint, the SF thickness changes on the 
average 2 to 3 mm. In addition, there are differences in 
skin compressibility that may become greater in older people 
(Durnin et al., 1974). In individuals with flabby, easily 
compressible tissue, the measurement presents a problem for 
obtaining valid measurements of SF thickness. 
6. The precision of a SF thickness measurement is 
dependent upon the skill of the person taking the 
measurements and upon the site measured. A precision within 
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5X could be attained easily by a trained individual 
(Lukaski, 1987). 
7. The accuracy of these measures is limited by the 
variability of the composition and density of the fat-free 
compartment in different individuals. 
8. There is little information on the distribution of 
fat in the body of the population at large. Therefore, the 
validity of using equations to predict body composition is 
restricted to populations from whom these equations were 
derived (Durnin & Womersley, 1974). 
9. Ultrasound and CT may be more accurate methods for 
predicting body fat, but generally they are not suitable for 
epidemiological studies due to the cost of these procedures 
(Lukaski, 1987). The cost and general availability of 
modern CT scanners prohibit the routine use of this 
instrumentation for body composition assessment. Another 
difficulty is the need for uniform and constant pressure 
applied by the probe to the scan site. Changes in pressure 
by probe application can affect the distribution of adipose 
tissue and bias the ultrasonic estimation of adipose 
thickness. Validation studies are needed using large 
populations of people with different amount of body fat. 
10. Even when the WHR provides a useful estimation of 
the proportion of abdominal or upper body fat, it does not 
distinguish between accumulations of deep abdominal fat and 
subcutaneous abdominal fat. 
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Relationship between Insulin, Glucose intolerance, 
and Non Insulin Dependent Diabetes Mellitus (NIDDM) with 
obesity measured by BMI and SK, and adipose tissue 
distribution measured as the WHR. 
The second National Health and Nutrition Examination 
Survey (NHANES II) found that 26% of Americans adults, or 
about 34 million people aged 20 to 75 years, are overweight. 
The survey used a BMI of 27.8 kg/m2 or greater for males and 
27.3 or greater for females to define overweight (NRC, 
1990). The NHANES II survey showed that for overweight 
adults aged 20 to 75 years, the relative risk of diabetes is 
2.9 times that for non-overweight people of comparable ages. 
Among overweight Americans aged 20 to 45 years, the relative 
risk for diabetes is 3.8 times that for non-overweight 
Americans in the same age group. Among overweight Americans 
aged 45 to 75 years, the relative risk for diabetes is 
almost twice that for non-overweight people in the same age 
group (Van Itallie, 1985). 
Lonnroth (1988) established that obesity is often 
associated with insulin resistance and type II diabetes (non 
insulin dependent diabetes mellitus [NIDDM]). 
Hyperinsulinemia accompanies obesity as a marker of the 
insulin resistance, and fasting plasma insulin levels 
correlated with the degree of obesity. Bagdade, Bierman, 
and Port (1967) found that fasting insulin levels of obese 
subjects (36uU + 17.6) were significantly higher (p<0.001) 
than in nonobese subjects (15ull + 4.8). Subjects with 25% 
of ideal body weight (IBW) according the Metropolitan Life 
Insurance Table were classified as obese, while subjects who 
were within 15% of IBW were classified as non obese. 
Recent studies indicate that the association between 
obesity and diabetes is highly influenced by the regional 
location of body fat, and that the abdominal (android 
pattern, central fat distribution, apple shape, male 
habitus) but not the gluteal (gynoid pattern, peripheral fat 
distribution, pear shape, female habitus) obesity is 
correlated with insulin resistance and glucose intolerance 
(Despres, Nadeau et al ., 1989; Freedman & Rimm, 1989; 
Haffner et al., 1987; Hartz et al., 1983; Landin, 
Krotkiewski & Smith, 1989). 
Vague (1956) found that abdominal fat distribution 
correlates with various metabolic aberrations related with 
NIDDM suggesting that obese subjects with an abdominal fat 
distribution are more prone than others to develop insulin 
resistance. In studies where selected obese subjects have 
been investigated (Haffner et al., 1987; Lundgren et al., 
1989; and, Ohlson et al., 1985), body fat measured as BMI or 
WHR represents two independent factors correlating with 
glucose intolerance. Several studies suggest that the risk 
contributions of WHR and BMI to NIDDM might be mediated via 
separate mechanisms. Hyperinsulinemia and insulin 
resistance are important factors for NIDDM (Bjorntorp, 
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1988b). Various investigators have found that BMI 
correlates positively with insulin secretion and, that WHR, 
when it is high, is associated with insulin resistance with 
a decreased hepatic clearance of insulin which contribute to 
the hyperinsulinemia characteristic of obesity (Holm & 
Krotkiewski, 1988). The increased insulin resistance might 
be due to increased insulin secretion by secondary down-
regulation of the insulin receptor (Bjorntorp, 1990; 
Kissebah and Peiris, 1989). There seems to be a consensus 
that NIDDM develops when there is a decrease in the 
effectiveness of the insulin produced. The association 
between obesity and NIDDM is probably due to insulin 
resistance in obesity. The tissues responsible for the 
impaired insulin response are those where insulin action is 
quantitatively important for glucose homeostasis including 
liver, muscles, and adipose tissue (Hunt & Groff, 1990). 
Some cellular events that account for the insulin resistance 
in obesity have been studied. The possibilities that could 
explain these events are: elevated counterregulatory 
hormones and/or target tissues defects. Two anti-insulin 
hormones that may play a role are Cortisol and androgens. 
Glucocorticoids in the presence of insulin markedly 
increase lipoprotein lipase (LPL) activity in vitro in human 
adipose tissue (Cigolini & Smith, 1979, cited by Leibel et 
al., 1989). Lipid synthesis by adipocytes is favored by 
high levels of LPL, insulin, glucose, and triglycerides 
(TG). Hydrolysis of stored TG is favored by circumstances 
tending to lower the availability of these substrates and 
hormones. Hormone sensitive lipase (HSL) catalyzes the 
breakdown of the TG molecule into three molecules of free 
fatty acids (FFA) and one molecule of glycerol. Hormone 
sensitive lipase can be activated or deactivated by beta-1 
or alpha-2 adrenergic receptors, respectively (Leibel et al. 
1989). Glucocorticoid receptor number is greater in omental 
than in abdominal subcutaneous adipose tissue, and this 
difference may explain the changes in fat distribution that 
occur when plasma corticosteroid concentration are 
chronically elevated (Rebuffe-Scrive, Lundholm & Bjorntorp, 
1985) . 
Androgens and body fat distribution 
Haffner et al. (1988) cited by Kissebah and Peiris 
(1989) found a highly significant decrease in the plasma 
level of sex hormone binding globulin (SHBG) and an increase 
in percent free testosterone (XFT) with increasing WHR in 
healthy, premenopausal females without significant history 
of hirsutism, amenorrhea, or clinical evidence of endocrine 
disorders. Since plasma levels of SHBG are determined 
largely by the androgen/estrogen balance, the decrease in 
SHBG and the increase in SKFT indicates a relative increase 
in androgenic activity. Kirschner and Samojlik, (1991) 
found that obese females with AO had higher free 
testosterone levels (98.8 + 39.2 vs. 82.2 + 33 pmol/1) and 
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lower SHBG levels (16.1 + 5.7 vs. 18.9 + 6.1 nmol/1) when 
compared with obese females with GFO (p<0.05). Decreased 
SHBG have been reported in obese premenopausal females 
(Kissebah, Peiris & Evans, 1988). Decreased SHBG and 
increased XFT levels have been observed in obese males who 
also demonstrated decreased total testosterone levels. 
The importance of androgenic/estrogenic activity on 
body fat distribution is supported by the following 
observat i ons: 
1. Vermeulen et al. (1969) cited by Kissebah and Peiris 
(1989) reported that the onset of androgen secretion in the 
pubertal male or administration of exogenous testosterone to 
the hypogonadal male is accompanied by localization of fat 
in the upper body and a decrease in SHBG levels. 
2. In subjects that had sexual transformation, after 
45-months of testosterone treatment, females increased upper 
body adipocyte cell volumes, while estrogen therapy in males 
increased fat cell number in the femoral area after 34-
months of treatment. No p-values were reported (Vague, 
Meignen & Negrin, 1984). 
3. Yen (1989) cited by Kissebah and Peiris (1989) 
reported an increased fat deposition and increased androgen 
production in females with polycystic ovary syndrome, 
obesity, and excess plasma androgens. Many of these females 
with polycystic ovary syndrome exhibit a predominance of 
upper body fat. 
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4. Sparrow, Bosse, and Rowe (1980) found a relationship 
between body fat distribution and hormone levels. They 
found that estradiol levels were higher in males with 
gluteofemoral obesity (r=0.22; p=0.03) and lower in males 
with abdominal obesity (r=-0.19; p=0.05) after controlling 
for age. 
Evans, Hoffmann, Kalkhoff, and Kissebah (1983) found 
that WHR was negatively correlated with SHBG (r=-0.49; 
p<0.001 ) and with SKfree testosterone (%FT) (r=0.44; p<0.001) 
in premenopausal females. This strong correlation between 
increased androgenic activity and WHR suggests that body fat 
distribution might be a manifestation of increased exposure 
to unbound androgens (Evans et al., 1983). The increased 
androgenic activity may influence the deposition of 
adipocytes in areas around the waist that are 
morphologically and metabolical1y different from those 
deposited in the gluteofemoral region. In addition, 
androgens could increase plasma FFA flux and overexpose 
hepatic and extrahepatic tissues to FFA. This mechanism is 
suggested by the following observations: Upper body 
adipocytes are larger than gluteofemoral adipocytes and 
exhibit high rates of basal and catecholamine stimulated 
lipolysis, maybe due to an increased beta to alpha 
adrenergic activities and to a diminish sensitivity to the 
anti1ipolytic action of insulin (Rebuffe-Scrive et al . , 
1987). Ostman et al. (1979) cited by Leibel et al (1989) 
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reported that the lipolytic sensitivity of the abdominal 
regions of adipose tissue was higher than that of the 
gluteal-femoral regions, especially the intra-abdominal, 
omental fat cells. Leibel and Hirsch (1985) reported an 
enhanced alpha-2 receptor activity in abdominal subcutaneous 
adipocytes of males, as compared to females. They suggested 
that this situation may contribute to a greater tendency of 
males to accumulate fat in the abdominal region. Richelsen 
(1986) found that alpha-2 receptor binding was increased by 
13% (p<0.01) in gluteal adipocytes of females in comparison 
to males. The increased in binding was due to a increase in 
receptor number (438 vs. 262 fmol/mg of protein; p<0.001). 
Rebuffe-Scrive (1988) found that the gluteofemoral 
depot is primarily a storage organ dedicated to such female 
stresses as pregnancy and lactation, and that the abdominal-
visceral depot is dedicated primarily to storage of easily 
and rapidly mobilizable energy reserves. Lactation was 
associated with an enhanced lipolytic response in femoral 
adipose tissue. It was not determined if this action was 
due to increased beta or decreased alpha-2 adrenergic 
activity. This anatomical and functional specialization is 
governed by the sex hormone balance. 
Upper body obesity is associated primarily with fat 
cell hypertrophy, whereas lower body obesity is associated 
primarily with fat cell hyperplasia. Enlarged fat cells 
have been demonstrated to be relatively resistant to insulin 
action in vitro (Stern & Haffner, 1986). According to 
Bjorntorp, et al. (1981) cited by Stern and Haffner (1986), 
adipose depots account for only about 5% of total body 
glucose disposal. Therefore, insulin resistance in this 
tissue alone should not produce significant total body 
insulin resistance. Insulin (a lipolytic inhibitor) has 
less effect on abdominal adipose tissue which may be due to 
a small number of insulin receptors. Abdominal adipose 
tissue is more easily mobilized and, when enlarged will 
cause elevations of circulating FFA in the portal vein. 
Obese females with abdominal obesity demonstrated an 
increased FFA flux despite higher plasma insulin levels 
(Leibel et al., 1989). The potential effects of elevated, 
circulating FFA on glucose transport and insulin resistance 
are more pronounced in abdominal obesity. Insulin 
resistance is also higher in abdominal obesity (Bjorntorp, 
1988b). Females specifically accumulate body fat in the 
gluteofemoral region. This characteristic is probably 
related by increased lipoprotein lipase activity in the 
gluteofemoral regions mediated by progesterone and estrogen 
(Bjorntorp, 1988a). In females with abdominal obesity and 
irregular ovulation there is an irregular production of 
progesterone, and the excess fat accumulates in the 
abdominal region (Hartz et al., 1983). Both androgens and 
corticosteroids may directly affect abdominal adipose tissue 
fat storage. 
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Insulin receptors in obesity 
According to Olefski and Kolterman (1981), the effector 
site of insulin on target cells is its specific receptor. 
The abnormalities of insulin binding at the receptor site 
are present with mild insulin resistance, and, with more 
severe insulin resistance, the postreceptor defects are also 
involved. Insulin concentration by itself can regulate 
insulin binding to target cells. 
High insulin concentrations decrease the affinity and, 
eventually reduce receptor number possibly by increasing 
receptor internalization. There are some explanations for 
the decrease in insulin binding in obesity with peripheral 
insulin resistance. It seems that increased insulin is 
followed by insulin receptor down regulation. Olefski 
(1976) cited by Bjorntorp (1988a) found a direct 
relationship between hyperinsulinemia and receptor loss in 
obesity. He also found obese patients with normal insulin 
binding, little insulin resistance, and normal plasma 
insulin levels. These previous observations suggest that 
the defects of insulin binding to target cells in obesity 
are secondary to high insulin plasma levels. 
Hepatic uptake of insulin in obesity 
After insulin is secreted by the pancreatic beta cells, 
insulin goes through the portal circulation where a major 
portion is normally taken up by the liver. A simple way to 
measure this insulin hepatic uptake is to measure the 
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peripheral molar concentration ratio of insulin/C-peptide. 
A high ratio indicates little hepatic insulin uptake because 
the C-peptide is not taken up by the liver. High insulin/C-
peptide ratios have been reported in obesity (Bjorntorp, 
1988a). Peiris et al. (1989) have shown a decrease in 
hepatic insulin uptake in abdominal obesity and a negative 
correlation between insulin clearance and WHR (p<0.05). 
Therefore, one might speculate that the peripheral 
hyperinsulinemia of abdominal obesity is at least partially 
due to a decrease in hepatic insulin uptake. Androgens may 
play a role since testosterone and dihydrotestosterone seem 
to inhibit hepatic insulin clearance in physiological 
concentrations (Kissebah et al., 1988). 
Analysis of selected studies 
The final section of this review of literature 
represents a critical analysis of four prospective studies 
(Table 1). This review includes a general description of 
the findings of each study, a review of the design of these 
studies (e.g., sample size selection), a review of the 
methods used to collect blood samples, a review of the 
methods used to measure body fat and body fat distribution, 
a review of the criteria used to diagnose diabetes mellitus, 
and finally, a review of the analytical methods used. 
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Study Parameters 
The main purpose of these four studies was to compare 
baseline characteristics of subjects who converted to NIDDM 
with those subjects who remained free of diabetes during the 
follow up period. 
The number of subjects in the four studies was 
relatively large. The sample size ranged from 146 in the 
study conducted by Bergstrom et al., (1990), to 1351 in the 
study conducted by Lundgren et al. (1989). Only females 
were studied in one study (Lundgren et al. 1989). Only 
males were included in two studies (Ohlson et al ., 1985; 
Bergstrom et al., 1990). Haffner, Stern et al. (1990) 
studied a mixed sample of 276 females and 198 males. 
The ages of the subjects in these studies ranged from 
25 to 64 years of age. Subjects were 25-64 years old in the 
Haffner, Stern et al. study (1990) and 54 years old in the 
Ohlson et al. study (1985). Lundgren et al. (1989) studied 
subjects aged 38, 46, 50, 54, 60 years old. 
Haffner, Stern et al. (1990) restricted their sample to 
those who were free of diabetes at the baseline examination 
in 1979-1982 and who attended the medical examination 8 
years later. The sample represented low income, middle 
income, and a cluster of suburban census tracts. 
The sample selection method varies among the studies. 
Lundgren et al. (1989) used a systematic sampling method 
based on date of birth to select their sample. Ohlson et 
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al. (1985) restricted their sample to males from Goteborg, 
Sweden born in 1913, and whose date of birth was divisible 
by 3. Subjects that were diabetics were excluded from the 
sample. Bergstrom et al. (1990) reexamined during the 
follow up period 146 of the nondiabetic males including 75 
NGT, and 71 IGT. The follow up period varied among the four 
studies ranging from 30 months in the study conducted by 
Bergstrom et al. (1990), to 13.5 years in the study 
conducted by Ohlson et al. (1985). 
Blood Sampling 
All studies used fasting blood samples for glucose 
concentration determination and similar blood collection 
procedures. In addition, Haffner, Stern et al. (1990) 
determined insulin and, glucose concentration 2-hours after 
a 75-g glucose load. Bergstrom et al. (1990) also 
determined glucose concentration after a 75g oral glucose 
load (Glucola) at 30, 60, 90, 120, and 180 minutes. In 
addition, plasma insulin, and C-peptide were analyzed. 
Serum glucose were measured by an automated glucose oxidase 
method. Plasma insulin and C-peptide were measured by 
radioimmunoassay. Lundgren et al. (1989) determined serum 
glucose concentration by the ferric cyanide reduction method 
adapted for autoanalyzer by Technicon N-26. In the follow 
up study the glucose oxidase method was used to analyze 
glucose levels. Ohlson et al. (1985) did not provide 
information about the procedure used for blood analysis. 
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Measures of Body fat 
All the studies (Haffner, Stern et al. , 1990; Lundgren 
et al. , 1989; Ohlson et al., 1985; and Bergstrom et al., 
1990) obtained skinfold measurements, weight, height, and 
controlled for the effect of BMI. Haffner, Stern et al. 
(1990) and Lundgren et al. (1989) obtain the skinfolds 
measurement from the right side of the body using a 
Harpenden's caliper. Ohlson et al. (1985) also used a 
Harpenden's caliper but they did not specify what side of 
the body the measurements were taken. Bergstrom et al. 
(1990) obtained the skinfold measurements from the left side 
of the body using a Lange caliper. Some of the 
investigators studied skinfolds ratios to assess fat 
distribution. Haffner et al. (1990) and Bergstrom et al. 
(1990) used the ratio of subscapular to triceps skinfold 
(STR) as a measure of central adiposity, and BMI as a 
measurement of general adiposity. Lundgren et al. (1989) 
used the sum of the subscapular and triceps skinfold (SF) to 
assess body fat. The waist circumference was measured to 
the nearest 1 mm at the level midway between the lower rib 
margin and the iliac crest using a steel tape measure. The 
hip circumference was measured to the nearest 1mm at the 
widest point between hip and buttocks. All the initial 
anthropometric measurements were performed by one observer 
in order to avoid inter-observer differences in the studies 
by Lundgren et al. (1989) and Ohlson et al. (1985). 
Ohlson et al. (1985) obtained the anthropometric 
measurements using a similar procedure used by Lundgren et 
al. (1989) for height, weight, BMI, and waist circumference. 
The hip circumference was measured at the level of the iliac 
crest. The parathoracic skinfold (midway between the axilla 
and iliac crest) was taken in addition to the triceps and 
subscapular skinfolds. Bergstrom et al. (1990) measured the 
cross-sectional body-fat areas (cm2) by CT. Four sites were 
examined: subcutaneous thorax, subcutaneous abdomen, 
subcutaneous thigh, and intra-abdominal area. 
Criteria for diagnosing diabetes mellitus 
Haffner, Stern et al. (1990), Lundgren et al. (1989), 
and Bergstrom et al. (1990) used the criteria of the World 
Health Organization (WHO) to diagnosed diabetes mellitus. 
Fasting plasma glucose level equal or greater than 7.8mM 
and/or 2-hour plasma glucose level equal or greater than 
11.1mM are indicative of diabetes. Bergstrom et al. (1990) 
initially classified subjects as normal glucose tolerance 
(NGT), impaired glucose tolerance "(IGT) or NIDDM. Ohlson et 
al. (1985) diagnosed subjects as diabetics if they were 
previously diagnosed as diabetics (by another doctor) or if 
fasting venous blood glucose was equal or greater than 7mM/l 
or a glucose value equal or greater than 10.0mM/l 2-hours 
after an oral glucose load of 100g. 
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Statistical Analysis 
Haffner, Stern et al. (1990) used analysis of 
covariance in which the STR was controlled for sex. The 
STR, fasting glucose, and insulin concentration were treated 
as categorical variables having the highest quartile 
compared with the lowest three quartiles. However, the 
results were similar when all risk factors were analyzed as 
continuous variables. Relative risk (RR) was calculated 
dividing the incidence in the highest quartile by the 
incidence in the lowest three quartiles. Both Lundgren et 
al. (1989), Ohlson et al. (1985), and Bergstrom et al. 
(1990) used Student t-test to evaluate the differences 
between baseline and follow up values. In addition, 
Lundgren et al. (1989), and Ohlson et al., (1985) tested 
correlations between graded and continuous variables by the 
Pitman's permutation test which is a nonparametric test for 
simple correlations and multivariate analysis. The Mantel-
Haenszel's procedure was used by Lundgren et al . (1989) when 
adjusting for confounding variables. All the statistical 
calculations controlled for age. 
In the study by Bergstrom et al. (1990) variables with 
skewed distributions were analyzed using the Wicoxon's rank-
sum test (a non-parametric procedure). The Pearson's 
correlation coefficient was used to measure linear 
association between fasting C-peptide levels and intra­
abdominal fat. In the univariate analysis of serum glucose 
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variables, subjects were subdivided into males initially 
classified with IGT or NGT. 
Summary of Study Results 
Generally, in the four studies, the subjects who 
converted to diabetes were older and had greater overall 
adiposity (BMI), more central adiposity (STR), higher SF, 
larger WHR, higher fasting and higher 2-hour glucose, higher 
fasting insulin levels, and higher C-peptide levels than the 
nonconverters to diabetes. In the study by Haffner, Stern 
et al. (1990) gender did not make a difference in the 
proportion of subjects who develop diabetes. 
The univariate analysis showed that BMI (p=0.009), STR 
(p=0.032), fasting insulin (p<0.001), and glucose 
concentration (p<0.001) (Haffner, Stern et al . , 1990), 
waist (p=0.0012) and WHR (p=0.0037) (Ohlson et al., 1985), 
and age (p<0.04), C-peptide (p<0.03), and glucose (p<0.001) 
(Bergstrom et al., 1990) were all significant predictors of 
the incidence of NIDDM. Haffner, Stern et al. (1990) found 
that subjects with IGT at baseline had 6.17 times greater 
risk of developing diabetes than subjects with NGT 
(p<0.001). Subjects in the highest quartile of the insulin 
distribution had 6.60 times the risk of conversion to 
diabetes as subjects in the lowest three quartiles 
(p<0.001 ). In the multiple logistic analysis where each 
factor was adjusted for all the other risk factors, fasting 
glucose (p<0.001) and insulin (p=0.006) concentrations 
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remained significantly associated with the incidence of 
NIDDM. 
Both, Lundgren et al. (1989) and Ohlson et al. (1985) 
found an increase in the incidence of diabetes in the upper 
quintile of BMI, SF, and WHR compared to subjects in the 
corresponding lowest quintile. Ohlson et al. (1985) found 
the risk for diabetes in the upper 5% of the distribution of 
the WHR was 16.6 times higher than the risk in the lowest 
quintile. Not a single subject in the lowest quintile of 
BMI developed diabetes as compared with 21.45K of those who 
did within the upper 5* of the BMI distribution. Lundgren 
et al. (1989) also found that the correlations between BMI, 
SF, and WHR and the incidence of diabetes were all 
significant (p<0.001). They also found that for females the 
incidence for diabetes in the upper quintile increased by 
8.0 times for BMI, 22.0 times for SSF, and 13.6 times for 
WHR compared to females in the corresponding lowest 
quintile. Lundgren et al. (1989) also found marked 
differences between mean values for BMI, SF, and WHR in 
females who developed and who did not develop diabetes. 
Nine percent of all the females belonged to the fifth 
quintile of WHR as well as of BMI. Forty four percent of 
the females who developed diabetes belonged to this group. 
Females with initially high WHR seemed to increase their 
serum glucose concentrations during the 12-year study period 
(p=0.02). The same relationship was not seen for BMI and 
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SF. An increase in BMI and SF was associated with an 
increase in fasting serum glucose concentration (p<0.001). 
On the other hand, an increase in WHR was not associated 
with an increase in serum glucose concentration (p=0.192). 
They concluded that both abdominal fat distribution as well 
as the total amount of fat were important risk factors for 
diabetes. 
Ohlson et al. (1985) found that all the anthropometric 
measurements were predictors of diabetes incidence. 
However, when BMI was accounted for, only the waist 
circumference (p=0.0012) and the WHR (p=0.0037) remained as 
predictors for the development of diabetes. After dividing 
the WHR and BMI into tertiles, they found that the risk of 
diabetes increased with increasing WHR within each tertile 
of BMI. The highest risk (15.2%) was observed in the 
highest tertile for both BMI and WHR while the lowest risk 
(0.5%) was found in the lowest tertile for both variables. 
They concluded that both the degree of obesity and the 
localization of the adipose tissue are risk factors for 
diabetes. The two factors seemed to be independent of each 
other and to potentiate each other as risks factors for the 
development of diabetes. 
Bergstrom et al. (1990) found that baseline fasting 
plasma C-peptide (p<0.005), baseline fasting glucose levels, 
and adjusted fasting C-peptide (C-peptide/glucose) (p<0.02) 
were higher in subjects who developed diabetes. Among the 
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71 males initially classified as IGT, the initial fasting 
glucose and 120-minute glucose levels were significantly 
elevated in those who subsequently developed diabetes. Age, 
C-peptide, and glucose levels at 120-minutes were 
independently predictive for NIDDM development. Only the 
initial intra-abdominal fat area assessed by CT was 
significantly higher in males who developed NIDDM (p<0.005). 
The STR also evaluated by Haffner, Stern et al. (1990) 
was not different between the two groups. The intra­
abdominal fat area and the fasting C-peptide levels were 
linearly correlated (r=0.263; p=0.002). Twenty percent (9 
of 45) of the males in the quadrant defined by high fasting 
C-peptide level and high intra-abdominal fat area 
subsequently developed NIDDM, while only 2.5% (1 of 40) 
developed diabetes in the quadrant defined by low fasting C-
peptide level and low intra-abdominal fat area. This 
longitudinal study was the first to demonstrate that an 
elevated fasting C-peptide level was associated with a 
greater risk of subsequently developing diabetes, and that a 
direct measure of intra-abdominal fat area as determined by 
CT was associated with the subsequent development of 
diabetes. They concluded that an increased fasting C-
peptide level and an increased deposition of intra-abdominal 
fat were antecedent events in the pathogenesis of NIDDM. 
Not one of these studies controlled for dietary intake 
or for physical activity which are two variables closely 
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related to the pathogenesis of NIDDM. In the studies where 
females were included (Haffner, Stern et al. 1990; Lundgren 
et al. 1989), no discrimination between premenopausal and 
postmenopausal females was made. 
Table 1 
Summary table for studies related to glucose, insulin. Non-Insulin Dependent Diabetes Mellitus. body fat and body fat 
distribution. 
Investigators Subjects Methodol ogv Blood Work Statistics Findings 
Haffner, Stern, 
Mi tchel1, Hazuda, 
and Patterson, 
1990. 
474 subjects 
from The San 
Antonio Heart 
Study. 
198 males and 
276 females 
Ages 25-64. 
Comparison of 
baseline character­
istics of subjects 
who converted to 
type II diabetes 
with those who 
remained free of 
diabetes after 8-
year follow up. 
STR=subscapular/ 
tricep SF ratio as a 
measure of central 
adipocity. Height, 
wt, BMI. 
Fasting glucose 
and insulin, 
and 2-hour 
glucose level 
after a glucose 
load. 
Analysis of 
Covariance, 
Multiple logis­
tic regression 
analysis. 
Relative 
risk=RR=inci-
dence in high­
est quartile/ 
incidence in 
the lowest 3 
quartiles. 
Converters to DM (6X) 
were older, greater BMI 
(p<0.001), greater STR 
(p<0.036), and higher 
fasting and 2-hour glu­
cose and fasting insulin 
(P<0.001) than non-
converters. BMI 
(p<0.009) STR (p<0.032), 
fasting insulin and 
glucose (p<0.001) were 
univariate predictors of 
the incidence of NIDDM. 
Fasting glucose and 
insulin remained associ­
ated with the incidence 
of NIDDM after adjusting 
for all the other 
variables. 
Lundgren, 
Bengtsson, Blohme, 
Lapidus, and 
Sjostrom, 1989. 
1351 Swedish 
women, ages 38, 
46, 50, 54, and 
60 years old. 
Correlation between 
initial AT amount 
and distribution and 
incidence of 
diabetes and change 
in serum blood 
glucose after a 12 
yrs of follow up. 
Ht, Wt, BMI, SF 
(sub-scapular and 
tricep). Waist girth 
taken between the 
lower rib margin and 
iliac crest. Hip 
girth taken at 
widest point between 
hip and buttocks. 
Fasting blood 
glucose. 
Student t-test, 
Pitman's non-
parametric 
permutation 
test. Mantel-
Haenszel's 
procedure used 
when adjusting 
for confounding 
variables. 
Converters to DM (3%), 
had higher BMI, SF, and 
WHR (p<0.001). During 
the 12-yrs follow up an 
increase in BMI and SF 
corr with an increase in 
glucose (p<0.001). Women 
with the initially high­
est WHR increased their 
glucose conc (p<0.02). 
The incidence of NIDDM 
in the upper quintile 
increased 8X for BMI, 
20X for SF, and 13.6X 
for WHR when compared to 
lower quintiles. The 
antropometric vars were 
corr with the incidence 
of diabetes (p<0.001). 
•f* 
Oh1 son, Larsson, 
Svardsudd, Wei in, 
Eriksson, 
Wilhelmsen, 
Bjorntorp, and 
Tibblin, 1985. 
792 Swedish men 
ages 54 years 
old. 
Comparison of 
baseline character­
istics of subjects 
who converted to 
diabetes after a 
13.5 years of follow 
up. Height, wt, BMI. 
SF were taken at 
triceps, subscapular 
and parathoracic 
(between axilla and 
iliac crest) area. 
Waist girth taken at 
the level of the 
umbilicus, and hip 
taken at the iliac 
crest level. 
Bergstrom, Newel 1-
Morris, Leonetti, 
Shuman, Wahl, and 
Fujimoto, 1990. 
146 Japanese-
American men 
ages 62, 
classified at 
baseline as: 
Normal glucose 
tolerance n=75, 
Impai red 
glucose 
tolerance n=71. 
Comparison of 
characteristics of 
subjects who con­
verted to diabetes 
after 30-months 
follow up study. 
Height, wt, BMI. 
Skinfolds taken at 
tricep, bicep, sub-
scapula, STR=subsca-
pular/tricep ratio. 
Cross-sectional body 
fat areas were 
determined by CT at 
4 sites: 
subcutaneous thorax, 
abdomen, and thigh, 
and intra-
abdominal=IAF. 
Fasting blood 
glucose. 
Student t-tegt, 
Chi-squared 
test. Pitman's 
permutation 
test, and 
Isotonic 
regression 
analysis. 
Converters to diabetes 
(6.3%) had higher WHR 
(p<0.0001). Glucose was 
corr to WHR (r=0.08; 
p<0.05). Risk for DM in 
the upper 5% distribu­
tion of WHR was 16.6X 
higher when compared 
with lower quintiles. 
In the upper 5X of the 
BMI distribution 21.4% 
developed diabetes. 
Waist (p<0.001) and WHR 
(p<0.0037) remained as 
predictors for the 
development of diabetes 
after adjusting for BMI. 
Risk of DM increased 
with increasing WHR 
within each BMI tertile. 
Fasting 
glucose, 
insulin, and C-
peptide. 
Glucose at 30, 
60, 90, 120, 
and 180 min 
after 75g of 
oral glucose 
load. 
Two tailed t-
test, 
Wilcoxon's rank 
sum test, 
Pearson's corr 
coeff, Stepwise 
multiple 
regression 
analysis. 
Converters to NIDDM 
(10.3%) had higher 
baseline C-peptide 
levels (p<0.005), higher 
C-peptide/glucose ratio 
(p<0.02), and higher IAF 
(p<0.005). C-peptide 
corr with IAF (r=0.26; 
p<0.002). In the quad­
rant defined by high C-
peptide and high IAF, 
20% developed DM versus 
2.5% in the low C-
peptide,low IAF 
quadrant. Age, C-
peptide, and glucose 
levels at 120-min were 
independently predictive 
for development of DM. 
-P". 
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The relationship between systolic blood pressure (SBP), and 
diastolic blood pressure (DBP) with obesity and body fat 
distribution. 
Obesity and blood pressure 
Considerable epidemiological and clinical evidence 
exists to support an association between obesity and 
hypertension. The National Health and Nutrition Examination 
Survey (NHANES II), a federal survey conducted in the 1970's 
on a sample of U.S. residents (Van Itallie, 1985) showed 
that overweight American adults aged 20 to 75 years were 2.9 
times more likely than non-overweight people to have 
hypertension. Hypertension was defined as 160 mm Hg or 
higher SBP or a 95 mm Hg or higher DBP, or both. Overweight 
people aged 20 to 45 years were 5.6 times more likely to 
have hypertension than were non-overweight people of the 
same age. The relative risk among overweight Americans aged 
45 to 75 years was double that of non-overweight people in 
the same age range. 
In the Framingham study (Kannel, Brand, Skinner, 
Dawber, & McNamara, 1967), the risk of developing 
hypertension increased with increased body weight. In the 
most obese group, 46% were hypertensive. In the same 
population, the prevalence of obesity was much greater in 
hypertensive than in normotensive. 
Epidemiological studies have demonstrated that age is 
positively correlated with blood pressure (BP), which is 
partly related to the increased adiposity associated with 
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aging (Lucas, Estigarribia, Darga, and Reaven, 1985; Gerber, 
Schnall, and Pickering, 1990). Industrialized populations 
gain weight as they age, and hypertension is prevalent in 
these populations (Dustan, 1985). 
Chiang, Perlman, and Epstein (1969) hypothesized that 
between 20 to 30% of hypertensive were 20% or more above the 
ideal weight. Recently, MacMahon, Cutler, Brittain, and 
Higgins (1987) found that approximately one-third of the 
prevalence of hypertension was attributable to obesity in 
males and in females aged 25 to 64 years. 
Adipose tissue distribution and blood pressure 
Recent studies indicate that adipose tissue 
distribution may also be a risk factor for hypertension. 
Some time ago, Vague (1956) reported his experience on the 
relationship between body fat distribution and the 
complications of obesity including hypertension. Vague 
noted that the metabolic and cardiovascular complications of 
obesity were associated with the accumulation of excess 
adipose tissue in the upper body (android pattern) including 
abdomen and chest. Obese subjects with a body fat 
distribution that favored the lower body, including the 
gluteal and femoral regions (gynoid pattern), were less 
likely to suffer from diabetes, hypertension, and 
cardiovascular diseases. Recently, the waist circumference 
(Gerber et al., 1990), the ratio of the intra-abdominal 
visceral fat area to the subcutaneous fat area (Kanai et 
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al., 1990), and the WHR (Landin et al., 1989) have been 
positively correlated with diastolic and systolic blood 
pressure. These studies suggest that central adiposity has 
more detrimental effects on blood pressure than peripheral 
fat accumulation. 
Relationship between insulin and blood pressure in obese 
subjects. 
There are associations between hypertension, impaired 
glucose tolerance, and obesity that suggest a common 
pathogenic mechanism. Gillum (1987), Landsberg and Krieger 
(1989), Lucas et al. (1985), and Rocchini (1991) suggested 
that variations in plasma insulin levels may play a role in 
the regulation of blood pressure. 
Ferrannini, Haffner, and Stern (1990) estimated that by 
the fifth decade of life, 8596 of diabetic individuals are 
hypertensive and obese, 80% of obese subjects have abnormal 
glucose tolerance and high blood pressure, and 67* of 
hypertensive subjects are both diabetic and obese. Insulin 
resistance and the resultant hyperinsulinemia are the key 
metabolic abnormalities that link hypertension, obesity, 
diabetes, and hyper 1ipidemia (Rocchini, 1991). Rocchini et 
al. (1989) using the euglycemic hyperinsulinemic clamp 
technique, found a significant inverse relationship between 
whole body glucose uptake and blood pressure in obese 
subjects. They also found a significant correlation between 
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DBP and fasting insulin concentration in obese adolescents 
(r=0.64; p<0.001). 
Data from the San Antonio Heart Study (Haffner, Stern, 
et al., 1990) showed that hyperinsulinemia is more common 
among Hispanics than among white non-Hispanics. However, 
the prevalence of hypertension is higher among the white 
non-Hispanics than among the Hispanics. Therefore, it seems 
that other factors besides hyperinsulinemia may play a role 
in the pathogenesis of obesity hypertension. 
The hyperinsulinemia of some obese subjects may 
contribute to the higher blood pressure among the obese as a 
result of insulin-induced renal sodium retention. Insulin 
may control blood pressure in obese subjects by a direct 
effect on renal sodium retention or by releasing 
norepinephrine (Landsberg, 1987). The sympathetic nervous 
system stimulates sodium reabsorption by direct effects on 
renal tubules, by inducing alterations in intrarenal 
hemodynamics and by stimulating the secretion of renin, all 
contributing to an increase in blood pressure. 
Rocchini (1991) recently proposed a mechanism to 
explain how insulin resistance may result in the development 
of hypertension. He stated that the degree to which insulin 
resistance is tissue- or pathway-specific may determine 
whether hypertension will develop or not. According to the 
schema presented by Rocchini (1991) insulin resistance could 
be selective (affecting primarily glucose metabolism), 
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tissue-specific (affecting primarily skeletal muscle even 
though liver, adipocytes, and leukocytes may also be 
affected), and pathway-specific (glycogen synthesis usually 
affected). Some of the mechanisms by which insulin 
resistance could result in hypertension include changes in 
vascular structure and function, alterations in cation flux, 
activation of the sympathetic nervous system, and increased 
renal sodium retention. 
The purpose of the last part of this section is to 
review and critically analyze five research papers published 
in the literature that specifically examined the effects of 
body fat distribution on blood pressure (Table 2). This 
section includes a review of the design of the studies, a 
review of the methods used to determine blood pressure, a 
review of the methods to determine body fat and body fat 
distribution, and finally, a review of the analytical 
methods used. 
These five studies represent relatively diverse 
populations from Sweden (Landin et al., 1989), Japan (Kanai 
et al . , 1990), Nigeria (Adams-Campbell et al., 1990) and the 
United States (Gerber et al., 1990; Peiris et al., 1989; 
and, Adams-Campbell et al., 1990). These studies are 
unusual because four of the five studies included only 
females, while Gerber et al. (1990) included only males. 
From an epidemiological perspective, the sample size in four 
of these studies was relatively small. The sample size 
ranged from 33 (Peiris et al . , 1989) to 305 (Adams-Campbell 
et al., 1990). The total sample was divided into subsamples 
in several studies which were used to compare differences 
between populations living in different countries (e.g., 
Adams-Campbell et al., 1990), differences between 
normotensive vs. borderline hypertensive vs. hypertensive 
populations (Kanai et al., 1990), and a group of 40 Swedish 
females who were matched according to lean vs. obese status 
as well as WHR using a 2x2 design (Landin et al., 1989). 
The age ranges of these populations were quite 
different. The population evaluated by Adams-Campbell et 
al. (1990) included very young adult females ranging in age 
from 18.6 to 22.4 years while Landin et al. (1989) studied 
middle-aged females 54-56 years of age. The mean age of the 
population evaluated by Peiris et al. (1989) was 32.2 + 0.6 
years. Thus, these studies controlled for the effects of 
age by using a narrow age range in their research. The 
range in age varied from 31-73 years of age (Kanai et al., 
1990) to 30-60 years (Gerber et al., 1990). Gerber et al. 
(1990) and Kanai et al. (1990) controlled for age in their 
multiple regressions analyses. In the former study, age was 
significantly associated with most measures of BP. 
WHR was defined using the umbilicus as a landmark in 
three studies (Landin et al., 1989; Kanai et al., 1990; and 
Adams-Campbell et al., 1990) while Gerber et al. (1990) and 
Peiris et al. (1989) used the smallest circumference at the 
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abdominal region. BMI was also used as an estimate of body 
fat by (Kanai et al., 1990; Adams-Campbell et al., 1990; 
and, Gerber et al., 1990). Landin et al. (1989) calculated 
body fat from estimates of LBM based on total body potassium 
measurements and Peiris et al. (1989) used hydrostatic 
weighing to estimate body fat. Kanai et al. (1990) and 
Peiris et al. (1989) used CT to measure subcutaneous and 
intra-abdominal body fat. Skinfolds were used by Kanai et 
al . (1990) and Peiris et al. (1989) to estimate subcutaneous 
fat. 
Blood pressure measurements in all studies were 
obtained using the same general equipment (i.e., standard 
mercury sphygmomanometers). Adams-Campbell did not report 
the "positional" state of the subjects when BP was measured. 
Landin et al. (1989) measured BP when the subjects had been 
in a supine position for at least 10 minutes while the other 
investigators measured BP of subjects in the sitting 
position. Gerber et al. (1990) examined the effects of body 
fat distribution on ambulatory, sitting, and supine (during 
sleep) BP. 
Descriptions of all independent and dependent variables 
were made using descriptive statistics (e.g., means, 
standard deviations, and standard errors). All 
investigators except Landin et al. (1989) used correlation 
coefficients to identify any significant associations 
between selected dependent and dependent vari ables. Li near 
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and multiple regression analyses were used in all studies to 
measure the relative contribution of each of the selected 
dependent measures on BP. Landin et al. (1989) evaluated 
differences between groups using the Pitman's non-parametric 
test. It is not clear if the other investigators determined 
if their data were normally distributed. Peiris et al. 
(1989) used Canonical correlations to determine the 
relationships between the entire set of selected metabolic 
variables with the set of selected anthropometric variables. 
Kanai et al. (1990) used the student t-test for unpaired 
data to determine statistical differences in the selected 
dependent and independent variables. P-values were reported 
for all studies; however, only Landin et al. (1989) clearly 
established that they used the p<0.05 a-priori for their 
statistical analyses. 
Results of these investigations did not consistently 
support the hypothesis that a strong association was present 
between body fat distribution and BP. Landin et al. (1989) 
reported that SBP was higher in obese females with a high 
WHR (WHR>0.8) compared to lean females with a high WHR as 
well as lean females with a low WHR (WHR<0.8; p<0.05). DBP 
was about 30mmHg higher (p<0.01) among obese females 
compared to lean females regardless of body fat 
distribution. However, there was no significant difference 
in DBP between females according to high vs. low WHR 
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suggesting that obesity in general, but not body fat 
distribution affected BP in this group of females. 
Gerber et al. (1990) did not find any significant 
association between WHR and any measure of BP; however, 
waist (r=0.20) and hip circumferences (r=0.22) were 
significantly associated (p<0.01) with sleep (supine) SBP. 
Waist circumference was highly correlated (p<0.01) with 
weight (r=0.87), hip circumference (r=0.94), and BMI 
(r=0.83). Using stepwise multiple regression, waist 
circumference was predictive of both sleep SBP and DBP. 
Kanai et al. (1990) did not find any significant 
difference in WHR among 67 Japanese females according to 
their BP status (i.e., hypertensive vs. borderline 
hypertensive vs. normotensive). Using CT to measure intra­
abdominal visceral fat (VF) and subcutaneous fat (SF), the 
VF/SF ratio was significantly higher (p<0.01) in the 
hypertensive vs. the normotensive groups. After adjusting 
for age and BMI, VF/SF ratio was positively correlated with 
SBP (r=0.62; p<0.001) and DBP (r=0.53; p<0.001). 
Adams-Campbell et al. (1990) found that Nigerian 
females had the largest WHR, and also had significantly 
higher DBP than white females. Among black American 
females, the BMI (r=0.24; p<0.05), waist circumference 
(r=0.22; p<0.05), and hip circumference (r=0.19; p<0.05) 
were significantly correlated with SBP after controlling for 
age. Among whites, SBP was correlated with BMI (r=0.34; 
p<0.01 ), with waist circumference (r=0.40; p<0.001), with 
hip circumference (r=0.33) p<0.01), and with the WHR 
(r=0.25; p<0.01). Among Nigerian females no significant 
correlations were found between BP and the anthropometric 
measures. 
Peiris et al. (1989) reported that both SBP and DBP 
were correlated with abdominal fat area determined by CT 
(r=0.52 for SBP, r=0.55 for DBP, p<0.01); the WHR (r=0.55 
for SBP, r=0.45 for DBP, p<0.01), and total body fat mass 
(r=0.38 for SBP, r=0.42 for DBP, p<0.05). No significant 
correlation was found between SBP or DBP with subscapular SF 
or the subscapular/tricep SF ratio. 
Table 2 
Suaaary table -for studies related to body fat, body fat distribution, sistolic, and diastolic blood pressure. 
Investi gators Subjects Measurements taken Blood Work Statistics 
Peiris, Sothmann, 
Hoffmann, Hennes, 
Wilson, Gustafson, 
and Kissebah. 
1989. 
33 healthy 
premenopausal 
women. 
Ages: 32.2 + 
0.6 
Body fat estimated 
from body density by 
hydrostatic weigh­
ting. Intra­
abdominal fat area 
estimated by CT at 
the 4th lumbar 
vetebrae level. 
Waist circumference 
taken at minimal 
waist circumference. 
Hip circumference 
taken at the maximal 
hip girth. Lange 
caliper were used 
for subscapular and 
tricep skinfold 
measurement. 
OGTT, Fasting 
insulin, 
cholesterol, 
and HDL-C. 
Mean + SE, 
Linear 
regression 
analysis. 
Multivariate 
regression 
analysis. 
Gerber, Schnall, 
Pickering 1990. 
135 non-obese 
normotensive or 
mildly 
hypertensive 
men. 
Ages: 30-60. 
BMI, WHR, waist 
taken at minimum 
girth abdomen area. 
Hip taken at maximum 
hip area circumfer­
ence. The effect of 
body fat distribu­
tion on ambulatory, 
sitting, and supine 
position blood 
pressure was 
assessed. 
Stepwi se 
multiple 
regressi on 
procedure. 
Findings 
Total body fat mass, CT, 
WHR, subscapular SF, and 
subscapular to tricep SF 
ratio were positive 
corr. with cumulative 
insulin response and 
triglyceride 
concentration (p< 0.01). 
Intra-abdomi nal fat 
area, WHR, subscap SF 
and subscap:tricep were 
inversely related to 
HDL/chol levels (p< 
0.05). Intra-abdom. fat 
area and total body fat 
mass correlated with SBP 
and DBP (p<0.01). WHR 
corr with SBP (r=0.55) 
and DBP (r=0.45) pc0.01. 
Visceral fat mass by CT 
was a predictor of SBP 
and DBP (p<0.05). 
Mean ambulatory work BP 
> home BP > sleep BP. 
Waist (r=0.26) and hip 
circumference (0.22) 
corr with sleep SBP and 
DBP (p<0.01). WHR not 
corr w/ any BP 
measurements. Waist 
girth highly corr with 
wt (r=0.87), hip 
(r=0.94) and BMI 
(r=0.83) p<0.01. In 
Stepwise procedure waist 
was predictive of sleep 
SBP and C3P explaining 
7X of the variance. 
Landin, 
Krotkiewski, and 
Smith 1989. 
Forty Swedish 
lean and non-
obese post­
menopausal 
women. Ages 54-
56. 10 lean 
women WHR>0.8 
were matched 
for 8F and LBM 
with 10 lean 
women WHR<0.8. 
Ten obese women 
WHR>0.8 were 
matched for 
age, fat, and 
LBM with 10 
obese women WHR 
<0.8. 
Waist girth was 
measured at the 
umbilicus level. 
Hip girth was 
measured over widest 
part of hip area. 
Total body potassium 
was determined to 
assess LBM. 
Body fat=body wt-
LBM. 
Kanai, Matsuzawa, 
Kutani, Keno, 
Kobatake, Nagai, 
Fujioka, Tokunaga, 
and Tarui, 1990. 
67 Japanese 
obese women. 
33 hyper­
tensives (HP), 
9 borderline 
hypertensive 
(BHP), and 25 
normotensi ves 
(N). Ages 31-
73. Mean=50 + 
11 years. 
Women with 
SBP>160 mmHg 
and DBP>95 mmHg 
= HP. 
Women with 
SBP<140 mmHg 
and DBP<90 = N. 
Women with SBP 
between 140 and 
159 and with 
DBP between 90 
and 94 were 
classified as 
BHP. 
Height, weight, BMI. 
For WHR, waist girth 
was measured at the 
umbilicus level, hip 
girth was taken at 
the widest 
circumference over 
the greater 
trochanter. 
Triceps, 
subscapular, and 
periumbilicar 
skinfold were taken 
with an Eiyoken 
cal i per. 
Subcutaneous and 
i ntra-abdomi nal 
visceral fat area 
were measured by CT 
at the umbilicus 
level. 
0GTT, fasting 
glucose, 
insulin, 
cholesterol and 
triglycerides. 
Fasting serum 
TG, TC, HDL-C, 
OGTT, glucose, 
and insulin. 
Mean + 3D. 
Linear 
regression 
analysis. 
Pitman's non-
parametric test 
to test 
di fferences 
between groups. 
Mean + SO. 
Student t-test. 
Linear and 
multiple 
regression 
analysis. 
SBP higher in obese 
women WHR>0.8 than in 
nonobese groups p<0.05. 
DBP was higher in obese 
women compared with the 
lean (p<0.01). For DBP 
no diff found according 
WHR. TG were higher in 
the obese women with 
WHR>0.08 than in both 
groups of lean women. 
No diff. found between 
the non-obese groups. 
Obese women had higher 
fasting glucose, and 
glucose levels at 30 min 
during OGTT than lean 
groups (p<0.01). 
No differences in WHR 
between HP and N. 
Vi sceral/subcutaneous 
fat ratio (V/S) was 
higher in HP than in N 
group (p<0.01). 
Positive correlation 
between V/S and SBP 
(r=0.62; p<0.001) and 
with DBP (r=0.53; 
p<0.001) after adjusting 
for age and BMI. No 
significant correlation 
between WHR and BP in 
any group. 
Adams-Campbel1, 
Nwantwa, Okoli, 
Omene, Haile, and 
Kuller, 1990. 
93 Black 
American women 
(BAW). 88 
White American 
(WA), and 124 
Nigerian Women 
(NW). Ages 18.6 
to 22.4. 
Height, weight, WHR 
BMI. Wai st gi rth 
was taken at the 
umbilicus level. 
Hip girth was taken 
at widest part of 
the buttocks. 
BMI>30 Kg/mz= obese 
30>8MI>24.1= 
overwei ght, and 
BMK24.1 Kg/m2 = 
lean. 
Pearson's 
Product Moment 
Correlation 
Coeffi ci ent. 
Analysis of 
Variance. 
BAW more overweight and 
obese than WAW and NW. 
NW had the highest WHR, 
and and higher OBP than 
BAW and WAW. Among BAW, 
BMI (r=0.24), waist 
(r=0.22) and hip 
(r=0.19) were correlated 
with 3BP after 
controlling for age 
(p<0.05), but not corr 
with DBP. Among WAW 3BP 
corr with WHR (r=0.25; 
p<0.01), waist (r=0.40; 
p<0.001), hip (r=0.33; 
p<0.01, and with BMI 
(r=0.34; p<0.01). DBP 
was corr with BMI 
(r=0.2l; p,0.05). Among 
NW no significant 
correlations were found 
between BP and 
anthropometric measures. 
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Body Fat, Body Fat Distribution, Plasma Lipoproteins, and 
Coronary Heart Disease. 
The association between obesity and alterations in the 
lipid and lipoprotein profiles has long been recognized in 
the literature. The results from NHANES II revealed that 
the relative risk of hypercholesterolemia for overweight 
Americans aged 20 to 75 years is 1.5 times that of those who 
are not overweight (Van Itallie, 1985). Overweight was 
defined as a BMI > 27.8 for males, and a BMI > 27.3 for 
females. Among overweight Americans aged 20 to 45 years, 
the relative risk of hypercholesterolemia is 2.1 times that 
of non-overweight Americans in the same age group (Van 
Itallie, 1985). 
Pouliot et al. (1989) found that in non-obese 
premenopausal females, total adiposity measured by CT was 
negatively correlated with HDL apo A-1/LDL apoB (r=-0.47; 
p<0.05), and positively correlated with LDL-C (r=0.46; 
p<0.05), and with LDL-apo B (r=0.51; p<0.05). In a sample 
of obese premenopausal females, Despres, Moorjani et al. 
(1989) found that adiposity measured as BMI was negatively 
correlated with HDL-C (r=-0.32), HDL2-C (r=-0.30), HDL3-C 
(r=-0.28), and the ratio of HDL-C/LDL-C (r=-0.30) p<0.05. 
Similarly in males, Terry, Wood, Haskell, Stefanick, and 
Krauss (1989) found that BMI was negatively correlated with 
HDL-C (r=-0.32; p<0.01), and HDL2 (r=-0.31; p<0.01). 
Landin et al. (1989) studied the associations between 
the proportions of abdominal fat (estimated by the WHR) and 
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TC in a group of lean and obese postmenopausal females. 
They found that TC was lower in obese females with low WHR 
compared with obese females with high WHR (p<0.05). No 
differences in TC levels were found in the lean group 
according to WHR, suggesting that obesity is a necessary 
condition for the association between fat distribution and 
plasma cholesterol concentration. 
Other studies (Table 3) have demonstrated that 
variations in plasma lipids and lipoproteins are related to 
the regional distribution of body fat (Despres, Moorjani et 
al., 1989; Terry et al . , 1989; Pouliot et al., 1989; 
Freedman et al., 1990; Meilahn et al., 1991; Peeples, 
Carpenter, Israel, and Barakat, 1989; and, Van Gaal et al., 
1989). Fujioka, Matsuzawa, Tokunaga, and Tarui (1987) were 
the first to suggest that the amount of visceral fat is 
important to consider when assessing the association between 
body fat distribution and lipoprotein levels. 
Investigators who have used CT and or WHR to evaluate 
regional body fat distribution have found that females with 
a higher proportion of abdominal fat tend to have increased 
LDL-C, triglycerides, Apo B levels, and decreased HDL-C 
levels (Despres, Moorjani et al., 1989; Pouliot et al., 
1989). These studies suggest that the relationship between 
obesity and HDL-C levels is primarily explained by the 
amount of abdominal fat. Despres, Moorjani et al. (1989) 
found that abdominal fat measured by CAT, independent of 
total body fat, was negatively correlated with HDL-C 
(r=-0.35; p<0.01), HDLZ-C (r=-0.37; p<0.01), HDL-C/LDL-C 
(r=-0.40; p<0.01), and HDL2-C/HDL3-C (r=-0.32; p<0.05) 
ratios. They also found negative correlations between WHR 
and HDL-C (r=-0.47; p<0.001), HDLZ-C (r=-0.43; p<0.01), and 
HDL3-C (r=-0.44; p<0.01). 
Role of the Lipoprotein Lipases 
Lipoprotein lipases (LPL) and hepatic-1ipases (HL) play 
important roles in lipoprotein metabolism. Nikkila, 
Taskinen, and Kekki (1978) found that high LPL activity in 
adipose tissue was associated with high HDL levels (r=0.66; 
p<0.001), while high HL activity has been associated with 
low HDL levels. Despres, Ferland et al. (1989) examined the 
association between LPL, HL and plasma lipoprotein levels in 
16 obese premenopausal females. They found that HL activity 
was negatively correlated with HDL2-C (r=-0.60; p< 0.05), 
but positively correlated with deep abdominal fat after 
adjusting for total adiposity (r=0.48; p< 0.05). HL may 
play a role in the catabolism of HDL2 or in the conversion 
of HDLZ to HDLg. The mechanism by which intra-abdominal fat 
accumulation is correlated with plasma HL activity is 
unknown. This relationship may also be affected by sex 
steroids that are associated with regional body fat 
distribution (Rebuffe-Scrive, 1988). 
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Role of sex steroids 
Obese females with a high proportion of abdominal fat, 
had higher plasma free testosterone levels, and lower sex 
hormone binding globulin (SHBG) than obese females with a 
peripheral fat accumulation, suggesting that obese females 
with high androgenic activity could be at higher risk of 
developing CHD (Leibel, 1989). 
Tikkanen and Nikkila (1987) reported that sex steroids 
affect plasma HDL2-C levels by up- or down-regulating the HL 
activity. Steroids with androgenic activity increased the 
HL activity and reduced plasma HDLZ-C levels, while 
estrogenic Steroids decreased HL activity and increased 
HDL2-C concentrations. 
Estrogens may also increase HDL-C by increasing 
apo A-1 synthesis. Apo A-1 is the major proteic component 
associated with HDL and apo B is the major proteic component 
associated with VLDL and LDL (Hunt and Groff, 1990). These 
results indicate that variations in sex steroids may 
represent an important factor for the association between 
intra-abdominal fat and HL activity. These studies contrast 
with the results by Soler, Folsom, Kaye, and Prineas (1989) 
who found that WHR was significantly associated with plasma 
TG (beta=2.17 + 0.65), HDL-C (beta=-52.4 ± 19.5), apo A-1 
(beta=-73.4 + 32.0), and apo B (beta=75.8 + 30.4) p<0.05 
after adjusting for insulin, sex hormone binding globulin 
(SHBG), and estrone level. These results suggest that other 
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mechanisms besides sex hormone levels affect the fat 
distribution-!ipoprotein association. 
Role of glucocorticoids 
Glucocorticoids may affect the body fat distribution-
lipids association. A higher Cortisol production rate has 
been reported in subjects with abdominal obesity compared to 
individuals with peripheral fat accumulation (Vague et al., 
1985) cited by Bjorntorp (1988a). According to Bjorntorp 
(1991) high Cortisol levels in abdominal obesity may lead to 
an increased VLDL production and subsequently to a decreased 
clearance of LDL through the apo B, and E receptor. 
The precise role of obesity in the etiology of coronary 
heart diseases is not clear. According to the studies of 
Larsson et al. (1984), and Lapidus, Bengtsson, Larsson, 
Pennert, Rybo, and Sjostrom (1984) the changes in plasma 
lipid and lipoprotein profile after several years of follow 
up could be partly responsible for the relationship between 
body fat distribution and the incidence of coronary heart 
disease (CHD). Since dyslipoproteinemic states have been 
associated with the development of CHD, the relationship of 
fat distribution to plasma lipids and lipoproteins could be 
an additional factor linking abdominal fat to CHD (Despres, 
1991 ). 
Various prospective studies on the relationship between 
body fat distribution and CHD have been reported in the 
literature. Higgins, Kannel, Garrison, Pinsky, and Stokes 
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III (1988) reported that the relative risk of death 
increased 1.5 for males and 1.3 for females in the fifth 
quintile values of BMI, waist girth, and waist/height ratio 
in the Framingham study (a 24-year follow up study for the 
incidence of CHD for males and females). In addition, 
within each tertile of BMI the risk of CHD increased with 
increasing subscapular skinfold thickness. In the Honolulu 
Heart Program (a 12-year follow up study in males), the risk 
of CHD doubled in highest tertile compared to lowest tertile 
of SSF (p< 0.01) (Donahue, Abbott, Bloom, Reed, and Yano, 
1987). Larsson et al. (1984) reported that WHR was a 
significant predictor for stroke and CHD even after 
adjusting for the degree of obesity. Within each tertile of 
BMI, the risk of stroke, CHD, and death doubled in the 
highest WHR tertile compared to the lowest WHR tertile. 
Similarly, in a prospective study of females by Lapidus et 
al. (1984), the WHR was the best anthropometric predictor 
for CHD. The probability of remaining free from CHD was 
higher for those in the lowest quintile of WHR than for 
those in the highest quintile. Among females with the 
lowest WHR not a single females developed myocardial 
infarction or stroke. When they compared females in the top 
5% of the distribution with females in the lowest quintile 
for WHR, the risk ratios were 14.8 for myocardial 
infarction, 11.0 for stroke, and 4.8 for death from any 
cause. 
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These previous prospective studies consistently show 
that truncal or abdominal fatness assessed either by 
skinfolds or circumferences, is a risk factor for CHD. 
However, these findings do not mean that abdominal fatness 
causes CHD since there are other possible explanations for 
the association between obesity (including abdominal 
obesity) and CHD, (e.g., diet, exercise, stress, smoking, 
environment, and genetic predisposition among others). 
Adiposity is also associated with the prevalence of 
hypertension, glucose intolerance, and hyperinsulinemia. 
Bjorntorp (1985) has suggested that the association between 
obesity and CHD is moderate because a lag period occurs 
prior to the detection of complications associated with 
obesity. 
The last part of this section consists of a 
critical review of seven cross-sectional studies published 
in the literature that examined the relationship between 
body fat distribution, lipids, and lipoproteins profile 
(Table 3). 
Study Parameters 
These studies were conducted using different 
populations. Both Pouliot et al. (1989); and, Despres, 
Moorjani et al. (1989) examined Canadian lean and obese 
premenopausal females, respectively. Van Gaal et al. (1989) 
examined a group of Belgian males and females. The other 
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four studies were conducted in the United States, and 
included a mixed sample of American males and females. 
The ages of subjects ranged from 30 in the study by 
Terry et al. (1989) to 60 in the study by Peeples et al. 
(1989). Van Gaal et al. (1989) did not report subjects' 
ages. 
The sample size in these studies ranged from nine pairs 
of males (Peeples et al. 1989) matched for age and body fat, 
but differing in WHR, to 415 females and 709 males studied 
by Freedman et al. (1990). Meilahn et al. (1991) used a 
relatively large sample consisting of 429 females who were 
divided according menopausal state. Van Gaal et al. (1989) 
classified the 43 males and the 148 females according to 
major area of fat deposition (e,g., abdominal or 
gluteofemoral). Terry et al. (1989) studied males below 
140% of ideal body weight, while Pouliot et al. (1989) and 
Jespres, Moorjani et al. (1989) studied a group of lean 
premenopausal females, and a group of obese premenopausal 
females, respectively. 
Anthropometric measurements 
WHR and BMI were used as an estimate for body fat 
distribution, and as an estimate of general obesity, 
respectively, in all seven studies. However, the 
measurement site for the waist and the hip circumferences 
were not consistent among the studies. Freedman et al. 
(1990); and Terry et al. (1989) measured waist circumference 
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at the umbilicus and hip circumference at the widest part of 
the hips and buttocks. Van Gaal et al. (1989), and Peeples 
et al. (1989) measured waist circumference at the umbilicus 
but measured hip circumference in the iliac crest. Meilahn 
et al. (1991), Despres, Moorjani et al. (1989), and Pouliot 
et al. (1989) measured waist circumference at the smallest 
area of the torso and hip circumference at the widest part 
of the hips and buttocks. 
Body density was determined by hydrostatic 
weighing and percent body fat was calculated from body 
density using Siri's equation in four of the seven studies 
(Pouliot et al., 1989; Peeples et al. , 1989; Terry et al., 
1989; and Despres, Moorjani et al., 1989. Despres, Moorjani 
et al. (1989) and Pouliot et al. (1989) used computed axial 
tomography for the determination of deep and subcutaneous 
abdominal adipose tissue at the thoracic level (Th8-Th9) and 
at the abdominal level (L4-L5), and at the mid-thigh region 
adipose tissue (mid distance between the knee joint and the 
iliac crest). Both groups of investigators used the same 
scanner and the same procedure. Despres, Moorjani et al. 
(1989) found a close correlation (r=0.94, p<0.0001) between 
the adipose tissue volume obtained by computed tomography 
and body fat mass derived from hydrostatic weighing. SF 
thicknesses were used to estimated body fat and body fat 
distribution in only one of the studies (Terry et al., 
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1989). The subscapular to triceps skinfold thickness ratio 
(STR) was used as an estimate for central adiposity. 
Blood work 
Six studies determined TC levels, TG, and HDL-C. In 
addition, Meilahn et al. (1991), Despres, Moorjani et al. 
(1989), and Pouliot et al. (1989) determined HDL-C, HDL2-C, 
and HDLg-C. Freedman et al. (1990) and Peeples et al. 
(1989) determined the TC/HDL-C ratio, and ApoA-1. Van Gaal 
et al. (1989) determined LDL-C and the TC/HDL-C ratio that 
they used as an atherogenic index (Al). Despres, Moorjani 
et al. (1989), Pouliot et al. (1989), and Terry et al. 
(1989) in addition to the basic lipoproteins and lipids, 
determined a variety of lipoprotein subfractions and ratios. 
Statistical Analysis 
Pouliot et al. (1989), Freedman et al. (1990), Terry et 
al. (1989), and Despres, Moorjani et al. (1989) used the 
Pearson's product-moment correlation coefficient and partial 
correlations adjusting for other measures of adiposity to 
measure relationships between variables. Meilahn et al. 
(1991) used nonparametric tests to assess associations 
between variables. Freedman et al. (1990), Van Gaal et al . 
(1989), Peeples et al. (1989), and Despres, Moorjani et al. 
(1989) used a t-test to assess differences in lipids and 
lipoproteins among groups. Meliahn et al. (1991), Freedman 
et al. (1990), and Despres, Moorjani et al. (1989) used 
multiple regression analysis to evaluate the variance in TC, 
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lipoproteins, and apoproteins levels that could be explained 
by body fat, and body fat distribution. 
Results 
Van Gaal et al. (1989) found that males with abdominal 
obesity (AO) had higher TG (p<0.05) and lower HDL-C 
(p<0.005) than males with GFO, while females with AO had 
higher levels of TG (p<0.001) and TC (p<0.05) than females 
with GFO. Similarly, Peeples et al. (1989) found that males 
with AO had higher TG (89 ± 13 vs. 151 ± 12), TC/HDL-C (3.39 
+ 0.5 vs. 4.95 + 0.4), and Apo B levels (95 + 7 vs. 138 + 8) 
than males with GFO (p<0.05), but lower levels of HDL-C (53 
+ 7 vs. 38 + 4), Apo A-1 (100 ± 7 vs. 84 ± 8), and Apo A-1/ 
Apo B ratio (1.11 + 0.19 vs. 0.64 + 0.05) than males with 
GFO (p<0.05). Terry et al. (1989) found that after 
adjusting for %BF and STR, the WHR was negatively correlated 
with HDL-C (r=-0.32; p<0.01), and positively correlated with 
TG (r=0.27; p<0.05). 
Freedman et al. (1990) also found a positive 
correlation between WHR and TG (males; r=0.37, females; 
r=0.38; p<0.001), TC (males; r=0.27, females; r=0.26; 
p<0.001), apo B (males; r=0.30, females; r=0.34; p<0.001), 
TC/HDL-C (males; r=0.35, females; r=0.30; p<0.001), and a 
negative correlation between WHR and HDL-C (males; r=-0.22, 
p<0.001, females; r=-0.14, p<0.01), and apo A-1 (males; r=-
0.14, p<0.001). However, it is not clear if these 
correlations were adjusted by other measures of general 
obesity. Despres, Moorjani et al . (1989) found similar 
results. WHR was negatively correlated with HDL-C 
(r=-0.47; p<0.001), HDL2-C (r=-0.43, p<0.01), and HDL3-C 
(r=-0.44, p<0.01 ). Deep abdominal fat (DAF) was negatively 
correlated with HDL-C (r=-0.35, p<0.01), HDL2-C (r=-0.37, 
p<0.01 ), and HDL3-C (r=-0.27, 0.05<p<0.06). WHR was a 
better predictor than DAF for HDL-C, HDL2-C, and Apo A-1 
levels, while DAF was better than WHR for the lipoprotein 
ratios. Meilahn et al. (1991) found that WHR and BMI 
divided into quintiles were negatively associated with HDL-
C, HDL2-C, and HDL3-C levels (p<0.01). For females in the 
highest quintile of BMI, HDL-C, HDL2-C, and HDL3-C were, 
respectively, 15mg/dl, 10.5mg/dl, and 4.5mg/dl lower than 
for females in the lowest quintile of BMI (p<0.01). For 
females in the highest quintile of WHR, HDL-C, HDL2-C, and 
HDLg-C were, respectively, 14mg/dl, 10mg/dl, and 4.4mg/dl 
lower than for females in the lowest quintile of WHR 
(p<0.01). Apo A-1 did not vary significantly by WHR 
(p=0.22), but tended to be lower among females with a high 
WHR. However, apo A-1 was negatively associated with BMI 
(p<0.01). When the sample was cross-stratified by BMI and 
WHR in tertiles, HDL2-C showed a decrease with increased BMI 
and WHR, (no statistical value was reported). When the 
sample was divided according to certain "healthy" habits 
such as exercise habits and cigarette smoking, HDL-C was 
18mg lower in the unhealthy behavior group than in the 
healthy behavior group (p<0.05). The unhealthy behavior 
group included females who smoked, who were in the highest 
two quintiles for BMI, and in the lowest two categories of 
physical activity. Pouliot et al. (1989) reported that 
total adiposity measured as body density was positively 
correlated with LDL-C (r=0.46), LDL apo B (r=0.51), and 
negatively correlated with HDL apo A-1/LDL apo B (r=-0.47) 
(p<0.05). Adipose tissue volume (measured by CAT), BMI, and 
WHR were not correlated with HDL-C, HDL2-C or HDL3-C. The 
abdominal fat cell weight correlated negatively with HDL-
apo A-1 (r=-0.51; p<0.05), and HDL2-C (r=-0.51;* p<0.05). 
Conclusions: 
Six of the seven studies consistently reported a 
significant negative correlation between WHR and 
lipoproteins. WHR was negatively correlated with HDL-C 
(Freedman et al., 1990 (males: r=-0.22, p<0.001; females: 
r=-0.14, p<0.01); Van Gaal et al., 1989 (p<0.005); Terry et 
al., 1989 (r=-0.32, p<0.01); Peeples et al., 1989 (p<0.05); 
and Despres, Moorjani et al., 1989 (r=-0.47, p<0.001), with 
HDL2-C (Meilahn et al., 1991 (p<0.01); and Despres, Moorjani 
et al., 1989, (r=-0.43, p<0.01), and with HDL3-C (Despres, 
Moorjani et al., 1989, r=-0.44, p<0.01). Pouliot et al. 
(1989) did not found any correlation between WHR or adipose 
tissue volume measured by CT and HDL-C, HDL2-C, or HDL3-C. 
Pouliot et al. (1989) explained that their findings suggest 
that in lean premenopausal females, variations in WHR did 
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not reflect the variations in regional fat distribution and 
fat cell size that are associated with an altered 
lipoprotein-lipid profile. 
These results support previous reports of associations 
between regional adiposity patterns and plasma lipid and 
lipoprotein cholesterol concentrations. 
Table 3 
3u—ary table for studies related to lipids and lipoproteins, body fat and body fat distribution. 
Investigators Subjects Measurements Taken Blood Work Statistics Findings 
Freedman, 
Jacobsen, 
Barboriak, 
Sobocinski, 
Anderson, 
Kissebah, Sasse 
and Gruchow, 1990. 
Van Gaal, Vansant, 
and Leeuw, 1989. 
415 women, mean 
age = 39. 
709 men. mean 
age = 40. 
Belgi an 
Women=148 
Men=43 
Women: 
with abdominal 
obesity (A0)= 
118, 
with gluteo-
femoral obesity 
(GF0)=30. 
Men: 
A0=24, GF0=19. 
Weight, Height, BMI, 
Waist girth was 
taken at umbilicus 
level. Hip girth was 
taken at the widest 
part of the hips and 
buttocks. 
Waist girth taken at 
umbilicus level. 
Hi p gi rth taken at 
the iliac crest 
level. 
Cholesterol, 
triglycerides, 
HDL-C, Apo B, 
Apo A1. 
TC, TG, LDL-C, 
HDL-C, 
Atherogenic 
Index=(AI) 
AI=TC/HDL-C. 
Wilcoxon Chi-
square test. 
Pearson 
correlation 
coeff. 
Regression 
analysis 
adjusting for 
covariates. 
Paired t-test. 
Unpaired t-
test. 
Higher levels of TG, 
TC/HDL-C, and Apo B 
among men (p<0.001).WHR 
and BMI higher in men 
(p<0.001). WHR corr 
wi th: men women 
(r-values) 
TC: 0.27 0.26 
TG: 0.37 0.3B 
ApoB 0.30 0.34 
TC/HDLC 0.35 0.30 
HDLC -0.22 -0.14 
apo A1 -0.14 
(p<0.001) 
TG, HDL-C, and AI were 
diff between sexes 
(p<0.001). Men higher in 
TG and AI. Men with AO 
had higher TG (p<0.05) 
and lower HDL-C 
(p<0.005). Women with 
AO had higher TG 
(p<0.001) and TC 
(p<0.05). Females AI 
higher for AO groups 
(p<0.005). 
Terry, Hood, 
Haskel1, 
Stefanick, and 
Krauss, 1989. 
81 men, ages 
30-55, below 
140X of ideal 
wei ght. 
Ht, wt, BMI, WHR, 
STR, waist girth 
taken at umbilicus 
level, hip girth 
taken at the largest 
area around 
buttocks. SF taken 
with Harpenden 
caliper in subscap­
ular, abdominal, 
suprailiac, mid-
thigh, and calf 
areas. XBF 
estimated by 
hydrostatic 
weighing. 66 people 
completed a 3-day 
diet record. 
Peeples, 
Carpenter, Israel, 
and Barakat, 1989. 
Nine pairs of 
men matched for 
age and body 
fat, with 
different WHR. 
Ages 34-60. 
Waist girth taken at 
umbilicus level, hip 
girth taken at 
superior iliac spine 
level. 
WHR >1.0= AO. 
WHR < 1.0= GFO 
XBF estimated by 
hydrostatic 
weighing. 
Heilahn, Kuller, 
Mathews, Wing, and 
Caggeula, 1991. 
429 women ages 
45-54. 
282 pre­
menopausal , 
74 peri -
menopausal, 
62 post­
menopausal , and 
11 hysterecto-
mi zed. 
Height, weight, BMI. 
Waist girth taken at 
smallest area around 
natural waist. Hip 
girth taken at the 
largest circumfer­
ence around hips. 
Cholesterol, 
Serum 
1i poprotei n 
mass concen­
tration, HDL-
c, HDL2, HDL3, 
LDL, VLDL. 
Pearson's 
Product Moment 
correlation 
coefficient, 
Partial 
correlations, 
p< 0.05 
considered 
significant. 
After adjusting for XBF 
and STR, WHR corr with: 
r-value 
TG 0.27 
HDL2 -0.47 
p-value 
p<0.05 
p<0.0001 
p<0.01 
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HDL-C -0.32 
No corr between HDL3 and 
WHR. WHR was not corr 
with Kcals, fat, 
protein, carbohydrate or 
alcohol intake. Polyun­
saturated fat/1000 Kcals 
was neg corr with WHR. 
TG, TC, HDL-C, 
LDL-C, Apo A1, 
ApoB. 
Two tailed 
student t-test. 
TC, HDL-C, 
HDL2-C, HDL3-
C, Apo A1. 
Spearman's p 
(non-
parametric) 
corr. Multiple 
linear regres­
sion, 1-way 
AN0VA. Tests 
performed 
separate for 
each menopausal 
status. 
Subjects with AA had 
lower levels of: 
HDL-C: 53 + 7 vs 38 + 4 
ApoAl: 100 + 7 vs 84 + 8 
ApoA1/ApoB: 1.11 + 0.19 
vs 0.64 ± 0.05, (p<0.05) 
and higher levels of: 
TG: 89 + 13 vs 151 ± 12 
TC/HDLC: 3.39 + 0.5 vs 
4.95 + 0.4, and 
Apo B: 95 + 7 vs 13B + 8 
than subjects with GFO. 
(p<0.05). 
WHR and BMI in quintiles 
neg associated with HDL-
C, HDL2-C, and HDL3-C. 
When cross-stratified by 
BMI and WHR (tertiles), 
HDLg-C decline with 
increases in WHR and 
BMI. Kcals/wk was neg 
corr with WHR (r=-0.17; 
p<0.01). 
Despres, Moorjani, 
Ferland, Tremblay, 
Lupien, Nadeau, 
Pinault, 
Theriault, and 
Bouchard, 1989. 
52-
premenopausal 
Canadian obese 
women, ages 
35.7 ± 5.5 yrs. 
Pouliot, Despres, 
Moorjani, 
Tremblay, Lupien, 
Nadeau, Theriault, 
and Bouchard, 
1989. 
22-healthy 
sedentary, lean 
pre-menopausal 
Canadian women 
ages 34.6 + 
3.1. CT taken 
at thoracic 
Th8-Th9, and at 
abdominal L4-
L5, and at mid-
thigh (mid 
distance 
between the 
knee and the 
iliac crest. 
Waist girth taken at 
narrowest part of 
torso, hip girth 
taken at maximal 
extension of 
buttocks. CT taken 
for determination of 
DAF and subcutaneous 
abdomi nal adi pose 
tissue (AT) and mid-
thigh region. Body 
density, %BF and fat 
mass estimated by 
hydrostatic 
weighing. 
Waist girth taken at 
smallest torso area. 
Hip girth taken at 
buttock area. Mean 
fat cell size and wt 
determined by adi­
pose tissue biopsy. 
Body density and BF 
determined by 
hydrostatic 
weighing. Deep 
abdom. and sub. fat 
areas determined by 
CT. 
TC, TG, HDL-C, 
HDL2-C, HDLg-
C, VLDL, LDL, 
Apo A1, Apo B. 
Pearson's 
Product Moment 
Corr Coeff. 
Student t-test, 
Multiple re­
gression 
analysis, 
Stepwise re­
gression analy­
sis. 
WHR was neg corr with: 
r-value p-value 
HDL-C -0.47 p<0.001 
HDL2-C -0.43 p<0.01 
HDLg-C -0.44 p<0.01 
DAF was neg corr with: 
HDL-C -0.35 p<0.01 
HDL2-C -0.37 p<0.01 and 
HDL-C/LDL-C -0.40 p<0.01 
WHR was better than DAF 
as an independent 
covariate of HDL-C, 
HDL2-C, and HDL Apo A1 
levels. 
TC, TG, HDL-C, 
HDL2-C, HDL3-
C, LDL-C, HDL 
Apo A1, LDL Apo 
B. 
Pearson's 
Product Moment 
correlation 
coefficient. 
Total adipocity po3 corr 
with: r-value p-value 
LDL-C: 0.46 p<0.05 
LDLApoB: 0.51 p<0.05 
and neg corr with: 
HDLApoAl/LDLApo B 
r=-0.43, pc0.05. BMI, 
WHR and AT were not corr 
with HDL-C, HDL2-C or 
HDL3-C. Abdominal fat 
cell weight neg corr 
with: HDL Apo A1 r=-
0.51, and HDL2-C r=-
0.51 (p<0.05). 
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The Relationship Between Physical Activity, Diet, Obesity, 
and Body Fat Distribution. 
Obesity is the result of a positive energy balance. The 
accumulation of fat suggests that more food energy has been 
stored than has been utilized. Increased physical activity 
leading to increased energy expenditure and subsequently 
reduced body fat can be an effective treatment for obesity 
(Krotkiewski, 1988). The critical question is whether 
physical activity can induce changes in adipose tissue 
distribution. Two important key factors are physical 
activity; and, the quality and quantity of food intake. 
Effects of aerobic exercise on body fat distribution 
Researchers are interested in determining if exercise 
training can reduce or mobilize fat from different body 
regions. Despres, Tremblay, Nadeau, and Bouchard (1988) 
have postulated that since males have larger abdominal fat 
depots than females, a caloric deficit induced by aerobic 
exercise may produce a greater fat mobilization in males 
that females. Tremblay, Despres, and Bouchard (1988) found 
that after 15-weeks of high intensity exercise, 7-sedentary 
non-obese males reduced trunk skinfolds (sum of subscapular, 
suprailiac, and abdomen) by 27% and reduced peripheral or 
extremities skinfolds (sum of biceps, triceps, thigh, and 
calf) by 15% suggesting a preferential mobilization of trunk 
fat. Similarly, Bouchard et al. (1990) reported that trunk 
and extremities SF decreased 31% and 24%, respectively, in 
a group of five males after high intensity exercise. Thus, 
abdominal fat may be less difficult to mobilize than 
gluteofemoral fat. 
The next section of this review represents a critical 
analysis of five recently published articles dealing 
specifically with the effect of physical activity on body 
fat, and body fat distribution measured by BMI, WHR, 
skinfolds ratio, or by CT (Table 4). 
Four of the five studies (Anderson et al., 1991; 
Bouchard et al., 1990; Bjorkelund et al., 1991; and Marti et 
al., 1990) were longitudinal studies on the effects of an 
exercise intervention program on body composition. 
Tremblay, Despres et al. (1990) conducted a cross-sectional 
study in which they evaluated relationships between 
estimates of leisure-time energy expenditure with 
anthropometric measures. 
The ages of the subjects were relatively similar in 
four of the five studies ranging from an average of 25 years 
(Bouchard et al . , 1990) to an average of 39 years (Marti et 
al., 1990). Bjorkelund et al. (1991) studied an older group 
of females (average age 55 years). Two of the research 
groups (Bouchard et al., 1988; and, Marti et al., 1990) 
studied 5 and 65 males, respectively. Bjorkelund et al. 
(1991) studied a group of 65 females. Anderson et al. 
(1991) and Tremblay, Despres et al. (1990) included both 
males and females; however, they analyzed the data for males 
and females independently. 
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In order to compare males with females of a similar 
body fat mass, Anderson et al. (1991) divided the females 
group arbitrarily in lean and obese groups based on percent 
body fat. This resulted in one group of females with a mean 
BF of 24.8 kg, and another group with a mean BF of 31.2 kg. 
Bjorkelund et al. (1991) developed three groups according 
BMI and WHR. Group #1 included females with gluteofemoral 
obesity (GFO); group #2 included females with abdominal 
obesity (AO); and, group #3 included females with general 
obesity. Tremblay, Despres et al. (1990) categorized their 
sample by gender, into four groups on the basis of the mets 
value for leisure-time activities estimated by the used of a 
questionnaire. Group A: mets<5; group B: 5<mets<7; group C: 
7<mets<9; and group D: mets>9. A met was defined as the 
energy cost of the activity expressed as kilocalories 
expended per kilogram of body weight per hour of activity 
(1met= 1 kcalorie/kg of body weight/hour of activity). 
All of these subjects were outpatients except those studied 
by Bouchard et al. (1990) who lived as inpatients in a 
research center for four months. 
The WHR was used as an estimate of body fat 
distribution in every study. Anderson et al. (1991) defined 
the waist circumference at the level of the umbilicus. 
Bouchard et al. (1990) and Tremblay, Despres et al. (1990) 
measured the waist circumference at the smallest area of the 
trunk, while Bjorkelund et al. (1991) defined the waist area 
between the lower rib margin and the iliac crest. Marti et 
al. (1990) did not specify the area used for measuring waist 
or hip circumference. For the other four studies, hip 
circumference was measured at the widest part between hips 
and buttocks. In addition to using various estimates of 
WHR, other measures of body composition have been used. 
These measures included: K40 estimates of lean body mass 
(Anderson et al., 1991), underwater weighing to estimate 
body density (Bouchard et al., 1990), bioelectrical 
impedance to estimate body fat (Marti et al., 1990), and 
skinfolds measurements to estimate subcutaneous fat 
(Bouchard et al., 1990; Marti et al., 1990; and Tremblay, 
Despres et al., 1990). 
The exercise prescription and the kind of activities 
prescribed varied among these studies. The duration of the 
program lasted from 12 weeks (Anderson et al., 1991; 
Bjorkelund et al., 1991) to 16 weeks (Bouchard et al., 1990; 
Marti et al., 1990). The type of exercise was mainly 
aerobic. Exercise prescription included cycling twice a day 
for 53-minutes (Bouchard et al., 1990), walking 1-hour every 
two weeks or jogging 120-minutes/week (Bjorkelund et al., 
1991; Marti et al., 1990) or a combination of high intensity 
exercise, mixed with less intense exercise such as jogging 
(Anderson et al., 1991). 
Diet was monitored in 3 of the 4 studies that included 
physical activity. Marti et al. (1990) did not assess diet 
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but subjects were asked to keep diet constant. Anderson et 
al. (1991) collected a diet history 3-times during the study 
but the participants did not receive any dietary advice. 
Bjorkelund et al. (1991) provided the subjects with food and 
nutrition education, and cooking activities. Bouchard et 
al. (1990) monitored daily food intake to make sure each 
subject ate only the amount of energy prescribed. 
Results: 
In most of the studies, the subjects experienced a 
decrease in body weight, BMI, waist circumference, hip 
circumference, and percent of body fat except for the 
subjects studied by Marti et al. (1990). Only WHR decreased 
significantly in the latter study. WHR was not reduced in 
every study. Both males and females had a similar decreased 
in hip and waist circumference (p<0.05) leading to an 
unaltered change in WHR in the study by Anderson et al 
(1991). Bouchard et al. (1990) found that the subcutaneous 
fat in the trunk decreased more (31%) than the subcutaneous 
fat in the extremities (24%), with no change in WHR. 
Bjorkelund et al. (1991) found that females with abdominal 
obesity decreased waist circumference by 3.9%, hip 
circumference by 1.3% and WHR 2.4% while the females with 
general obesity or gluteofemoral obesity did not change 
waist or hip circumference or WHR. Tremblay, Despres et al. 
(1990) found that both males and females categorized in the 
highest activity intensity group where characterized by a 
reduced WHR even after controlling for SSF (p<0.05). 
A common finding among the 6 studies was that the 
fattest subjects tended to lose more weight and more fat. 
Also the subjects with abdominal obesity decreased WHR while 
the subjects with gluteofemoral obesity seemed to be more 
resistant to changes in WHR (Bjorkelund et al., 1991). 
The reason for the more rapid decrease in abdominal fat 
in abdominal obesity in comparison to gluteofemoral obesity 
could be due to a combination of factors: 
1. higher lipolytic activity in the upper abdominal 
region in comparison with the gluteofemoral region (Rebuffe-
Scri ve et al., 1988); 
2. higher LPL activity in the gluteofemoral region in 
gynoid obesity (Leibel et al., 1989); 
3. the lipolytic response to norepinephrine (NE) is 
greater in abdominal than in femoral adipocytes in 
premenopausal females. Femoral and gluteal LPL activity is 
greater in premenopausal females than in males. This high 
gluteal-femoral LPL activity disappears with menopause, 
which is associated with the female adoption of an android 
male habitus pattern. Administration of estrogen plus 
1evonorgestrel specifically increased femoral LPL activity 
in postmenopausal females (Rebuffe-Scrive et al., 1987); 
4. the contribution of the fat mobilization from the 
intra-abdominal fat depots, in addition to subcutaneous fat, 
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exerting an additive effect on the decrease in the waist 
circumference (Krotkiewski, 1988). Intra-abdominal fat has 
higher basal and catechol amine-stimulated lipolysis 
activities (Fried and Krai, 1987); 
5. Vansant, Den Besten, Weststrate, and Deurenberg 
(1988) reported that abdominal fat cells are relatively 
larger than gluteofemoral fat cells, and that in the 
gluteofemoral area the number of fat cells is elevated. 
Therefore, the gluteofemoral or hyperplastic obesity would 
be more resistant to weight loss than abdominal or 
hypertrophic obesity. 
Effect of diet on body fat distribution: 
Most of the available data related to alterations in 
adipose tissue distribution with nutritional intervention 
deals with changes in subcutaneous fat thicknesses. Most of 
the literature on nutritional interventions focused on 
changes in total body composition and not on changes in body 
fat distribution. The quality of food intake may indirectly 
affect body composition. Krotkiewski (1988) reported that 
an increase in the percentage of fat intake depresses the 
synthesis of SHBG, which in turn leads to an increased 
concentration of free testosterone. Testosterone, like 
other anabolic steroids induces changes that give rise to 
metabolic abnormalities similar to those observed in 
abdominal obesity. 
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Vansant et al. (1988), Krotkiewski (1988), and Wadden et al. 
(1988) studied the effect of a low calorie diet on body fat 
distribution in a group of females (Table 4). In addition 
Wadden et al. (1988) assessed the effect of behavior therapy 
alone or in combination with a low calorie diet on body fat 
distribution. Vansant et al. (1988) divided their group 
according to WHR, matching for weight, age, and BMI. The 
subjects in the three studies consumed very low calorie 
diets (VLCD); 1OOOKcals/day (Vansant et al., 1988), 
544Kcals/day (Krotkiewski, 1988), and from 400 to 1200 kcals 
(Wadden et al., 1988). The duration of the diet treatments 
were 4-weeks (Krotkiewski, 1988), 4-6 months (Wadden et al., 
1988), and 8-weeks (Vansant et al., 1988). 
Results: 
Vansant et al. (1988), Wadden et al. (1988), and 
Krotkiewski et al , (1988) found that subjects, especially 
those with abdominal obesity, had a significant decrease in 
body weight, and WHR. Vansant et al. (1988) found that the 
abdominal obese group decreased WHR (p<0.01) but the 
gluteofemoral obese group did not. Similarly, Wadden et al. 
(1988) found that the abdominal obese group decreased WHR by 
2.1% versus 0.1% in the gluteofemoral obese group. 
Krotkiewski (1988) found a decrease in WHR of 3% at the end 
of the first two-weeks, and a decrease of 6% at the end of 
four weeks. At both intervals, Krotkiewski (1988) found that 
fat cell weight decreased more in the abdominal region 
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(1496), compared to the gluteofemoral region (7%). The group 
studied by Wadden et al. (1988) that received a combination 
of a low kcalorie diet plus behavior therapy lost more fat 
than the group that received the low calorie diet or 
behavior therapy alone (p<0.053). No information was 
reported about changes in WHR according to treatment. 
Summary 
It seems that subjects with isolated abdominal obesity 
benefit more from exercise and/or diet intervention programs 
than subjects with general obesity (Bjorkelund et al., 
1991). In subjects with general obesity, exercise failed to 
modify the WHR even when they had a decrease in waist and 
hip circumference (Anderson et al., 1991). Subjects 
consuming low calorie diets decreased their WHR. With 
exercise intervention some subjects reduced Xbody fat, BMI, 
and subcutaneous fat without changes in WHR (Anderson et 
al., 1991; Bouchard et al., 1990) suggesting that fat 
distribution may be determined by a strong genetic 
component. Subcutaneous fat and WHR were generally lower in 
subjects who regularly practiced vigorous physical 
activities (Tremblay, Despres et al., 1990). More research 
on the effects of exercise and/or diet on fat distribution 
are needed. The intervention programs should be longer in 
duration and body fat distribution should be assessed with 
more refined tools. 
Table 4 
Summary table for studies related to exercise and diet and the effect ori body fat and body fat distribution. 
Investigators Subjects Measurements taken Treatment Statistics Findings 
Anderson, Xu, 
Rebuffe-Scri ve, 
Terning, 
Krotkiewski, and 
Bjorntorp, 1991. 
22 pre­
menopausal 
women and 9 
men. Selection 
criteria: ages 
25 to 40 yrs 
and BMI 24-27. 
Height, ht, BMI, WHR 
waist girth taken at 
the umbilicus level, 
hip girth taken at 
the widest part of 
the hip region. Lean 
body mass (LBM) 
estimated by K40. 
Body fat=body wt-
LBM. 
60-min sessions 
3X/wk for 12 
wks consisting 
of 10-min warm 
up plus 3 peri­
ods of stren­
uous exercise 
(5-min each) 
with a mean 
intensity of 
aprox 80X of 
maximal working 
capacity. This 
was inter­
spersed with 
less intensity 
exercise like 
jogging, coor­
dination and 
strength exer­
cises. Exer­
cise was ended 
with a 10-min 
cool down. 
Student t-test, 
ANOVA. 
Men decreased BW, BMI, 
waist, hip circumference 
and body fat (p<0.05). 
No changes in WHR. 
Leaner women decreased 
waist (p<0.05) and hip 
(p<0.01) and increased 
LBM (p<0.05). Obese 
women decreased waist 
(p<0.001), hip (p<0.05), 
and body fat (p<0.05) 
and increased LBM 
(p<0.05). No WHR 
changes. Obese women had 
a significant decrease 
in energy intake. 
Bouchard, 
Tremblay, Nadeau, 
Dussault, Despres, 
Theriault, Lupien, 
Serresse, Boulay, 
and Fournier, 
1990. 
5-men,moderate 
overweight 
BMI=27.5 + 2.9 
Ages 25+3. 
Weight, ht, BMI, 
body density deter­
mined by underwater 
weighing. Waist 
girth taken at 
smallest area around 
the trunk, hip girth 
taken at the widest 
part around the 
buttocks. WHR was 
determined. Ten 
skinfolds measure­
ments were taken and 
the trunk/extremi­
ties skinfold ratio 
was determined. 
Two 53-min 
sessi ons/day, 
6-days/wk on a 
bicycle ergo-
meter for 16 
weeks. Exer­
cise induced a 
4.2 MJ/day 
(1000 kcals) 
energy surplus 
above RMR. 
Duncan multiple 
range test, 
ANOVA. 
Body wt, BMI, XBF, and 
fat mass decreased 
(p<0.001). Body density 
increased (p<0.01) and 
the sum of the 10 
skinfold measurements 
decreased (p<0.001). 
Subcutaneous fat in the 
trunk decreased by 31X 
and the subcutaneous fat 
in the extremities 
decreased by 24X 
(p<0.001). No changes in 
WHR, trunk/extremities 
skinfold ratio or in 
fat-free mass. 
Bjorkelund, 65-woinen Weight, ht, BMI, 
Bengtsson, Carazo, group 1: 22 waist girth taken 
Palm, Tarschys, women with: between the lower 
and Wassen, 1991. BMI > 30 and rib margin and the 
WHR < 0.82, iliac crest. Hip 
group 2: 27 girth taken at the 
women with: widest point between 
BMI < 30 and hips and buttocks. 
WHR > 0.82, 
group 3: 16 
women with: 
BMI > 30 and 
WHR > 0.82. 
Ages 45-64. 
Marti, Suter, 81-sedentary Height, wt, BMI, 
Riesen, Tschopp, Swiss men, ages WHR, 4-SF taken: 
Wanner, and 38.8 i I 8.9. (suprailiac, sub­
Gutzwiller, 1990. 39 jogging scapular, tricep. 
group, » and radial). Body 
22 controls. fat estimated by 
bioelectrical 
impedance measure­
ment. 
Tremblay, Despres, 
Leblanc, Craig. 
Ferris, Stephens, 
and Bouchard, 
1990. 
1366 women and 
1257 men 
participants in 
the 1981 Canada 
Fitness Survey 
ages: 20-49. 
Groups: 
A: mets<5 
B: 5<mets<7 
C: 7<mets<9 
D: mets>9. 
Height, weight, BMI. 
Waist girth taken at 
smallest area around 
the trunk, hip girth 
taken at widest part 
around buttocks. WHR 
was determined. 
SF: bicep, tricep, 
suprai1i ac, 
subscapular and 
calf. 
Nutrition edu­
cation meetings 
3 hours every 
two weeks and 
walking for 1-
hour. Duration 
of the pro-
gram=12 weeks. 
Student t-test, 
Duncan multiple 
range test. 
Group *2 decreased BW by 
4X, BMI by 3.9X, and 
waist girth by 3.9X 
(p<0.001). WHR was 
reduced by 2.4X 
(p<0.01). Group *1 
reduced BW and BMI 
(p<0.05). No diffe­
rences for group *3. 
Group *2 had greater 
reductions in WHR than 
group *1 and group *3 
(p<0.01). 
Home base 
program of 120-
min/wk jogging 
or jogging/ 
walking divided 
into 2 to 6 
sessions/wk for 
16 weeks. 
Intensity at 
85X of HR at 
the anaerobic 
threshold. 
Unpaired t-
test, Pearson's 
Product Moment 
corr coeff. 
BMI, SK, XBF, and WHR 
decreased during the 
intervention program. 
Only WHR achieved 
statistical significance 
(p<0.001). 
Energy 
expenditure of 
leisure 
activities 
estimated by a 
questionnaire. 
met=1kcal/kg/ 
hour of activ­
ity. Subjects 
were divided 
into 4-groups 
on basis of the 
mets values 
according 
activities 
performed. 
ANOVA, ANCOVA 
controlling for 
SSF. 
Men and women catego­
rized in the high met 
group were characterized 
by the lowest WHR even 
after controlling for SF 
(p<0.05). Women in 
groups C and D had lower 
skinfolds than women in 
group A. Men in group D 
had lower skinfolds than 
men in group A (p<0.05). 
Vansant, Den 
Besten, 
Weststrate, and 
Deurenberg, 1988. 
17 pre­
menopausal 
obese women 
BHI > 27, ages 
28-44 yrs, 
divided into: 
9 AO, WHR>0 .a 
and 8 GFO 
WHR<0.8. Groups 
were matched 
for age, wt and 
BMI. 
Weight, ht, BMI, 
WHR. Body fat mass 
estimated by under­
water weighing. 
Wadden, Stunkard, 
Johnston, Hang, 
Pierson, Van 
Itallie, Costello, 
and Pena, 1988. 
88-women ages 
42.5 + 9.5 yrs 
divided into: 
group #1: 22 
women in a 
VLCD, 400-500 
Kcals for 2 
months and 
1000-1200 Kcals 
for other 2 
months. 
Group *2: 22 
women Behavior 
therapy and 
1000-1200 Kcal 
diet for 6-
months. 
Group *3: 24 
women with a 
combination of 
groups 1 and 2. 
Body fat was 
evaluated by total 
body K, total body 
water, and by 
anthropometry. Waist 
girth was taken at 
smallest area of 
torso, hip girth was 
taken at the iliac 
crest level. Five 
circumferences were 
taken: arm, chest, 
waist, iliac crest, 
and thigh. 
8-week diet of 
4.2MJ/day (1000 
Kcals/day) 
providing 20* 
protein, 30X 
fat. A 24-hr 
diet recall was 
collected every 
two weeks. 
Women were 
divided into 3 
groups 
receiving: a 
low calorie 
diet, behavior 
therapy or a 
combination of 
both. 
Student t-tests 
and paired t-
test. 
Paired t-test, 
AN0VA. 
Both groups had a 
decrease in BMI and XBF. 
Body fat mass decreased 
an average of 7.0 Kg. 
WHR decreased in the AO 
group (p<0.01). WHR did 
not change in the GFO 
group. Waist girth 
decrease more in the AO 
than in the GFO group 
but it was not statis­
tically significant. 
Group *1 lost 10.4 ±4.1 
Kg, group #2 lost 10.8 ± 
8.3 Kg, group #3 lost 
15.2 ± 7.8 Kg. Group #3 
lost significantly more 
than groups 1 and 2 
(p<0.03). Group #3 lost 
more fat than the other 
groups (p<0.053). 
Heavier and fatter 
subjects lost more wt 
and fat. WHR decreased 
by 1.2 X in the 3 groups 
(p<0.05). Waist de­
creased by 8.3X and hip 
decreased by 7.3X. The 
X reduction in waist was 
greater that the one for 
hips (p<0.04). Subjects 
with AO decreased WHR by 
2.7X, subjects with GFO 
increased WHR by 0.1X. A 
decrease in the 5 cir­
cumferences accounted 
for 61X of the variance 
in fat loss. 
Krotkiewski, 1988. 25-obese 
premenopausal 
women. 
Weight, WHR, fat 
cell weight. 
544 ..i 1 /day T-test. 
diet :or 
4-weeks. 
At the end of 2-weeks, 
body wt decreased 7.4 Kg 
(p<0.05), fat cell 
weight decreased 5% in 
gluteal region and 8X in 
abdominal region. Waist 
girth decreased 8% 
(p<0.001), hip 4% 
(p<0.05)t and WHR 3X 
(p<0.01). At the end of 
four-weeks, cell wt 
decreased 7X in gluteal 
region, 14X in abdoMinal 
region. Waist was 
reduced by 10X, hip 5X, 
and WHR 6X (p<0.001). 
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The Relationship Between Exercise, Glucose, Insulin, 
Lipoproteins, Systolic Blood Pressure, and Diastolic Blood 
Pressure. 
Exercise and the effect on insulin and glucose levels 
Training can reduce plasma insulin without any 
deterioration in glucose tolerance (Tremblay, Nadeau et al . , 
1990). This information is consistent with the concept that 
insulin sensitivity is improved in trained people. The low 
plasma insulin levels observed in trained individuals may be 
explained by an increased clearance and by a reduced 
secretion of the hormone. 
Inactive individuals have improved insulin sensitivity 
after endurance training. This observation is supported by 
experiments with rats. The rate of insulin release from 
islets of Langerhans of trained rats was lower than that 
from islets of sedentary controls. According to Rodnick et 
al. (1987) cited by Vranic and Wasserman (1990) strenuous 
training increases insulin sensitivity in liver, muscle, and 
adipocytes in athletes. Krotkiewski et al. (1985) found 
that moderate exercise improved glycosylated hemoglobin and 
insulin secretion independently of body weight loss in 
subjects with NIDDM. Trovati et al. (1984) cited by Vranic 
and Wasserman (1990) found that insulin sensitivity improved 
with exercise training in NIDDM patients. In addition, 
Taylor, Ram, Zimmet, Raper, and Ringrose (1984) found that 
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the prevalence of NIDDM was two times larger in sedentary 
than in active males. 
In obese subjects a training program may improve 
insulin sensitivity even with no changes in weight or body 
composition (Krotkiewski et al . , 1985). However, since 
weight reduction by itself can also improve insulin 
sensitivity, a combined program of exercise and diet may 
enhance weight reduction and improve insulin action. 
Skeletal muscle is the major site of the increase in 
insulin action that occurs with training. The skeletal 
muscle adapts to aerobic exercise training to use fuel and 
oxygen more efficiently. In addition to skeletal muscle, 
adipose tissue undergoes several adaptations to training. 
James, Kraegen, and Chisholm (1985) found that regular 
physical activity increases insulin-stimulated glucose 
uptake, oxidation, and incorporation into fatty acids in rat 
adipocytes. The improvement in insulin action may be 
related to reduced fat cell size after physical training. 
Exercise and the effect on lipoproteins levels 
Physical activity may affect lipoprotein levels 
although other lifestyle habits such as alcohol consumption, 
cigarette smoking, certain drugs, body fat gain or lost, and 
diet, may also be involved. According to Haskell (1986) 
when active males and females are compared with the more 
sedentary ones, the active ones have lipoprotein patterns 
associated with a reduced risk of atherosclerosis. Exercise 
programs, especially jogging, may be potentially effective 
as a non-pharmacological way of increasing serum HDL-C 
(Marti et al., 1990). 
Manninen et al. (1988) stated that every 1X increase in 
HDL-C may translate into as much as a 35K reduction of 
coronary risk. Marti et al. (1990) found a significant 
increase in HDL-C levels (0.12mmol/l; p<0.028) in a group of 
joggers when compared to a control-sedentary group after 4-
months of exercise. The increase in HDL-C levels was 
apparently mediated through a decrease in body fat content. 
Body fat was a more powerful predictor Of HDL-C 
concentration than were the changes in physical activity. 
From the regression analysis of change in HDLZ-C, Marti et 
al . (1990) estimated that a decrease in the sum of 4 SF by 
18mm would raise the HDL2-C concentration by 0.15 mmol/1. 
According to Leibel et al . (1989) lipoproteins levels 
may be affected by body fat distribution and adipose tissue 
lipolysis. Abdominal adipocytes seems to be more responsive 
to the lipolysis induced by catecholamines than femoral 
adipocytes resulting in selective loss of abdominal fat 
versus gluteofemoral fat. Beta-receptor sensitivity to 
norepinephrine (NE) is increased with exercise training, 
probably enhancing the lipolytic effect of catecholamines. 
Sopko et al. (1985) and Thompson et al. (1988) found 
that HDL-C increased without a decrease in fat loss with 
exercise training. Other investigators (Savage et al., 
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1986; and Hagan, Upton, Wong, and Whittam, 1986) found no 
increase in HDL-C despite a substantial decrease in body 
fat. Tran and Weltman (1985) cited by Marti et al. (1990) 
concluded that exercise and weight loss separately and 
independently increase HDL-C; and, that their effects are 
additive. The mechanism of the effect of long term exercise 
on HDL-C concentration is not fully understood (Eckel, 
1989). An increase in adipose tissue LPL activity may 
mediate the conversion of VLDL to HDL. LPL activity 
increases by exercise training and is higher in runners than 
in sedentary people. On the other hand, hepatic lipase (HL) 
is lower in active people, and is decrease by exercise. 
These changes following endurance exercise training are 
associated with an improved lipoprotein profile (Wood and 
Stefanick, 1990). The HL plays a major role in the 
conversion of HDLZ to HDL3, and participates in the 
conversion of VLDL, IDL, and large LDL to IDL and small LDL. 
Wood and Stefanick (1990) reported that LPL activity is 
greater in red (slow-twitch) muscle fibers than in white 
(fast-twitch) fibers. In addition, higher levels of HDL-C 
are observed in people who have higher ratios of red to 
white fibers than do people with high ratios of white to red 
fibers. Red fibers play an essential role in endurance 
activities, such as long distance running. 
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Effect of exercise training on blood pressure. 
According to Hagberg (1990) hypertension is one of the 
most serious problems in industrialized societies. McArdle 
et al. (1986) reported that hypertension imposes a chronic, 
excessive strain on the normal functioning of the 
cardiovascular system. Uncorrected chronic hypertension can 
lead to heart failure or stroke. According to Kannel et al. 
(1984), males with blood pressures greater than 160/95 have 
a threefold elevation in their risk for developing coronary 
artery disease and intermittent claudication, and a fourfold 
increase in their risk for congestive heart failure and 
stroke. Even males with blood pressures between 140/90 and 
160/95 have their risk doubled for these cardiovascular 
complications. The same relationship seen for males exists 
for females but their disease prevalence is lower than males 
at any level of blood pressure. 
Although the degree to which regular exercise can 
benefit a hypertensive condition is still unclear, it 
appears that both systolic and diastolic blood pressures can 
be lowered to a modest degree with a program of aerobic type 
exercise (Seals and Hagberg, 1984). Several studies have 
examined the relationship between physical activity and 
blood pressure. Montoye et al. (1972) cited in Hagberg 
(1990) in a review of 15 epidemiological studies concluded 
that when a difference was noted between active and inactive 
populations, the active group always had the lowest blood 
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pressure. They also found a close relationship between body 
fatness and blood pressure. They also noted that more 
active populations were also leaner than sedentary 
populations. Therefore, these data suggest that physical 
activity may result in lower systolic and diastolic blood 
pressure. However this lowering effect in blood pressure 
may also be the result of less body weight and body fat in 
active individuals instead of a direct result of exercise. 
Hagberg (1990) recently concluded that endurance-exercise 
training results in a lowering of both systolic and 
diastolic blood pressures by approximately 10 mm Hg in 
individuals with essential hypertension. 
According to Urata et al. (1987) and Kiyonaga et al. 
(1985) cited by Hagberg (1990) some of the mechanisms 
proposed to mediate the antihypertensive effect of 
endurance-exercise training are: the reduction in body 
weight and body fat, and reductions in plasma norepinephrine 
1evels. 
The last part of this section consists of a review of 
seven research articles published in the literature that 
have examined the effect of physical activity on glucose, 
insulin, lipoprotein levels, and systolic and diastolic 
blood pressure, or a combination of two or more of these 
parameters (Table 5). 
The studies were conducted using different populations: 
United States (Blumenthal et al. , 1991; and Nieman et al., 
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1990), Canada (Despres, Tremblay et al., 1990; and Tremblay, 
Nadeau et al., 1990), Sweden (Andersson et al., 1991; and 
Bjorkelund et al., 1991), and Switzerland (Marti et al., 
1990). Marti et al. (1990), Despres, Tremblay et al. 
(1990), and Tremblay, Nadeau et al. (1990) evaluated only 
males. Anderson et al. (1991) studied both males and 
females. Anderson et al. (1991) analyzed their data for 
males and females separately since the parameters studied 
may have a different response for each gender. 
The sample sizes for each study were different. 
Despres, Tremblay et al. (1990) and Tremblay, Nadeau et al. 
(1990) used a very small sample size of only 5 males. The 
sample sizes in the other five studies were also relatively 
small ranging from 21 to 65 subjects. 
All the subjects in the seven studies participated in 
some kind of aerobic exercise. Only two studies (Marti et 
al . , 1990; and Nieman et al., 1990) included a control group 
of non-exercising subjects. The duration of the exercise 
programs was not similar in all the studies varying from 5 
weeks to 16 weeks. The exercise frequency and intensity 
were different for each study ranging the frequency from 
120-minutes/week to 636-minutes/week, and the intensity from 
55 to 80% V02 max. 
Despres, Tremblay et al. (1990) and tremblay, Nadeau et 
al. (1990) working with the same sample used the same 
exercise intervention previously described by Bouchard, 
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Tremblay et al. (1990). In these two studies, subjects 
performed their exercise sessions (two 53-minute sessions 
per day) on a bicycle ergometer for a period of 100 days, 6-
days/week with one day of rest/week. Blumenthal et al. 
(1991) randomly assigned the group to either aerobic 
exercise or to a circuit Nautilus training program. 
Anderson et al. (1991) had the subjects exercise strenuously 
for 5-minutes three times per session alternating with less 
intense exercise for 60-minutes. Blumenthal et al. (1991), 
Marti et al. (1990), Bjorkelund et al. (1991), and Nieman et 
al. (1990) included walking and/or jogging in the exercise 
program as part of the aerobic exercise. 
Tremblay, Nadeau et al. (1990) and Anderson et al. 
(1991) examined the effect of aerobic exercise upon glucose, 
insulin, and C-peptide levels. Bjorkelund et al. (1991) 
examined the effect of exercise on blood pressure, glucose 
and TC. Nieman et al. (1991), Despres, Tremblay et al. 
(1991), Blumenthal et al. (1991), and Marti et al . (1991) 
examined the effect of aerobic exercise on lipids, 
specifically TC, HDL-C, LDL-C. Only Marti et al. (1991) 
included the HDL2-C and HDL3-C subfractions. 
Tremblay, Nadeau et al . (1990), Despres, Tremblay et 
al . (1990), and Nieman et al. (1990) controlled the quantity 
and quality of the diet the subjects received. In the first 
two studies, the mean energy intakes during the exercise 
program were 13.8 + 2.0 MJ/day. Subjects received a 1268 
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calories lactovegetarian diet through the duration of the 
study in the study by Nieman et al (1990). Anderson et al. 
(1991) collected a diet history before, during and after the 
program to verify that the subjects did not change their 
eating patterns. The participants in this study did not 
receive any dietary advice during the study. Blumenthal et 
al. (1991) requested that the subjects follow their usual 
dietary patterns throughout the study. Dietary habits were 
assessed by self-report, including a 4-day food diary and a 
2-week retrospective food recall questionnaire. Marti et 
al. (1990) also requested that their subjects keep diet 
constant but diet was not assessed. 
In general, the response of fasting insulin, glucose, 
TC, and C-peptide values were similar among these studies. 
Both Tremblay, Nadeau et al. (1990) and Anderson et al. 
(1991) reported a decrease in insulin values after exercise 
training (p=0.006 and p=0.05, respectively) but did not find 
any changes in fasting glucose. Anderson et al. (1991) 
found a decrease in C-peptide (p<0.01 for males, p<0.05 for 
females), insulin and TC (p<0.05) for both males and obese 
females. No changes in insulin were observed in the group 
of lean females. Bjorkelund et al. (1991) did not find any 
decrease in fasting glucose, systolic or diastolic blood 
pressure in any of the groups even when body fat decreased. 
Blumenthal et al. (1991) and Anderson et al. (1991) 
collected systolic and diastolic blood pressure data, but 
did not report their findings after intervention. In 
addition, Blumenthal et al. (1991) found that after 
adjusting for age and initial lipid values, the aerobic 
exercise group had lower Apo-II values (41.9 + 9.7 vs. 46.7 
+ 4.2 mg/dl, p=0.08) and higher apo A-I/apo A-II ratio (3.5 
+ 0.4 vs. 3.8 + 0.5, p=0.08) than the strength exercise 
group. HDL-C increased slightly but not significantly in 
both groups. Marti et al. (1990) and Despres, Tremblay et 
al. (1990) found a significant increase in HDL-C at the end 
of the program (p<0.03 and p<0.05, respectively). Despres, 
Tremblay et al. (1990) also found a decrease in VLDL-TG, TC, 
and LDL-C, and an increase in HDL-C/LDL-C (p<0.05). Marti 
et al. (1990) reported an increase in HDL-C/TC (t=0.023, 
p=0.47), and a decrease in VLDL cholesterol (t=-0.25, 
p=0.009). Nieman found that HDL-C decreased in both groups 
from baseline to the first 2-weeks from 1.54 to 1.33 mmol/L 
(p<0.05). The non-exercising group decreased HDL-C more 
than the exercising group from 1.49 to 1.10 mmol/L (p<0.05). 
However, by the fifth week the exercising group increased 
HDL-C to baseline values (1.54 mmol/L) while the non­
exercising group did not (1.33 mmol/L). In this last study, 
moderate exercise training attenuated the decrease in HDL-C 
and by the fifth week values were back to baseline 
concentrations. Both exercising and control groups 
experienced a decreased in body weight and body fat, TC, TG, 
LDL-C, and fasting glucose levels (p<0.05). These results 
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are consistent with other studies (Follick et al., 1984; and 
Kohlmeier et al., 1985) cited by Nieman et al. (1990) who 
reported that HDL-C decreased in females or remain unchanged 
during active stages of weight loss. 
It is difficult to assess both the cross sectional and 
longitudinal studies since there are many factors that 
affect lipids and blood pressure that are difficult to 
control. Gender, age, race, socioeconomic status, body 
composition, diet, alcohol consumption, and cigarette 
smoking are among these factors. 
Table 5 
Summary table for studies related to diet and exercise and the effect on lipids. lipoproteins, fasting •insulin, and glucose. 
Investigators 
Blumenthal, 
Matthews, 
Fredrikson, Rifai, 
Schniebolk, 
German, Steege, 
and Rodin, 1991. 
3ubiects 
25-premeno-
pausal and 25 
post-menopausal 
non obese women 
ages 45-57. 
Treatment 
Sample was randomly 
assigned to aerobic 
exercise or 
strength/flexi bi1i ty 
groups. Aerobic 
group exercised 
3X/wk, consisting of 
15-min warm up, 35-
min walking and 
jogging at 70X HR 
reserve. The 
strength and flexi­
bility group exer­
cised 2X/wk, 20-min 
stretching and flex­
ibility exercises 
and 35-min circuit 
Nautilus training. 
Both groups exer­
cised for 12 weeks. 
Blood Work Statistics Findings 
TC, LDL-C, Analysis of After adjusting for age 
HDL-C. Apo A1 variance, and initial lipids 
and Apo A 11. Analysis of values, the aerobic 
covariance. group had lower Apo All 
values, and higher Apo A 
I/Apo All ratio 
(p=0.08). HDL-C 
increased lightly in 
both groups. 
Marti, Suter, 
Riesen, Tschopp, 
Wanner, and 
Gutzwiller, 1990. 
61-sedentary 
Swiss men, ages 
38.8 + 8.9. 
39 jogging 
group, 
22 controls. 
Home base program of 
120-min/wk jogging 
or jogging/walking, 
divided into 2 to 6 
sessions/wk for 16 
weeks. Intensity at 
85X of HR at the 
anaerobic threshold. 
TC, HDL-C, 
HDL,-C HDLo-C. 
VLDL-C. 
Unpaired t-
test, Pearson 
Product Moment 
corr coeff. 
Exercisers increased 
HDL-C (p<0.03), and 
HDL-C/TC (p<0.47), and 
decreased VLDL-C 
(p=0.009) as compared to 
controls. HDLj-C and 
HDL3-C did not change 
significantly. Changes 
in HDL2-C corr with 
changes in SSF 
p<0.001). 
(r=-0.39, 
Despres, Tremblay, 
Moorjani, Lupien, 
Theriault, Nadeau, 
and Bouchard, 
1990. 
5-men, moderate 
overweight 
BMI=27.5 + 2.9 
Ages 25+3. 
Two 53-min 
sessions/day, 
6-days/wk on a 
bicycle ergometer. 
At 55X V02max. 
Exercise induced a 
4.2 MJ/day energy 
surplus above RMR. 
TC, TG, HDL-C, 
and LDL-C. 
Duncan multiple 
range test. 
Subjects decreased VLDL-
TG, TC, and LDL-C 
(p<0.05), an increased 
HDL-C and HDL-C/LDL-C 
increased (p<0.05), at 
the end of the program. 
O 
O 
Tremblay, Nadeau, 
Despres, ST-Jean, 
Theriault, and 
Bouchard, 1990. 
5-men, moderate 
overwei ght 
BMI=27.5 + 2.9 
Ages 25+3. 
Same as below. 
Anderson, Xu, 
Rebuffe-Scrive, 
Terning, 
Krotkiewski and 
Bjorntorp, 1991. 
22 premeno­
pausal women 
and 9-men. 
Selection 
criteria: ages 
25-40 yrs and 
BMI 24-27. 
60-min sessions 
3X/wk for 12 weeks: 
10-min warm up plus 
3 periods of stren-
eous exercise (5-min 
each) with intensity 
of aprox. BOX 
V02max. This was 
interspersed with 
less intensity 
exercise: jogging, 
coordination and 
strength exercises. 
Bjorkelund, 
Bengtsson, Carazo, 
Palm, Tarschys, 
and Wassen, 1991. 
65-women 
22 with: 
BMI > 30 and 
WHR < 0.82 
27 with: 
BMI < 30 and 
WHR > 0.82 
16 with: 
BMI > 30 and 
WHR > 0.82. 
Ages 45-64. 
Dietary classes with 
3 hours meetings 
every two weeks and 
walking for 1-hour 
for 12-weeks. 
Nieman, Haig, 
Fairchield, 
De Guia, Dizon, 
and Register, 
1990. 
21 mildly obese 
women (20-40X 
overweight) 
randomly di­
vided into ex­
ercise (11) and 
non-exerci se 
group (10). 
Group were fed with 
a 1268-kcal 
lactovegetarian diet 
for 5-weeks. The 
exercise group 
walked at 60% heart 
rate reserve 45-min 
sessions, 5X/week. 
G1ucose, i nsu-
lin, 0GTT, 
glucagon and 
C-peptide. 
Duncan multiple 
range test, 
AN0VA. 
Pre and post-prandial 
insulin levels decreased 
(p<0.02). Fasting 
insulin (p=0.006) and 
glucagon (p=0.08) 
decreased. 
Glucose, 
insulin, C-
peptide, TC. 
Student t-test, 
AN0VA. 
Men and obese women 
decreased C-peptide 
(p<0.01 for men, p<0.05 
for women) insulin and 
TC (p<0.05). Leaner 
women decreased TC and 
C-peptide (p<0.05). 
Obese women decreased 
energy intake (p<0.05). 
Fasting glu- Student t-test, 
cose, TC, SBP, Duncan multiple 
and DBP. range test. 
No significant changes 
in glucose, TC, SBP or 
DBP in any group. 
TC, glucose, 
HDL-C, LDL-C. 
Pearson's 
Product Moment 
corr coeff, 
AN0VA, Dunn-
Si dak 
procedure, 
simple 
univariate t-
test. 
Both groups decreased 
HDL-C from baseline to 
the 1st 2 wks, control 
group decrease more than 
the ex-group. By the 5th 
week the ex-group 
increase HDL-C to 
baseline levels. Both 
groups decrease TC, LDL-
C, TG and glucose levels 
(p<0.05), but there was 
no diff. between groups. 
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CHAPTER III 
METHODOLOGY 
The methodology section consists of a description of 
the participants, the program and its implementation, the 
laboratory and anthropometric methods used, and the analysis 
of the data. Within each section, the specific procedures 
used to collect data and the protocols used to implement the 
objectives of the study are described. 
Subjects 
Following completion of the informed consent form 
approved by the departmental Human Subjects Review Committee 
(Appendix B), the subjects were recruited from participants 
in the spring 1990 RESHAPE program through TV and newspaper 
media. Fifty-five subjects were recruited. There were 20 
male subjects and 35 female subjects. 
Subjects were excluded from the RESHAPE program if they 
did not have the appropriate physician's clearance (Appendix 
C). Subjects who were over 35 years of age or had a medical 
history of heart disease, diabetes or hypertension, 
regardless of age, were required to have a physician's 
clearance. All subjects were given the opportunity to 
participate regardless of gender or age. 
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Data Col lection 
Demographic Information 
Demographic data, including age and sex, were collected 
at the time of the initial visit. Both personal and 
familial medical history information were collected for CHD, 
hypertension, diabetes, obesity, cancer, respiratory 
disease, renal disease, liver disease, GI disease, 
osteoporosis, and arthritis. 
Anthropometric Data 
The weight, height, blood pressure, skinfolds 
thickness, and waist and hip measurement were measured for 
each subject. Height and weight were determined using a 
"Detecto" beam balance scale with the attached stadiometer. 
The scale was calibrated at zero pounds. The participant 
was weighed without shoes, jewelry, and outer garments. 
Weight was recorded in pounds to the nearest tenth of a 
pound. Height was measured at week 0. The measurement was 
taken to the nearest tenth of an inch. Pounds and inches 
were converted to kilograms and centimeters, respectively. 
Lange skinfold calipers were used to determine the four 
skinfold thickness: triceps, biceps, subscapular, and 
suprailiac. All measurements were taken on the right side 
of the body by trained graduate students. 
Triceps and biceps skinfolds were measured at a point 
midway between the lateral margin of the acromion and 
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olecranon process with the right arm held pendant. The 
subscapular skinfold was measured at the medial angle of the 
inferior border of the scapula. The suprailiac skinfold was 
measured superior and medially from the tip of the iliac 
crest. Body fat was estimated from the sum of the four 
skinfolds according to standards developed by Durnin and 
Womersley (1974) (Appendix D). These variables were 
measured again at week 12. 
Regional adiposity, reflected by the WHR was measured 
as follows: using a non-stretchable measuring tape, waist 
circumference was measured at the level of the umbilicus. 
Hip circumference was measured at the widest part between 
hip and buttocks. 
Body mass index (BMI) = Wt/Ht2 was calculated for each 
subject. Obesity was defined according to the criteria of 
The National Research Council (1989) as described in the 
Review of Literature chapter. 
Diet Analysis 
A 4-day diet record was collected for Tuesday, 
Thursday, Saturdays, and Sundays for each subject during the 
first week and during the last week of the RESHAPE program. 
The subjects were instructed on the proper technique for 
collecting a food record at home (Appendix E). The food 
record was used because this method is the most reliable and 
valid dietary survey instrument (Bazzarre & Myers, 1978). 
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Nutrient values were obtained using The Food Processor II 
computerized program (Hefferren, 1989). The average daily 
intake for the 4-day period was used for statistical 
analysi s. 
Clinical Data 
Blood pressure was measured using a standard mercury 
sphygmomanometer after the subjects were seated in a quiet 
area for at least 5 minutes. The first and fifth Korotkoff 
(disappearance of sound) were taken as the systolic and 
diastolic pressures, respectively. The average of the two 
measurements, taken sequentially, was used in data analysis. 
Blood Analysis 
At the initial screening and again at week 12, 
approximately 20 ml of blood were drawn from each subject 
after a 12-hour fast. The blood analysis took place at the 
UNCG laboratory in the Department of Food and Nutrition and 
Food Service Management. 
Total plasma cholesterol was determined according to 
the procedure described by Allain, Poon, Chan, Richmond, and 
Fu (1974) (Sigma Chemical Company kit #352-20) (Appendix F). 
The procedure generated oxidation products by cholesterol 
oxidase following cholesterol ester hydrolysis by 
cholesterol esterase. The use of these enzymes was coupled 
with the p-hydroxybenzenesulfonate 
chromogenic system. The reactions 
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and 4-aminoantipyrine 
employed were as follows: 
1 . Cholesterol Esters cho1esterol Esterase > cholesterol + Fatty Acids 
2 . Cholesterol + 02 Cholesterol Oxidase > cholest-4-en-3-one + H202 
3. 2H202 + 4-Aminoantipyrine + p-Hydroxybenzene-sulfonate 
Peroxidase > Quinoneimina Dye + 4H20 
In the last step, hydrogen peroxide reacted with 4-
aminoantipyrine and p-hydroxybenzenesulfonate in the 
presence of peroxidase to yield a quinoneimine dye, which 
had a maximum absorbance at 500nm. The amount of color 
produced was directly proportional to the concentration of 
total cholesterol in the sample. Absorbancies were 
determined using the Bausch & Lomb Spectronic 2000 
spectrophotometer. The HDL-cholesterol fraction was 
measured following the precipitation of the VLDL and the LDL 
fractions with heparin manganese according to the procedure 
described by Warnick and Albers (1978) (Appendix F). The 
HDL3-C subfraction was determined by the dextran sulfate 
precipitation method (MW=15,000) according to Gidez, Miller, 
Burstein, Slagle, & Eder (1982). The HDL2-C subfraction was 
measured by subtracting HDL3-C from HDL-C. 
Glycosylated hemoglobin (HbA1) was determined using the 
procedure described by Gabbay, Hasty, Breslow, Ellison, 
Bunn, and Gallop (1977) (Sigma Chemical Company kit # 440, 
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P. 0. Box 14508, St. Louis, MO 63178) (Appendix F). 
Fasting insulin was measured by radioimmunoassay according 
to the procedure described by Hales and Randle (1963) (kit 
#TKIN2 from DPC Diagnostic Products Corporation 5700 West 
96th Street Los Angeles, CA 90045) (Appendix F). Fasting 
glucose levels was measured following the procedure by Stein 
(1963) (kit #16-UV from Sigma Chemical Company St. Louis, 
MO). This method uses the enzymatic action of hexokinase 
and glucose-6-phosphate dehydrogenase on glucose to 
ultimately produce NADH. Glucose concentration was 
determined from spectrophotometric changes in absorbance at 
340 nm. Absorbancies were measured with the Bausch & Lomb 
Spectronic 2000 spectrophotometer. Detailed procedure steps 
are listed in Appendix F. All samples were measured in 
duplicate. Duplicate samples were re-analyzed if the 
percent difference was greater than two percent. The 
average of the duplicate readings was used in data analysis. 
Measures of Stress 
Each subject's stress level was assessed by two 
different instruments: the Current Self-Appraisal 
Questionnaire developed by Bazzarre (unpublished) (Appendix 
G), and the State-Trait Anxiety Inventory (STAI) developed 
by Spielberger, Gorsuch, and Lushene (1970) (Appendix H). 
The purpose of these instruments was to have information 
about subject's feelings on the day the blood sample and 
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blood pressure were taken (Current Self Appraisal), and to 
determine actual levels of A-State intensity induced by 
stressful experimental procedures (STAI). The A-State scale 
is a sensitive indicator of the level of transitory anxiety 
experienced by patients in counseling, psychotherapy, and 
behavior therapy (Spielberger et al., 1970). Since stress 
and other factors such as body weight and age can have a 
marked impact on cardiovascular disease risk factors, an 
effort was made to evaluate the relative contribution of 
these factors and diet on the dependent variables. 
Intervention Program 
Physical Activity and Lifestyle Management Program 
Lifestyle workshops took place on Monday evenings from 
7:00 to 8:30 p.m. Topics discussed included: lifestyle 
management, proper foot attire for exercise, nutrition, 
benefits of physical activity and a healthy diet, evaluation 
of fad diets, cold weather workouts, stress management, 
behavior change techniques, cholesterol and fiber, food 
laboratories on low calorie meals, how to eliminate empty 
calories, and cutting out fat and sugar. 
Walking/Jogging Sessions 
The exercise program consisted of "fast" walking 
therapy sessions which met three times per week (Monday, 
Wednesday, and Thursday) for 12 weeks. The walking took 
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place along city streets close to the UNC-G campus. 
Subjects were encouraged to walk at least two additional 
times per week on their own. 
The sessions began with a 5-10 minute warm-up period. 
The first exercise session began with 20 minutes of 
walking/jogging at week 1 and was gradually increased five-
minute per week and maintained at 60 minutes per session for 
weeks 8-12. The exercise sessions ended with a 5-10 minutes 
cool-down, stretching period. 
Walking was performed at a calculated target heart rate 
of approximately 65-75% of maximal heart rate. The 
percentage of maximal heart rate for each participant was 
determined by the Karvonen method. 
The Karvonen formula: 
220-age= estimated maximal heart rate. 
maximal heart rate - resting heart rate= heart rate 
range. 
heart rate range X 0.65 = exercise heart rate. 
Exercise heart rate + resting heart rate = target heart 
rate(659S). 
The target heart rate was divided by six to obtain a rate 
for 10 seconds. Heart rates were recorded before and after 
each session as well as at intervals during each session. 
Participants learned how to take a 10 seconds pulse by 
palpating the radial artery or the external carotid artery. 
If the rate in 10 seconds exceeded the target range, the 
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participant was told to decrease their exercise intensity, 
or to increase their exercise intensity if the rate was 
below the target range. The exercise sessions were led by 
exercise therapists with proper training in measuring heart 
rate, stretching exercises, and CPR certification. 
Data Analysis 
Data analyses were conducted using SAS (Statistical 
Analysis System, Cary, NC). The statistical analyses were 
conducted for males and females, separately. Preliminary 
analysis included the calculation of descriptive statistics 
(mean, and standard error of the mean) for the independent 
variables age, height, body weight, BMI, SSF, %BF, WHR, 
waist and hip circumferences. 
The Pearson's Product Moment Correlation coefficients 
were used to assess the correlations between the dependent 
variables: fasting glucose, insulin, HbA1, SBP, DBP, TC, 
HDL-cholesterol, HDL2-C, HDL3-C, and the independent 
variables (WHR, BMI, and the SSF as well as dietary 
variables such as kcalories, protein, fat, carbohydrate, 
cholesterol, polyunsaturated/saturated fat ratio, dietary 
fiber, calcium, sodium, potassium, and the zinc/cooper, 
calcium/sodium, and potassium/sodium ratios). The Pearson 
product moment correlation coefficient was also used to 
assess associations between changes in SSF, WHR, and body 
weight, with changes in each of the dependent variables. 
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Since each group of variables can be measured in several 
ways, the initial correlation analyses were used to identify 
the related anthropometric variables (WHR, SSF, and BMI) 
that were significantly correlated with the dependent 
vari ables. 
Multiple regression analyses were used to assess the 
associations between the dependent variables and SSF and 
WHR. When the associations between the dependent variables 
and the SSF were estimated, age and WHR were included in the 
model to adjust for any confounding effect. Age and the SSF 
were controlled for when the associations between the 
dependent variables and WHR were estimated. 
The relationships between the dependent variables and 
the categorical WHR variable were estimated using analysis 
of covariance. The WHR was divided into tertiles for each 
gender as discussed in the review of the literature section. 
Age and the SSF were used a~ covariates. 
A paired-difference t-test was used to test the 
differences between week 0 and week 12 for each of the 
variables: BW, BMI, SSF, %BF, WHR, waist and hip 
circumference, stress scales: CSA and STAI, dietary 
variables: calories, fat, dietary fiber, and cholesterol, 
and the time taken to walk a mile as a measure of 
cardiovascular fitness. 
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CHAPTER IV 
RESULTS 
The results of this dissertation research are 
summarized in Tables 6 through 26. This section has been 
organized to include a general description of the population 
studied and the results of the statistical analyses for each 
hypothesis. 
This research consisted of two studies: The cross 
sectional component for hypotheses 1 through 4; and, the 
longitudinal component for hypotheses 5 through 12. For the 
cross sectional component, the associations between each of 
the nine dependent variables (insulin,glucose, Hb A,, SBP, 
DBP, TC, HDL-C, HDL2-C, and HDL3-C) and the independent 
variables (age, WHR, SSF, and BMI), were evaluated. For the 
longitudinal component, changes between week 0 and week 12 
were examined in the dependent variables, and in the 
following anthropometric variables: body weight, BMI, SSF, 
5KBF, and WHR; dietary variables: calories, fat, dietary 
fiber, and cholesterol; measures of stress: Current self 
appraisal and STAI scale; and the one-mile test as a measure 
of cardiovascular fitness. Each hypothesis was tested 
separately for males and females. 
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Participation 
Fifty-five subjects were recruited from participants in 
the Spring 1990 RESHAPE program as discussed in the 
methodology section. There were 20 male subjects and 35 
female subjects. Dropouts occurred in each group. At the 
end of the program 15 male subjects and 21 female subjects 
remained in the study. The reasons for dropping out were 
difficulty with parking, problems taking time off from work, 
and declining motivation. In the final experimental group 
only 5 females and 3 males returned dietary data at week 12. 
Eight males and 16 females participated in the final walk 
evaluation. For the cross sectional study in this 
dissertation research (hypotheses 1 through 4), data from 
all the participants at week 0 (baseline) were used. For 
the longitudinal component of this dissertation research 
(hypotheses 5 through 12) where comparisons between week 0 
and week 12 are made, only data for subjects available from 
both data collection periods were used. The control group 
was so small at week 12 that no hypotheses were tested for 
the control group. Although the small sample size and the 
less than complete follow-up data limit the generalizabi1ity 
of the results, the data from these participants were 
analyzed to determine whether there was evidence for an 
effect of the exercise and nutrition education program on 
body fat, body fat pattern, and various physiological 
vari ables. 
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Descriptive Characteristics of Participants 
The descriptive characteristics of the participants are 
given in Table 6. The average age for males was 46.9 + 1.5 
years (38 to 62 years). The average age for females was 
44.8 + 2.2 years (17 to 67 years). For males, the BMI was 
31.3 + 1.8, the XBF was 30.8 + 1.7, the SSF was 83.3 + 8.6, 
and the sum of tricep and subscapular SF was 47.6 + 4.2. 
For females, the BMI was 26.6 + 0.8, the 96BF was 35.3 + 0.7, 
the SSF was 73.4 + 3.4, and the sum of tricep and 
subscapular SF was 43.0 + 1.9. The average WHR for males 
was 1.05 + 0.04, while for females the average WHR was 0.90 
+ 0.01. Waist circumferences were 113.2 + 4.4 cm and 97.3 + 
2.4 cm for males and females, respectively. Hip 
circumferences were 109.1 ± 4.2 cm for males and 108.6 + 2.2 
cm for females. 
The WHR was divided into tertiles as a categorical 
variable to evaluate the association between an increase in 
WHR tertile and changes in the estimated means of the 
dependent variables. The ranges used to create the tertiles 
are presented in the following table: 
Ranges of the WHR tertiles 
Tert i1es 
Gender Low Medium High 
Mai es <0.92 0.92<WHR<1.07 IV
 
o
 
->
l 
Females <0.77 0.77<WHR<0.83 > 0.83 
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Table 6 
Age and Anthropometric Data for Males and Females 
Participants at Week 0 (baseline). 
Males Females 
Variable (Mean + SEM) (Mean + SEM) 
Age(yrs) 46.9 ±1.5 44.8 + 2.2 
n: 16 31 
Height (cm) 180.0 ± 1.8 163.0 ± 1.4 
n: 15 28 
Body weight(Kg) 
week 0 101.0 ± 5.2 72.4 ± 2.4 
n: 16 31 
BMI(Wt/Ht2) 
Week 0 31.3 ± 1.8 26.6 + 0.8 
n: 15 28 
SSF (mm) 
Week 0 83.3 + 8.6 73.4 ± 3.4 
n: 16 31 
Body fat (X) 
Week 0 30.8 + 1.7 35.3 ± 0.7 
n: 16 31 
Waist (cm) 
Week 0 113.2 + 4.4 97.3 + 2.4 
n: 16 30 
Hip (cm) 
Week 0 109.1 ± 4.2 108.6 + 2.2 
n: 16 30 
WHR 
Week 0 1.05 ± 0.04 0.90 ± 0.01 
n: 16 30 
1  1  6  
Dietary Variables 
Twenty-three females and 12 males completed food 
records at baseline. The mean calorie intake was 2311 + 175 
and 1740 ± 110 for males and females, respectively. The 
mean fat percent intake was 37+2 and 36 ± 2%, for males 
and females, respectively. The mean carbohydrate percent 
intake was 49 + 2, and 47 + 2%, for males and females, 
respectively. The mean dietary fiber intake was 19 ± 2 and 
15 + 1g, for males and females, respectively. 
Pearson product moment correlation coefficients between 
the dependent variables and the selected dietary variables 
are presented in Tables 7 through 9. Insulin was 
significantly correlated with polyunsaturated/saturated fat 
ratio (r=-0.64; p=0.001) and with dietary fiber (r=-0.46; 
p=0.03) in females (n=23). SBP was significantly correlated 
with dietary cholesterol in males (r=0.59; p=0.03) (n=13). 
TC was significantly correlated with calories (r=0.38; 
p=0.04) and carbohydrates (r=0.49; p=0.009) in females, and 
with protein (r=-0.53; p=0.03) and zinc/cooper ratio (r=-
0.52; p=0.04) in males (Table 8). HDL-C was significantly 
correlated with calories (r=0.39; p=0.04), protein (r=0.55; 
p=0.002), and fat (r=0.38; p=0.04) in females (Table 9). 
Glucose, Hb A,, DBP, HDLZ-C, and HDL3-C were not 
significantly correlated with any dietary variable in males 
or females. The hypertension risk factor variables (SBP and 
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Table 7 
Pearson Product Moment Correlation Coefficients Between 
Selected Dietary Variables and Diabetes Risk Factors. 
Variable Insulin Glucose Hb A1 
r-value; p-value 
Calories 
males=13 -0.27; 0.37 0.10; 0.74 -0.27; 0.38 
females=23 0.03; 0.89 0.21; 0.33 -0.07; 0.76 
Protein 
males=13 -0.06; 0.83 0.37; 0.21 0.12; 0.71 
females=23 -0.25; 0.27 0.13; 0.55 -0.00; 0.99 
Fat 
males=13 -0.12; 0.69 0.04; 0.90 -0.09; 0.77 
females=23 0.18; 0.43 0.26; 0.22 -0.12; 0.57 
Carbohydrates 
males=13 -0.32; 0.28 0.08; 0.78 -0.45; 0.12 
females=23 -0.08; 0.74 0.02; 0.93 -0.02; 0.92 
Choiesterol 
males=13 -0.04; 0.89 0.14; 0.64 -0.23; 0.45 
females=23 0.04; 0.84 0.12; 0.57 0.21; 0.32 
PS ratio" 
males=13 0.12; 0.69 0.09; 0.77 -0.06; 0.85 
females=23 -0.64; 0.001* -0.16; 0.44 0.09; 0.68 
Dietary Fiber 
males=13 -0.28; 0.34 0.38; 0.20 0.06; 0.84 
females=23 -0.46; 0.03* -0.08; 0.69 -0.01; 0.98 
Zinc/Copper 
males=13 0.48; 0.09 -0.20; 0.50 0.38; 0.20 
females=23 0.26; 0.26 0.04; 0.86 -0.01; 0.95 
* significant at p<0.05 level. 
a=polyunsaturated/saturated fat ratio. 
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Table 8 
Pearson Product MaMBnt Correlation Coefficients Between Selected Dietary Variables, Total 
Cholesterol as CHD Risk Factor and Hypertension Risk Factors. 
Variable 8BP DBP TC 
(r-value; p-value) 
Kcalories 
na1es=13 0.14; 0.64 -0.41; 0.17 -0.17; 0.53 
females=25 0.10; 0.64 0.11; 0.60 0.38; 0.04* 
Protein 
male8=13 0.32; 0.29 -0.27; 0.36 -0.53; 0.03* 
femalea=25 0.05; 0.81 0.12; 0.57 0.1B; 0.35 
Fat 
males=13 0.24; 0.42 -0.40; 0.17 -0.42; 0.10 
femal68=25 0.12; 0.58 0.21; 0.31 0.23; 0.23 
Carbohydrates 
ma1es=13 -0.09; 0.78 -0.26; 0.39 0.25; 0.34 
femal68=25 0.08; 0.71 -0.03; 0.89 0.49; 0.009* 
Cholesterol 
males=13 0.59; 0.03* 0.10; 0.76 -0.46; 0.07 
females=25 -0.14; 0.51 -0.02; 0.91 0.30; 0.12 
PS ratio* 
males=13 -0.05; 0.87 0.46; 0.11 0.14; 0.61 
females=25 0.07; 0.73 0.05; 0.80 -0.06; 0.78 
Dietary Fiber 
Rial68= 13 -0.22; 0.47 -0.54; 0.06 -0.11; 0.67 
females=25 -0.14; 0.49 -0.21; 0.32 0.16; 0.40 
Calciiai 
males=13 0.12; 0.68 -0.44; 0.12 X 
females=25 -0.19; 0.37 -0.16; 0.45 X 
Sodiue 
ma1es=13 0.21; 0.49 -0.26; 0.40 X 
females=25 0.11; 0.60 0.28; 0.18 X 
Potassiia 
males=13 -0.14; 0.65 -0.45; 0.12 X 
females=25 -0.09; 0.67 -0.13; 0.54 X 
CalciuHiSodiua 
males=13 -0.08; 0.79 -0.46; 0.11 X 
females=25 -0.29; 0.16 -0.36; 0.07 X 
Potassiue:Sodius 
males=13 -0.39; 0.18 -0.23; 0.45 X 
females=25 -0.22; 0.29 -0.37; 0.07 X 
Zinc: Copper 
Rial68= 16 X X -0.52; 0.04* 
females= X X -0.14; 0.50 
* significant at p<0.05 level. 
a=po1yunsaturated/saturated fat ratio 
X no correlation coefficient was calculated 
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Table 9 
Pearson Product Moment Correlation Coefficients Between 
Selected Dietary Variables and CHD Risk Factors. 
Vari able HDL--C 
(r-
HDL2-
-value; 
-C 
p-value) 
HDL3--C 
Kcalories 
males=16 
females=27 
0.09; 
0.39; 
0. 
0. 
75 
04* 
0.19; 
0.24; 
0.48 
0.23 
0.05; 
0.26; 
0. 
0. 
84 
20 
Protein 
males=16 
females=27 
-0.15; 
0.55; 
0. 
0. 
57 
002* 
0.10; 
0.31 ; 
0.71 
0.12 
-0.24; 
0.42; 
0. 
0. 
37 
03 
Fat 
males=16 
females=27 
0.17; 
0.38; 
0. 
0. 
52 
04* 
0.33; 
0.27; 
0.21 
0.17 
0.09; 
0.19; 
0. 
0. 
74 
35 
Carbohydrates 
males=16 
females=27 
-0.04; 
0.14; 
0. 
0. 
90 
46 
-0.05; 
0.09; 
0.84 
0.64 
0.01 ; 
0.10; 
0. 
0. 
97 
60 
Choiesterol 
males=16 
females=27 
0.05; 
0.51 ; 
0. 
0. 
84 
50 
0.13; 
0.34; 
0.62 
0.07 
-0.02; 
0.36; 
0. 
0. 
94 
06 
PS Ratio* 
males=16 
females=27 
0.10; 
0.15; 
0. 
0. 
71 
44 
-0.03; 
-0.18; 
0.91 
0.36 
0.17; 
0.22; 
0. 
0. 
53 
27 
Dietary Fiber 
males=16 
females=27 
0.09; 
0.29; 
0. 
0. 
72 
13 
0.28; 
0.13; 
0.28 
0.52 
0.03; 
0.33; 
0. 
0. 
90 
10 
Zinc:Copper 
males=16 
females=27 
-0.40; 
0.12; 
0. 
0. 
12 
55 
-0.29; 
0.31 ; 
0.27 
0.13 
-0.42; 
-0.04; 
0. 
0. 
10 
85 
* statistically significant at p£0.05 level. 
a=polyunsaturated/saturated fat ratio. 
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Table 10 
Pearson Product Moment Correlation Coefficients Between 
Selected Dietary Variables and Anthropometric Variables. 
Variable SSF WHR BMI 
(r-value; p-value) 
Calories 
males=12 
females=25 
Protei n 
males=12 
females=25 
0.04; 0.89 
0.07; 0.71 
-0.06; 0.84 
0.05; 0.80 
Fat 
males=12 
females=25 
Carbohydrates 
males=12 
females=25 
Cholesterol 
males=12 
females=25 
PS Ratio" 
-rial es=12 
females=25 
Dietary Fiber 
males=12 
females=25 
0.15; 0.61 
0.21; 0.30 
-0.03; 0.91 
- 0 . 1 0 ;  0 . 6 1  
0.16; 0.59 
- 0 . 1 1 ;  0 . 6 0  
0.28; 0.34 
-0.07; 0.72 
-0.16; 0.59 
-0.09; 0.66 
0.15; 0.61 
0.02; 0.93 
0.29; 0.36 
0.06; 0.78 
-0.07; 0.80 
-0.00; 0.98 
-0.14; 0.67 
-0.00; 0.99 
-0.22; 0.44 
-0.09; 0.67 
0.37; 0.23 
0.19; 0.37 
0.58; 0.02* 
0.19; 0.37 
0.17; 0.58 
-0.08; 0.70 
0.07; 0.82 
-0.24; 0.26 
0.25; 0.44 
-0.10; 0.65 
0.14; 0.62 
0.45; 0.02* 
0.09; 0.78 
-0.18; 0.41 
-0.07; 0.82 
0.12; 0.57 
0.03; 0.93 
-0.19; 0.37 
* significant at p<0.05 level. 
a=polyunsaturated:saturated fat rat io. 
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DBP) were not significantly correlated with calcium, 
potassium, calcium/sodium ratio, or the potassium/sodium 
rat io. 
Pearson product moment correlation coefficients between 
selected dietary variables and anthropometric variables are 
presented in Table 10. WHR was significantly correlated 
with polyunsaturated/saturated fat ratio in females (r=0.45; 
p=0.02), and with dietary intake of carbohydrates in males 
(r=0.58; p=0.02). No other significant correlations were 
found between these variables. 
Statistical Hypotheses 
The results for each hypothesis tested are reported in 
Tables 11 through 26. For all hypotheses the null and 
expected research hypotheses are given. 
For the first hypotheses, the Pearson product moment 
correlation coefficients were calculated in order to 
identify any significant correlations of the dependent 
variables with WHR, SSF, and BMI (Table 11). 
Hypotheses 1: 
H0: The correlations between the WHR, SSF, and BMI, and 
the dependent variables: fasting insulin, glucose, Hb A1, 
SBP, DBP, TC, HDL-C, HDLZ-C, and HDL3-C are each equal to 
zero. 
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Ha: a. The correlations between the WHR, SSF and BMI 
with selected diabetes risk factors: fasting insulin, 
glucose, and Hb A, are each positive. 
The correlations between WHR and fasting insulin, 
glucose, and Hb A, were not significant. Therefore, the H0 
was not rejected for these three dependent variables. SSF 
was significantly correlated with insulin (r=0.70; p=0.001 
for males, and r=0.48; p=0.004 for females), glucose 
(r=0.49; p=0.024 for males, and r=0.39; p=0.01 for females), 
and Hb A1 (r=0.33; p=0.09 for males). Thus, the H0 was 
rejected for insulin and glucose in males and females, and 
for Hb A, in females. BMI was significantly correlated with 
insulin (r=0.59; p=0.008 for males, and r=0.49; p=0.005 for 
females). Therefore, the H0 was rejected for insulin and 
BMI. Glucose and Hb An were not significantly correlated 
with BMI. Therefore, the H0 was not rejected for these 
vari ables. 
b. The correlations between WHR, SSF, and BMI and 
selected hypertension risk factors: SBP and DBP are each 
positive. 
The correlations between WHR and SBP and DBP were not 
significant. Therefore, the Hc was not rejected for the 
association with WHR. SSF was significantly correlated with 
SBP (r=0.44; p=0.03 for males) and DBP (r=0.58; p=0.004 for 
males, and r=0.50; p=0.001 for females). Therefore, the H0 
was rejected for SSF and SBP in males and for DBP in both 
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males and females. BMI was significantly correlated with 
SBP (r=0.54; p=0.001) and DBP (r=0.47; p=0.004) in females. 
Therefore, the He was rejected for BMI and the hypertension 
risk factor variables for females, but not for males. 
c. The correlations between WHR, SSF, and BMI and the 
selected CHD risk factor: TC are each positive. 
The correlations between WHR and TC were 0.49 (p=0.01) 
for males, and 0.44 (p=0.004) for females. Therefore, the 
H0 was rejected for TC. The correlation between TC and SSF 
was statistically significant for females (r=0.28; p=0.05) 
but was not for males. Therefore, the H0 was rejected for 
SSF in females. The correlations between BMI and TC were 
not statistically significant for males nor females. 
Therefore, the H0 was not rejected for BMI. 
d. The correlations between WHR, SSF, and BMI and 
selected CHD risk factors: HDL-C, HDL2-C, and HDL3-C are 
each negative. 
The correlations between WHR and HDL-C, HDL2-C, and 
HDLg-C were not significant. Therefore, the He was not 
rejected for the association between WHR and these three 
dependent variables. The correlations between SSF and HDL-
C, and HDL3-C were not significant for males nor females. 
SSF was significantly correlated with HDL2-C (r=-0.32; 
p=0.03) in females, but not for males. Therefore, the H„ 
was rejected for HDL2-C in females. The H0 was not rejected 
for the association between HDL-C and HDL3-C with SSF. 
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Table 11 
Suawry Table for Hypotheses 1 Using Pearson Product Mount Correlation Coefficients. 
H0: There are no correlations between HHR, SSF, and BMI and each of the dependent 
variables. 
Ha: The correlation between HHR, SSF and BMI and each of the dependent variables is 
positive or negative as indicated in the table by + or - sign. 
Dependent 
Variable HA MHR SSF BMI 
(r-value; p-value) 
Insulin (ulU/el) 
males n=17 
females n=30 
Glucose ((eg/dl) 
males n=17 
females n=32 
Hb A1 (X) 
males n=17 
females n=32 
SBP (ee/Hg) 
males n=19 
females n=34 
DBP (ee/Hg) 
males n=19 
females n=34 
TC (eg/dl) 
males n=20 
females n=34 
-0.34; 
-0.07; 
0.002; 
0.17; 
-0.27; 
0.13; 
0.13; 
0.21; 
0.24; 
0.07; 
0.49; 
0.44; 
0.91 
0.64 
0.49 
0.18 
0.70 
0.24 
0.29 
0.12 
0.16 
0.34 
0.01* 
0.004« 
0.70; 0.001* 
0.48; 0.004> 
0.49; 0.024* 
0.39; 0.01* 
0.33; 0.09 
0.43; 0.007* 
0.44; 0.03* 
0.27; 0.06 
0.58; 0.004* 
0.50; 0.001* 
-0.14; 0.73 
0.28; 0.053* 
0.59; 
0.49; 
0.41; 
0.24; 
0.26;  
0.17; 
0.36; 
0.54; 
0.36; 
0.47; 
-0 .22 ;  
0.14; 
0.008* 
0.005* 
0.06 
0.11 
0.17 
0.18 
0.075 
0.001* 
0.08 
0.004* 
0.81 
0 . 2 2  
HDL-C (eg/dl) 
males n=20 
females n=34 
-0.18; 
-0 .02;  
0 . 2 2  
0.46 
-0.06; 0.40 
-0.13; 0.22 
-0.07; 
-0.31; 
0.39 
0.04* 
HDLZ-C (eg/dl) 
males n=20 
females n=34 
-0.09; 
-0.09; 
0.34 
0.31 
-0.01; 0.47 
-0.32; 0.03* 
0.05; 
-0.38; 
0.58 
0.02* 
HDL3-C (eg/dl) 
males n=20 
females n=34 
-0 .26;  
0.03; 
0.13 
0.56 
-0.11; 0.32 
-0.06; 0.36 
-0.14; 
-0.16; 
0 . 2 8  
0 .20  
* statistically significant at p<0.05 level. 
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The correlations between BMI and HDL-C (r=-0.31; p=0.04) and 
HDL2-C (r=-0.38; p=0.02) was significant for females, but 
not males. The correlation between BMI and HDL3-C was not 
significant for either gender. Therefore, the H0 was 
rejected for BMI and HDL-C and HDL2-C in females, but not 
for HDLg-C. 
Associations between SSF as well as WHR and the dependent 
variables. 
Multiple regression analyses were used to evaluate the 
associations between the dependent variables and the SSF 
(hypotheses 2), or the WHR (hypotheses 3). When the 
associations between the dependent variables and SSF were 
assessed, age and WHR were included in the model to adjust 
for any confounding effect (Table 12). Age and the SSF were 
controlled for when the associations between the dependent 
variables and WHR were evaluated (Table 13). 
Hypotheses 2: 
H0: After controlling for the effects of the variables 
age and WHR, the regression coefficient for the SSF is zero 
for each of the dependent variables: insulin, glucose, Hb 
A,, SBP, DBP, TC, HDL-C, HDL2-C and HDL3-C. 
Ha: After controlling for the effects of the 
variables age and WHR, the regression coefficient for the 
SSF is greater than zero for each of: 
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a. Diabetes risk factors: insulin, glucose, and Hb A,. 
For insulin and glucose, the regression coefficients 
for SSF were significantly greater than zero for both males 
and females. The regression coefficient for insulin was 
0.17 + 0.05 (p=0.002) for males and 0.18 + 0.04 (p=0.0002) 
for females. The regression coefficient for glucose was 
0.57 ± 0.24 (p=0.017) for males and 0.21 ± 0.09 (p=0.015) 
for females. Therefore, the H„ was rejected for these 
dependent variables. For Hb A,, the regression coefficient 
for SSF was significantly greater than zero for females 
(0.02 + 0.01; p=0.009) but was not for males. Therefore, 
the H0 for the variable Hb A, was rejected for females, but 
was not rejected for males. 
b. Hypertension risk factors: SBP and DBP. 
The regression coefficients were significantly greater 
than zero for SBP (males: 0.18 + 0.07; p=0.009 and females: 
0.44 + 0.12; p=0.0004), and significantly greater than zero 
for DBP (males: 0.19 + 0.07; p=0.006, and females: 0.16 + 
0.07; p=0.01). Therefore, the H0 was rejected for both SBP 
and DBP. 
c. CHD risk factor: TC. 
For the variable TC, the regression coefficient for the 
SSF was not significantly different from zero for males or 
females. Therefore, the H0 for TC was not rejected. 
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Table 12 
Summary Table for Hypotheses #2 Using Multiple Regression 
Analysis. 
H0: After controlling for age and WHR, the regression 
coefficient for the sum of skinfolds is zero for each of the 
dependent variables. 
Ha: After controlling for age and WHR, the regression 
coefficient for sum of skinfolds is positive or negative 
indicated in the table by (+) or (-) sign for each of the 
dependent variables. 
Statistical Results 
Dependent Variable HFL (b + SE; p-value) 
Insulin (ulU/ml): 
males (n=17) + 0.17 + 0 .05; 0. 002* 
females (n=29) + 0.18 + 0 .04; 0. 0002* 
Glucose (mg/dl): 
males (n=17) + 0.57 + 0 • 24; 0. 017* 
females (n=32) + 0.21 + 0 .09; 0. 015* 
Hb A1 (X): 
males (n=17) + 0.01 + 0 .01 ; 0. 18 
females (n=31) + 0.02 + 0 .01 ; 0. 009* 
SBP (mm/Hg): 
males (n=18) + 0.18 + 0 .07; 0. 009* 
females (n=33) + 0.44 + 0 .12; 0. 0004* 
DBP (mm/Hg): 
males (n=19) + 0.19 + 0 .07; 0. 006* 
females (n=33) + 0.1 6 + 0 .07 ; 0. 01 * 
TC (mg/dl): 
males (n=20) + -0.13 + 0 .21 ; 0. 74 
females (n=33) + 0.28 + 0 .26; 0. 1 5 
HDL-C (mg/dl): 
males (n=20) - -0.02 + 0 .08; 0. 38 
females (n=33) — -0.14 + 0 .08; 0. 06 
HDL2-C (mg/dl): 
males (n=20) - -0.002 + 0 .04; 0. 47 
females (n=34) - -0.10 + 0 .05; 0. 04* 
HDL3-C (mg/dl): 
males (n=19) - -0.13 + 0 .04; 0. 002* 
females (n=34) — -0.04 + 0 .06; 0. 25 
* significant at p<0.05 level 
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d. After controlling for the effects of the 
variables age and WHR, the regression coefficient for the 
SSF is less than zero for each of the CHD risk factors: 
HDL-C, HDL2-C, and HDL3-C. 
For the variables HDL-C and HDL2-C, the regression 
coefficients for SSF were significantly less than zero for 
females (HDL-C: -0.14 + 0.08; p=0.06, and HDL2-C: -0.10 + 
0.05; p=0.04) but not significantly different from zero for 
males. Therefore, the H0 was rejected for females, but was 
not rejected for males for these two dependent variables. 
For the variable HDL3-C, the regression coefficient for 
SSF was significantly less than zero for males (-0.13 + 
0.04; p=0.002) but not for females. Therefore, the H0 for 
the variable HDL3-C was rejected for males, but was not 
rejected for females. 
Hypotheses 3: 
H„: After controlling for the effects of SSF and age, 
the regression coefficient for WHR is zero for each of the 
dependent variables: insulin, glucose, Hb A1f SBP, DBP, TC, 
HDL-C, HDL2-C, and HDL3-C (Table 13). 
Ha: After controlling for the effects of age and the 
SSF, the regression coefficient for WHR is greater than zero 
for each of: 
a. Diabetes risk factors: insulin, glucose, and Hb A,. 
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For the variables insulin, glucose, and Hb A,, the 
regression coefficient for WHR was not statistically 
different from zero. Therefore, the H0 was not rejected for 
these dependent variables. 
b. Hypertension risk factors: SBP and DBP. 
For SBP and DBP the regression coefficient for WHR 
was not larger than zero. Therefore, the H0 was not 
rejected for these dependent variables. 
c. CHD risk factor: TC. 
For TC, the regression coefficients were significantly 
greater than zero for both males and females. The 
regression coefficients were 90.53 + 40.84 (p=0.02) for 
males, and 125.29 ± 80.06 (p=0.06) for females. Therefore, 
the H„ was rejected for both males and females. 
d. After controlling for the effects of age and the 
SSF, the regression coefficient for WHR is less than zero 
for each of the CHD risk factors: HDL-C, HDLZ-C, and 
HDL3-C. 
For the variables HDL-C, HDL2-C, and HDL3-C the 
regression coefficients for WHR were not statistically 
different from zero for males nor females. Therefore, the 
He was not rejected. 
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Table 13 
Summary Table for Hypotheses #3 Using Multiple Regression 
Analysis. 
H0: After controlling for age and sum of skinfolds, the 
regression coefficient for WHR is zero for each of the 
dependent variables. 
Ha: After controlling for age and sum of skinfolds, the 
regression coefficient for WHR is positive or negative 
indicated in the table by (+) or (-) sign for each of the 
dependent variables. 
Statistical Results 
Dependent Variable HA (b + SE; p-value) 
Insulin (ulU/ml): 
males (n=17) + -10.81 + 9.17; 0.87 
females (n=29) + 1 1 .80 + 13.38; 0.19 
Glucose (mg/dl): 
males (n=17) + 18.37 + 43.84; 0.34 
females (n=32) + - 8.09 + 26.96; 0.62 
Hb A, (%): 
males (n=17) + - 1 .43 + 2.31 ; 0.73 
females (n=31 ) + 1 .74 + 2.54; 0.25 
SBP (mm/Hg): 
males (n=18) + 15.38 + 13.33; 0.13 
females (n=33) + 24.41 + 34.35; 0.24 
DBP (mm/Hg): 
males (n=19) + 16.93 + 12.92; 0.10 
females (n=33) + 8.86 + 20.01; 0.33 
TC (mg/dl): 
males (n=20) + 90.53 + 40.84; 0.02* 
females (n=33) + 125.29 + 80.06; 0.06 
HDL-C (mg/dl): 
males (n=20) - -11.81 + 15.50; 0.23 
females (n=33) — -40.20 + 26.40; 0.07 
HDL2-C (mg/dl): 
males (n=20) - - 2.88 + 7.51 ; 0.35 
females (n=34) — - 6.41 + 17.31; 0.36 
HDL3-C (mg/dl): 
males (n=19) - - 0.41 + 6.42; 0.48 
females (n=34) — -26.92 + 19.73; 0.09 
* significant at p<0.05 level. 
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Relationships between the dependent variables and the WHR 
divided into tertiles. 
For the hypotheses #4 (Table 14), the relationships 
between the dependent variables and the categorical WHR 
variable were evaluated using Analysis of Covariance. Age 
and the SSF were used as covariates. 
Hypotheses 4: 
He: After adjusting for age and SSF, there is no effect 
of the WHR tertile for each of the dependent variables: 
insulin, glucose, Hb A1, SBP, DBP, TC, HDL-C, HDL2-C, and 
HDL3-C. 
Ha: After adjusting for SSF and age, an increase in WHR 
tertile from low to medium to high is associated with: 
a. An increase in the estimated means of each of the 
following diabetes risk factors variables: insulin, glucose, 
and Hb A,, 
There was not a statistically significant increase in 
insulin, glucose, or Hb An, with an increase in WHR tertile. 
Therefore, the Hc were not rejected for these variables. 
b. An increase in the estimated means of each of the 
following hypertension risk factors: SBP and DBP. 
There was not a statistically significant increase in 
SBP or in DBP with an increase in WHR tertile. Therefore, 
the H0 was not rejected for these variables. 
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Table 14 
Suaaary Table for Hypotheses 14 Using Analysis of Covariance. 
Hq: After adjusting for age and sum of skinfolds, there is no effect of the WHR tertile 
for each of the dependent variables. 
Hfl: After adjusting for age and sum of skinfolds, an Increase in the WHR tertile from low 
to medium to high is associated with an increase or decrease in the estimated mean for each 
dependent variable as indicated in the table by the (+) or (-) sign. 
Statistical Results (Mean + SEN) 
Dependent Variable Hfl Low HadiLB High p-value 
Insulin (uIU/al): 
males (n=17) + 14 .0 + 0 0 24. 2 + 1. 4 18.5 + 2.6 0 08 
females (n=30) + 13 .6 + 4 .2 19 8 + 2 5 14.1 + 1.2 0 .15 
both (n=46)a + 16 .7 + 2 .0 16 0 + 1 5 20.2 + 1.7 0 16 
Glucose (ag/dl): 
males (n=16) + 90 .5 + 0 .0 99 3 + 5 6 114.8 * 10.4 0 24 
females (n=32) + 86 .7 + 7 6 93. 4 + 4 2 89.2 ± 2.2 0 62 
both (n=47)a + 93 .8 + 3 .4 88 8 + 2 6 98.7 + 3.1 0 06 
Hb A1 (X): 
males (n=16) + 5 .8 + 1 7 7. 4 + 0. 4 7.8 ± 0.6 0 39 
females (n=31) + 7 .0 + 0 7 6. 2 + 0. 4 6.9 + 0.2 0 40 
both (n=47) + 6 .4 + 0 3 7. 2 + 0. 2 7.2 ± 0.3 0 14 
SBP (M/Hg): 
males (n=19) + 116. 5 + 6. 9 126.9 + 3 .4 130.4 + 6.1 0 33 
females (n=34) + 127. 4 + 8. 4 121.9 + 5 .7 118.8 1 2.9 0 58 
both (n=53) + 119. 5 + 3. 4 122.4 + 2 .8 125.7 ± 3.7 0 48 
DBP (aa/Hg): 
males (n=19) + 75. 9 + 5. 6 86.0 + 2 .8 86.5 ± 4.9 0 27 
females (n=34) + 75 .9 + 4 6 79. 2 + 3. 1 75.5 + 1.6 0 60 
both (n=53) + 76 .6 + 2 0 78. 6 + 1 7 81.7 ± 2.3 0 28 
TC (mg/dl): 
males (n=20) + 199. 6 + 19 .9 209.7 + 9 .5 230.8 ± 17.4 0 47 
females (n=34) + 210. 1 + 15 .5 166.9 + 9 .9 211.0 ± 5.5 0 003 
both (n=54) + 191. 1 + 7 .7 209.0 + 6 .8 216.2 ± 8.2 0 08 
HDL-C (ag/dl): 
males (n=20) 51 .8 ± 6 3 45. 1 + 3. 0 35.7 ± 5.5 0 18 
females (n=35) 55 .5 + 7 7 54. 9 + 7. 7 58.4 * 2.7 0 81 
both (n=55) 54 .3 + 3 3 55. 0 + 2. 9 46.4 ± 3.6 0 14 
HDL2-C (mg/dl): 
males (n=20) 9 .5 + 3 3 7. 5 + 1. 5 6.8 + 2.9 0 83 
females (n=34) 15 .7 + 5 0 15. 3 + 2. 6 13.2 ± 1.4 0 76 
both (n=53)* 11 .7 + 1 8 11. 6 + 1. 4 10.1 ± 1.8 0 77 
HDL3-C (ag/dl): 
males (n=20) 43 .8 + 3 3 37. 5 + 1. 6 28.9 + 2.9 0. 01* 
females (n=34) 54 0 + 5 4 41. 1 + 2. 8 44.3 * 1.6 0. 11 
both (n=54) 44 .8 + 2 0 42. 3 + 1. 7 35.9 + 2.1 0. 01* 
* significant at p<0.05 level 
a= one outlier was removed. The sample size doeB not represent the sum of males plus 
females. 
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c. An increase in the estimated means of TC as a CHD 
risk factors. 
For females, there was a significant change in TC 
levels, which seems to be either from the low to medium 
tertile or from the medium to the highest tertile. For 
males, there was an increase in TC with an increase in WHR 
tertile but the increase was not significant. Therefore, 
the H0 were not rejected for either males or females. 
d. A decrease in the estimated means of each of the 
following CHD risk factors: HDL-C, HDL2-C, and HDL3-C. 
HDL-C, HDL2-C, and HDL3-C decreased with an increase in 
the WHR tertile in males, but only the increase in HDL3-C 
was statistically significant (p=0.01). Therefore, the H0 
was rejected for the variable HDL3-C in males. In females, 
an increase in WHR was not associated with a decrease in any 
of these dependent variables. Therefore, the H0 was not 
rejected for females. 
Hypotheses for the Longitudinal Study 
For the longitudinal component of this dissertation 
research, a paired-difference t-test was used to test 
hypotheses 5 through 9 (Tables 15 to 20). Hypothesis 5 
assessed the changes in the levels of each of the variables 
(insulin, glucose, Hb A,, SBP, DBP, TC, HDL-C, HDL2-C, and 
HDL3-C) after the 12-week exercise-nutrition program (Table 
15). 
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Hypotheses 5: 
H0: Among the participants of the RESHAPE program, 
there are no differences between week 0 and week 12 in each 
of the variables: insulin, glucose, Hb A1f SBP, DBP, TC, 
HDL-C, HDL2-C, and HDL3-C. 
Ha: At the end of the 12-week RESHAPE program, each of 
the following variables will decrease: 
a. Diabetes risk factors: insulin, glucose, and Hb A,. 
Fasting insulin decreased significantly by the end of 
the 12-week program for both males (t=4.7 + 1.2; p=0.002), 
and females (t=4.3 + 0.9; p=0.0002). Glucose decreased 
significantly for both males (t=10.6 + 3.8; p=0.008), and 
females (t=5.1 + 2.5; p=0.03). Hb A, decreased 
significantly for males (t=0.9 + 0.1; p=0.04), and females 
(t=0.9 + 0.3; p=0.003). The H0 was rejected for these three 
dependent variables for both males and females. 
b. Hypertension risk factors: SBP and DBP. 
SBP decreased significantly at the end of the 12-week 
program for males (t=9.7 + 2.7; p=0.002) and females (t=10.6 
+ 3.1; p=0.001). The H0 was rejected for SBP for both males 
and females. DBP decreased significantly only for males 
(t=7.7 + 2.4; p=0.003). DBP did not change significantly in 
females. The H„ was rejected for DBP for males, but was not 
rejected for females. 
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Table 15 
•ry Table for Hypotheses *5 Using Palrad-Dlfference T-test. 
"o;. Among the participants of the RESHAPE program, there are no differences for each of the 
following variables between week 0 and week 12. 
Hft: The participants of the RESHAPE program have lower or higher levels of the following 
variables at the end of the 12-wesk program as indicated by the (-) or (+) sign in the table. 
Dependent Variable H. Males ties 
Insulin (ulU/al): 
n: 
Week 0 
Week 12 
D1 f ference 
p-value 
Glucose (ag/dl): 
n: 
Week 0 
Week 12 
Difference 
p-value 
Hb A, (*)•' 
n: 
Week 0 
Week 12 
Di fference 
p-value 
3BP (M/Hg): 
n: 
Week 0 
Week 12 
Difference 
p-value 
DBP (mm/Hg): 
n: 
Week 0 
Week 12 
Difference 
p-value 
TC (ag/dl): 
n: 
Week 0 
Week 12 
Difference 
p-value 
11 
24.6 ± 2.2 
19.9 + 2.7 
4.7 + 1.2 
0.002* 
13 
115.3 + S.6 
104.7 + 7.2 
10.6 + 3.8 
0.008* 
12 
7.6 + 0.4 
6.7 ± 0.3 
0.9 ± 0.1 
0.04* 
15 
12B.7 + 3.1 
118.9 ± 1.7 
9.7 ± 2.7 
0.002* 
15 
88.0 + 2.4 
80.3 ± 1.4 
7.7 + 2.4 
0.003* 
15 
215.4 + 8.8 
185.6 + 7.3 
29.8 + 8.7 
0.002* 
17 
16.9 ± 1.9 
12.6  + 1 .6  
4.3 ± 0.9 
0.0002* 
18 
93.6 + 2.8 
88.6 ± 1.7 
5.1 ± 2.5 
0.03* 
18 
6.8 ± 0.3 
5.9 ± 0.1 
0.9 + 0.3 
0.003* 
21 
123.3 + 3.4 
112.7 + 2.9 
10.6 + 3.1 
0.001* 
21 
76.3 + 2.1 
75.1 ± 1.7 
1.1  +  1 .8  
0.27 
21 
216.1 ± 8.6 
187.7 ± 6.7 
28.4 ± 6.8 
0.0002* 
* significant at pc.0.05 level. 
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c. CHD risk factor: TC. 
TC decreased significantly in males (t=29.8 + 8.7; 
p=0.002) and females (t=28.4 ± 6.8; p=0.0002) at the end of 
the 12-week program. The H0 was rejected for both males and 
females. 
d. At the end of the 12-week RESHAPE program, each of 
the following dependent variables will increase: HDL-C, 
HDL2-C, and HDL3-C. 
HDL-C and HDL3-C decreased instead of increasing in 
both males and females. The H0 was not rejected for these 
two variables. HDL2-C increased in males and females at the 
end of the program. The difference in HDL2-C was 
statistically significant (t=-2.5 + 1.3; p=0.04) only for 
males. The H0 was rejected for males but not for females. 
Hypotheses 6 through 9 (tables 17 through 20) assessed 
changes after the 12-week program for the following 
variables: body weight, BMI, SSF, 5KBF, waist circumference, 
hip circumference, WHR, calories, fat, dietary fiber, and 
cholesterol intake, time to walk a mile, as well as the 
indices of stress: the perceived mood rating scale (CSA) and 
State-Trait Anxiety Inventory (STAI) . 
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Table 16 
Continuation: Stanry Table for Hypotheses *5 Using Paired-Difference T-Test. 
Among the participants of the RESHAPE program, there are no differences for each of the 
following variables between week 0 and week 12. 
Ha: The participants of the RESHAPE program have lower or higher levels of the following 
variables at the end of the 12-week program as indicated by the (-) or (+) sign in the table. 
Dependent Variable Hfl Males Feaales 
HDL-C (ag/dl): 
n: 
Week 0 
Week 12 
Difference 
p-value 
15 
42.5 ± 2.7 
41.6 + 2.3 
0.9 + 3.0 
0 .6 2  
21 
59.1 ± 2.7 
54.0 1 2.3 
5.1 ± 2.2 
0.99 
HDL2-C (ag/dl): 
n: 
Week 0 
Week 12 
Di fference 
p-value 
15 
6.9 + 1.2 
9.4 + 1.0 
-2.5 ± 1.3 
0.04* 
19 
15.0 + 1.8 
16.0 ± 2.2 
-1.0 + 2.1 
0.33 
HDL3-C (ag/dl): 
n: 
Week 0 
Week 12 
Difference 
p-value 
15 
35.6 + 1.9 
32.5 ± 1.8 
3.1 + 2.5 
0.88 
20 
45.5 ± 1.6 
38.4 + 1.9 
7.1 + 1.8 
0.99 
* significant at p<0.05 level 
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Hypotheses 6: 
H0: Among the participants of the RESHAPE program, 
there are no differences in each of BW, BMI, SSF, XBF, waist 
circumference, hip circumference, and WHR between week 0 and 
week 12. 
Ha: At the end of the 12-week RESHAPE program, each of 
BW, BMI, SSF, XBF, waist circumference, hip circumference, 
and WHR, will decrease. 
At the end of the RESHAPE program, body weight (males: 
t = 5.6 + 1.5 Kg; p=0.001, females: t=2.2 ± 0.6 Kg; p=0.0006), 
BMI (males: t=1.8 + 0.4; p=0.001, and females: t=0.9 + 0.2; 
p=0.001), SSF (males: t=25.1 + 4.7; p=0.00005, females: 
t = 10.2 + 2.2mm; p=0.0001 ), %BF (males: t =5.1 + 0.8%; 
p=0.00005, and females: t=2.2 + 0.4%; p=0.00005), waist 
circumference (males: t = 9.1 + 3.9cm; p=0.004, and females: 
t=3.6 + 1.2cm; p=0.017), and hip circumference (males: t = 
2.8 + 1.5cm; p=0.04 and females: t=2.1 ± 0.9cm; p=0.013) 
were significantly lower than week 0. The H0 were rejected 
for these independent variables. WHR decreased for males 
and females, but the change was not statistically 
significant. The H„ was not rejected for WHR. 
Hypotheses 7: 
H0: Among the participants of the RESHAPE program, 
there are no differences in CSA and STAI scales between week 
0 and week 12. 
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HA: CSA scale scores will increase, and the STAI scale 
scores will decrease at the end of the 12-week program among 
the participants in the RESHAPE program. 
Values for CSA were higher at the end of the 12-week 
program for both males and females. The increase was 
statistically significant (t=-3.9 + 0.9; p=0.0002) for males 
only. The H0 was rejected for CSA in males. Values for 
STAI decreased for both males (t=3.2 + 1.9; p=0.06) and for 
females (t=3.1 + 2.0; p=0.07). The H„ was rejected for 
STAI, for males and females. 
Hypotheses 8: 
H0: Among the participants of the RESHAPE program, 
there are no differences in each of calories, fat, dietary 
fiber, and cholesterol intakes between week 0 and week 12. 
HA: At the end of the 12-week program subjects will 
have a lower calorie, fat, and cholesterol intake, and a 
higher dietary fiber intake. 
Calorie and fat intake decreased for males and females, 
but the decrease was significant for males only. The 
calorie intake decreased 332 + 100 cals for males (p=0.04) 
while fat intake decreased by 35 + 9g (p=0.03). The He for 
calorie and fat were rejected for males but not females. 
Cholesterol intake was not reduced significantly in either 
group. The H„ was not rejected for cholesterol. Dietary 
fiber intake did not increase significantly. The H0 was not 
rejected for dietary fiber. 
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Table 17 
Suaury Table for Hypotheses *6 Using Paired-Difference T-test. 
Hq: Among the participants of the RESHAPE program there are no differences in each of the 
following variables between week 0 and week 12. 
Hft: The participants of the RESHAPE program have lower or higher levels of the following 
variables at the end of the 12-week program as indicated by the (-) or (+) sign in the table. 
Independent Variable Males ties 
Body weight (Kg): 
n: 
Week 0 
Week 12 
Di fference 
p-value 
BMI (ttt/Ht2): 
n: 
Week 0 
Week 12 
Difference 
p-value 
15 
103.1 + 5.1 
97.5 ± 4.2 
5.6 + 1.5 
0.001" 
14 
31.8 ± 1.7 
30.0 ±1.5 
1.8 ± 0.4 
0.001* 
21 
74.3 ± 3.2 
72.0 ± 3.2 
2.2 ± 0.6 
0.0006* 
19 
27.1 ± 1.0 
26.2  + 1 .0  
0.9 + 0.2 
0.001* 
SSF (m): 
n: 
Week 0 
Week 12 
Difference 
p-value 
Body fat (X): 
n: 
Week 0 
Week 12 
Difference 
p-value 
Waist (ca): 
n: 
Week 0 
Week 12 
Di fference 
p-value 
Hip (ca): 
n: 
Week 0 
Week 12 
Difference 
p-value 
HHR: 
n: 
Week 0 
Week 12 
Difference 
p-value 
15 
85.9 + 8.7 
60.8 + 6.1 
25.1 + 4.7 
0.00005* 
15 
31.4 + 1.8 
26.2 ± 1.8 
5.1 + 0.8 
0.00005* 
15 
114.8 + 4.3 
105.7 + 3.3 
9.1 + 3.9 
0.004* 
15 
110.4 ± 4.3 
107.6 + 3.2 
2.8 ± 1.5 
0.04* 
15 
1.05 ± 0.04 
0.98 ± 0.01 
0.07 ± 0.14 
0.07 
21 
75.6 ± 4.2 
65.4 ± 4.1 
10.2 + 2.2 
0.0001* 
21 
36.1 + 0.8 
33.9 + 0.8 
2.2 ± 0.4 
0.00005* 
20 
100.4 ± 2.8 
96.8 + 3.1 
3.6 + 1.2 
0.017* 
20 
111.1 + 2.8 
109.0 + 2.8 
2.1 ± 0.9 
0.013* 
20 
0.90 + 0.01 
0.89 ± 0.01 
0.01 + 0.01 
0.09 
* significant at p<0.05 level 
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Table 18 
Summary Table for Hypotheses #7 Using Paired-Difference 
T-test. 
H0: Among the participants of the RESHAPE program there are no 
differences in stress levels according to the following 
variables between week 0 and week 12. 
Ha: The participants of the RESHAPE program have higher or 
lower levels of the following variables at the end of the 12-
week program as indicated by the ( + ) or (-) sign in the table. 
Independent Variable HA Males Females 
CSAa 
n: 1 2  1 6  
32.7 ± 1.6 
33.8 + 1.5 
- 1 . 1  ±  1 . 2  
0.17 
Week 0 
Week 12 
33.3 + 1.1 
37.2 ± 1.2 
+ —3.9 + 0.8 
0.0002* 
Di fference 
p-value 
STAIb 
n: 11 1 6 
34.2 + 2.4 
31.1 + 1.6 
3.1 ± 2.0 
0.07* 
Week 0 
Week 12 
32.5 ± 2.7 
29.4 + 2.0 
3.2 + 1.9 Di fference 
p-value 0.06* 
* significant at p<0.10 level 
CSAa = Current Self appraisal 
STAIb = State-Trait Anxiety Inventory 
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Table 19 
Summary Table for Hypotheses #8 Using Paired-Difference 
T-test. 
H0: Among the participants of the RESHAPE program there are no 
differences in the intake of selected dietary variables 
between week 0 and week 12. 
Ha: The participants of the RESHAPE program have a higher or 
lower dietary intake of the following variables at the end of 
the 12-week program as indicated by the ( + ) or (-) sign in the 
tab!e. 
Independent Variable HA Males Females 
Sample Size: 3 5 
Calories: 
Week 0 
Week 12 
Difference 
p-value 
2210 + 242 
1878 + 214 
332 + 100 
0.04* 
1579 + 133 
1355 + 209 
224 + 217 
0.18 
Fat (g): 
Week 0 
Week 12 
Difference 
p-value 
9 4 + 1 3  
59 + 10 
3 5 + 9  
0.03* 
62 + 10 
4 4 + 7  
18 + 10 
0.07 
Fiber (g): 
Week 0 
Week 12 
Difference + 
p-value 
20 + 4 
22 + 3 
-2 + 2 
0.22 
14 + 2 
19 + 4 
-5 + 3 
0.09 
Cholesterol (mg): 
Week 0 
Week 12 
Difference 
p-value 
375 + 132 
381 + 184 
-6 + 87 
0.95 
251 + 40 
206 + 58 
45 + 47 
0.39 
* significant at p<0.05 level. 
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Changes in cardiovascular fitness as measured by changes in 
the time taken to walk a mile. 
Hypothesis 9: 
HQ: Among the participants of the RESHAPE program, 
there are no differences in the time taken to walk a mile 
between week 0 and week 12. 
Ha: The cardiovascular fitness will improve at the end 
of the 12-week program as measured by a decrease in the time 
taken to walk a mile. 
The time taken to walk a mile decreased significantly 
at the end of the 12-week program for males (t=1.3 + 0.3 
minutes; p=0.002) and females (t = 1.7 ± 0.6 minutes; 
p=0.009). The He for time to walk a mile was rejected for 
males and females. 
Hypotheses 10 through 12 assessed the associations 
between changes in SSF, WHR, and body weight, with changes 
in each of the dependent variables. Pearson Product Moment 
Correlation Coefficients were used to test hypotheses 10 
through 12. Subjects who lost 3 Kg or more of body weight, 
6 mm or more of SSF measurement, and subjects whose WHR's 
were reduced by 0.03 or more were included in these analyses 
(Tables 21 through 26). 
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Table 20 
Summary Table for Hypothesis #9 Using Paired-Difference 
T-test. 
H0: Among the participants of the RESHAPE program there is no 
difference in the time taken to walk a mile between week 0 and 
week 12. 
Ha: At the end of the RESHAPE program the subjects decreased 
the time taken to walk a mile. 
Independent Variable Males Females 
Time-Mile (minutes) 
n: 8 16 
Week 0 1 5 .2 + 0.6 1 7 .2 + 0.7 
Week 12 13 .8 + 0.5 15 .5 + 0.4 
Di fference 1 .3 + 0.3 1 .7 + 0.6 
p-value 0.002* 0. 009* 
* significant at p<0.05 level. 
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Hypotheses 10: 
H0: The correlations between the changes in SSF and the 
changes in each of the following dependent variables: 
insulin, glucose, Hb A,, SBP, DBP, TC, HDL-C, HDL2-C, and 
HDLg-C are zero for those who had a decrease in SSF of at 
least 6mm. 
Ha: Favorable reductions in the SSF are positively 
correlated with changes in each of: 
a. Diabetes risk factors: insulin, glucose, and Hb A,. 
Decreases in glucose and Hb A1 were not significantly 
correlated with decreases in the SSF for either males or 
females. Decrease insulin levels were correlated with 
decreased SSF for males only (r=0.53; p=0.04). 
The H0 for insulin was rejected for males. The H0 was not 
rejected for glucose and Hb A,. 
b. Hypertension risk factors: SBP and DBP. 
A decrease in SBP was not correlated with a decrease 
in SSF in males or females. The H0 was not rejected for 
SBP. Decrements in DBP were correlated with decrements in 
SSF for males (r=0.49; p=0.03) and females (r=0.42; p=0.06). 
The He was rejected for DBP for both males and females. 
c. CHD risk factor: TC, 
Changes in TC were not correlated with changes in SSF. 
The H„ was not rejected for TC. 
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Table 21 
Summary Table for Hypotheses #10 Using Pearson Product Moment 
Correlation Coefficients. 
H0: There are no correlations between changes in sum of 
skinfolds and changes in each of the dependent variables for 
those subjects who had a decrease in SSF of at least 6mm. 
Ha: The correlation between changes in sum of skinfolds and 
changes in each of the dependent variables is positive as 
indicated in the table by the (+) sign. 
Statistical Results 
Dependent Variable HA (r value; p value) 
Changes in: 
Insulin: 
males (n=12) 
females (n=12) 
both (n=24) 
+ 
+ 
+ 
0.53; 0.04* 
0.23; 0.23 
0.38; 0.03* 
Glucose: 
males (n=14) 
females (n=13) 
both (n=27) 
+ 
+ 
+ 
0.18; 0.27 
0.08; 0.40 
0.21; 0.15 
Hb A,: 
males (n=13) 
females (n=13) 
both (n=26) 
+ 
+ 
+ 
-0.14; 0.68 
0.31; 0.15 
0.00; 0.45 
SBP: 
males (n=16) + 
females (n=15) + 
bot h (n=31) + 
0.38 
0 . 1 2  
0.23 
0 . 0 8  
0.34 
0 . 1 0  
DBP: 
males (n=16) 
females (n=15) 
both (n=31) 
+ 
+ 
+ 
0.49; 0.03* 
0.42; 0.06 
0.51; 0.002* 
TC: 
males (n=16) 
females (n=14) 
both (n=30) 
+ 
+ 
+ 
-0.03; 0.53 
0.00; 0.99 
-0.04; 0.58 
*  s i g n i f i c a n t  a t  p < 0 . 0 5  l e v e l .  
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Table 22 
Continuation: Summary Table for Hypotheses #10 Using Pearson 
Product Moment Correlation Coefficients. 
H0: There are no correlations between changes in sum of 
skinfolds and changes in each of the dependent variables for 
those subjects who had a decrease in SSF of at least 6mm. 
Ha: The correlation between changes in sum of skinfolds and 
the changes in each of the dependent variables is negative as 
indicated in the table by the (-) sign. 
Dependent Variable 
Statistical Results 
(r-value; p-value) 
Changes in: 
HDL-C: 
males (n=16) 
females (n=14) 
both (n=30) 
0.35; 0.91 
0.16; 0.71 
0.18; 0.84 
HDL2-C: 
males (n=16) 
females (n=13) 
both (n=29) 
0.15; 0.71 
-0.71; 0.003* 
- 0 . 1 6 ;  0 . 2 1  
HDLA-C: 
males (n=16) 
females (n=14) 
both (n=30) 
0.55; 0.99 
0 . 2 6 ;  0 . 1 8  
0.32; 0.96 
•significant at p<0.05 level 
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d. Favorable reductions in the SSF are negatively 
correlated with changes in each of the CHD risk factors: 
HDL-C, HDL2-C, arid HDLg-C. 
A decrease in SSF was correlated with increased HDL2-C 
in females (r=-0.71; p=0.003), but not in males. Decrease 
SSF was not correlated with increased HDL-C, or HDL3-C for 
either males or females. Therefore, the H„ was rejected for 
HDL2-C in females. 
Hypotheses 11: 
H0: The correlations between the changes in WHR and the 
changes in each of the following dependent variables: 
insulin, glucose, Hb A,, SBP, DBP, TC, HDL-C, HDL2-C, and 
HDL3-C are zero for those who had a decrease in WHR of at 
least 0.03. 
HA: Favorable reductions in the WHR are positively 
correlated with changes in each of: 
a. Diabetes risk factors: insulin, glucose, Hb A.,. 
Decreased WHR was not correlated with decreased 
insulin, glucose, or Hb A,. Therefore, the H0 were not 
rejected for these variables. 
b. Hypertension risk factors: SBP and DBP. 
Changes in SBP or DBP were not significantly correlated 
with changes in WHR. The H0 were not rejected for these 
vari ables. 
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Table 23 
Summary Table for Hypotheses #11 Using Pearson Product Moment 
Correlation Coefficients. 
H0: There are no correlations between changes in body fat 
distribution as measured by WHR and changes in the dependent 
variables for those who decrease WHR by at least 0.03. 
Ha: The correlation between changes in body fat distribution 
measured by WHR and the changes in the dependent variables is 
positive as indicated in the table by the (+) sign. 
Statistical Results 
Dependent Variable HA (r value; p value) 
Changes in: 
Insulin: 
males (n=7) 
females (n=7) 
both (n=14) 
Glucose: 
males (n=9) 
females (n=8) 
both (n=17) 
Hb A,: 
males (n=9) 
females (n=8) 
both (n=17) 
SBP: 
males (n=9) 
females (n=9) 
both (n=18) 
DBP: 
males (n=9) 
females (n=9) 
both (n=18) 
TC: 
males (n=9) 
females (n=8) 
both (n=17) 
+ 0.41; 0.18 
+ -0.41; 0.82 
+ -0.11; 0.64 
+ 0.35; 0.18 
+ -0.36; 0.81 
+ 0.20; 0.22 
+ -0.00; 0.99 
+ -0.15; 0.64 
+ -0.01; 0.51 
+ -0.45; 0.89 
+  - 0 . 1 1 ;  0 . 6 1  
+ -0.26; 0.85 
+ 0.11; 0.39 
+ 0.04; 0.46 
+ 0.15; 0.28 
+ 0.68; 0.02* 
+ -0.03; 0.52 
+ 0.43; 0.04* 
*  s i g n i f i c a n t  a t  p < 0 . 0 5  l e v e l .  
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Table 24 
Continuation: Summary Table for Hypotheses #11 Using Pearson 
Product Moment Correlation Coefficients. 
H0: There are no correlations between changes in body fat 
distribution as measured by WHR and changes in the dependent 
variables for those subjects who had a decrease in WHR by at 
least 0.03. 
Ha: The correlation between changes in body fat distribution 
measured by WHR and the changes in the dependent variables is 
negative as indicated in the table by the (-) sign. 
Dependent Variable 
Statistical Results 
(r value; p value) 
Changes in: 
HDL-C: 
males (n=9) 
females (n=8) 
both (n=17) 
0.29; 0.78 
0.60; 0.94 
0.18; 0.75 
HDL2-C: 
males (n=9) 
females (n=8) 
both (n=17) 
0.06; 0.56 
0.81; 0.99 
0.16; 0.73 
HDL3-C: 
males (n=9) 
females (n=8) 
both (n=17) 
0.41; 0.87 
-0.06; 0.44 
0.02; 0.54 
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c. CHD risk factor: TC. 
Decreased WHR was positively correlated with decreased 
TC in males (r=0.68; p=0.02) but not females. The H0 was 
rejected for TC in males only. 
d. Favorable reductions in the WHR are negatively 
correlated with changes in each of the CHD risk factors: 
HDL-C, HDL2-C, and HDL3-C. 
Decreased WHR was not correlated with increased HDL-C, 
HDL2-C, or HDL3-C, in males or females. Therefore, the H„ 
was not rejected. 
Hypotheses 12: 
H0: The correlations between the changes in body weight 
(BW) and the changes in each of the following dependent 
variables: insulin, glucose, Hb A1, SBP, DBP, TC, HDL-C, 
HDL2-C, and HDL3-C are not zero for those who had a decrease 
in BW of at least 3.0 Kg. 
HA: Favorable reductions in BW are positively 
correlated with changes in each of: 
a. Diabetes risk factors: insulin, glucose, Hb Aj. 
Decreased BW was not correlated with decreased insulin, 
glucose, or Hb A,. The Hc was not rejected for these 
vari ables. 
b. Hypertension risk factors: SBP and DBP. 
Decreased BW was positively correlated with decreased 
DBP (r=0.46; p=0.06) in females but not in males. Changes 
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in SBP were not correlated with changes in BW in males or 
females. The H0 was rejected for DBP in females. 
c. CHD risk factor: TC. 
Decreased BW was correlated with decreased TC (r=0.73; 
p=0.002) in females but not males. The Hc was rejected for 
TC in females. 
d. Favorable reductions in BW are negatively correlated 
with changes in each of the CHD risk factors: HDL-C, HDL2-
C, and HDL3-C. 
Changes in BW were not correlated with changes in HDL-
C, HDL2-C, or HDL3-C in males or females. Therefore, the H0 
for HDL-C, HDLZ-C, or HDL3-C were not rejected. 
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Table 25 
Summary Table for Hypotheses #12 Using Pearson Product Moment 
Correlation Coefficients. 
H0: There are no correlations between changes in body weight 
and changes in the dependent variables for those who had a 
decrease in BW of at least 3 Kg. 
Ha: The correlation between changes in body weight and the 
changes in the dependent variables is positive as indicated 
in the table by the (+) sign. 
Statistical Results 
Dependent Variable HA (r value; p value) 
Changes in: 
Insulin: 
males (n=8) + 
females (n=11) + 
both (n=19) + 
Glucose: 
males (n=10) + 
females (n=11 ) + 
bot h (n=21 ) + 
Hb A,: 
males (n=10) + 
females (n=11) + 
bot h (n=21) + 
SBP: 
males (n=11 ) + 
females (n=13) + 
both (n=24) + 
DBP: 
males (n=11) + 
females (n=13) + 
both (n=24) + 
TC: 
males (n=11 ) + 
females (n=13) + 
both (n=24) + 
-0.01; 0.51 
0.24; 0.24 
0.08; 0.36 
0.30; 0.20 
0.27; 0.21 
0.33; 0.14 
-0.01; 0.51 
-0.06; 0.57 
-0.00; 0.50 
0.35; 0.15 
0.19; 0.27 
0.17; 0.21 
-0.25; 0.77 
0.46; 0.06 
0.19; 0.19 
0.25; 0.22 
0.73; 0.002* 
0.32; 0.06 
*  s i g n i f i c a n t  a t  p < 0 . 0 5  l e v e l .  
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Table 26 
Continuation: Summary Table for Hypotheses #12 Using Pearson 
Product Moment Correlation Coefficients. 
H0: There are no correlations between changes in body weight 
and changes in the dependent variables for those subjects who 
had a decrease in BW of at least 3 Kg. 
Ha: The correlation between changes in body weight and the 
changes in the dependent variables is negative as indicated 
in the table by the (-) sign. 
Dependent Variable 
Statistical Results 
(r value; p value) 
Changes in: 
HDL-C: 
males (n=11 ) 
females (n=13) 
both (n=24) 
0.24; 0.76 
0.03; 0.54 
0 . 1 8 ;  0 . 8 1  
HDL2-C: 
males (n=11) 
females (n=11 ) 
both (n=22) 
0.56; 0.96 
0.07; 0.58 
0.28; 0.89 
HDLG-C: 
males (n=11 ) 
females (n=12) 
both (n=23) 
0.06; 0.57 
-0.10; 0.38 
-0.01; 0.48 
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CHAPTER V 
DISCUSSION 
This discussion focuses on the findings according to 
the specific research hypotheses (HA) and the relationship 
of these hypotheses to previous findings reported in the 
literature. Direct comparisons cannot be made for all 
studies because the same set of variables included in this 
study were not used by each group of investigators. 
P-values greater than 0.05 are not reported in this chapter, 
except for the stress variables where p-values greater than 
0.10 are not reported. Recommendations for future research 
are addressed in the final section of this chapter. 
Hypotheses 1: 
Ha: There is a positive correlation between WHR, SSF, 
and BMI, and: 
a. each of the diabetes risk factors: fasting insulin, 
glucose, and Hb A, (Table 11). 
WHR was not correlated with insulin, glucose, or Hb A, 
in this investigation, which means that regional obesity is 
not significantly associated with these diabetes risk 
factors variables. Hb A, levels were measured in this study 
because obesity increases the risk on NIDDM. These findings 
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are consistent with some investigations (Van Gaal et al . , 
1989; and Peeples et al., 1989), but not others (Ohlson et 
al., 1985; Despres, Nadeau et al., 1989). Fasting insulin 
and glucose levels were not different among 43 obese males 
with high or low WHR (Van Gaal et al., 1989). Fasting 
glucose levels were not different among 9 pairs of nonobese 
males with different WHR studied by Peeples et al. (1989). 
Other investigators have reported positive correlations 
between diabetes risk factors and WHR, which means that 
regional fat distribution was significantly correlated with 
the diabetes risk factors. WHR was significantly correlated 
with insulin (r=0.08; p<0.05) in 792 males (BMI=25.0 + 3.2) 
studied by Ohlson et al. (1985). After 13.5 years of follow 
up, converters to diabetes (6.3%) had higher WHR than 
nonconverters (0.97 + 0.05 vs. 0.92 + 0.05; p<0.0001) 
(Ohlson et al., 1985). WHR was positively correlated with 
glucose (r=0.49; p<0.001) and insulin (r=0.41; p<0.01) in 52 
obese premenopausal females studied by Despres, Nadeau et 
al. (1989). Higher fasting glucose levels (100.1 + 13.1 vs. 
88.9 + 7.6 mg/dl; p<0.001) and insulin values (20.6 ± 13.0 
vs. 14.3 + 4.5 uU/ml; p<0.025), were reported in 107 obese 
females with AO compared to 40 females with GFO (Van Gaal et 
al., 1989). Obese males with high WHR had higher levels of 
Hb A, than non obese males with low WHR (absolute values 
were not reported; p<0.001). Insulin was significantly 
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correlated with WHR (r=0.47; p<0.05) in 75 postmenopausal 
females (BMI=25.6 + 4.7) studied by Soler et al. (1989). 
SSF was significantly correlated with insulin (males: 
r=0.70; p=0.001 and females: r=0.48; p=0.004), glucose 
(males: r=0.49; p=0.02 and females: r=0.39; p=0.01), and Hb 
A, in females (r=0.43; p=0.007) in this dissertation 
research (Table 11). These findings are consistent with 
some investigations (Ohlson et al., 1985) but not others 
(Bergstrom et al., 1990; and Lundgren et al., 1989). SSF 
(tricep, subscapular, and suprailiac) was a significant 
predictor (p<0.0001) for the development of diabetes in 792 
males studied by Ohlson et al. (1985). The SSF at baseline 
was not correlated with increased serum glucose in 1351 
females after 12 years of follow up (Lundgren et al . , 1989). 
The correlation between SSF and Hb A, was not assessed in 
any of the studies previously cited. Hb A, was measured in 
this study because obesity increases the risk for NIDDM. 
BMI was significantly correlated with insulin in males 
(r=0.59; p=0.008) and females (r=0.49; p=0.005) in this 
dissertation research, but was not significantly correlated 
with glucose or Hb A,. Different results have been obtained 
by several investigators. BMI was a significant predictor 
for the development of NIDDM (p=0.0003) in males after 13.5 
years follow up (Ohlson et al., 1985). Similarly, BMI was a 
significant predictor of diabetes (p<0.05) after adjusting 
for age, in 738 Mexican Americans. However, the effect was 
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no longer statistically significant after WHR was added to 
the model (Haffner et al., 1987). Insulin (r=0.47; p<0.05) 
and glucose (r=0.34; p<0.05) were significantly correlated 
with BMI in males (Houmard et al., 1991). BMI was not 
significantly different between 15 Japanese Americans who 
developed NIDDM and 131 who did not develop NIDDM (26.5 + 
0.9 vs. 25.4 + 0.2; p=0.17) after 30 months of follow up 
(Bergstrom et al., 1990). 
Fasting insulin, glucose, and Hb A1 were correlated 
with total body fat measured as the SSF in this dissertation 
research. However, insulin was the only diabetes risk 
factor variable significantly correlated with BMI which is 
also an index of general obesity. Probably, BMI does not 
estimate body fat as well as SSF. Stature, i.e., height is 
one component of BMI, and BMI may be stature dependent over 
part of the age range (Garn, Leonard, & Hawthorne, 1986). 
Body fat distribution measured as the WHR was not 
significantly correlated with the diabetes risk factors. 
These findings indicate that the diabetes risk factor 
variables were correlated with general obesity and not with 
body fat distribution. The place where the waist 
measurement was taken was not a factor for not finding 
significant correlations between the diabetes risk factors 
and WHR since other investigators found significant 
correlations measuring waist circumference at the umbilicus 
level (Ohlson et al., 1985; Van Gaal et al., 1989; Soler et 
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al. , 1989). Since WHR was not significantly correlated with 
SSF (males: r=-0.40; p=0.88, females: r=0.06; p=0.72) or BMI 
(males: r= -0.60; p=0.80, females: r=0.08; p=0.69) then, 
total obesity was not a factor diminishing the association 
between WHR and the diabetes risk factors. However, as in 
cross-sectional studies, there is the possibility that 
extraneous variables, not controlled in this study, affected 
the relationship between WHR and diabetes risk factors. 
Correlations do not indicate a cause-effect relationship. 
Thus, the lack of a significant association between body fat 
distribution and diabetes risk factors does not mean that 
body fat distribution does not affect diabetes. More 
studies are required that consider other factors such as 
hormonal status. Such studies would be ideally based on a 
large, random sample of obese subjects who reflect a wide 
range of body fat distribution patterns. 
b. There is a positive correlation between WHR, SSF, 
and BMI and each of the selected hypertension risk factors: 
SBP and DBP (Table 11). 
The positive correlations of WHR with SBP and DBP did 
not reach statistical significance in this dissertation 
research (Table 11). These findings are consistent with 
some investigations (Gerber et al., 1990; Kanai et al., 
1990; Adams-Campbell et al., 1990) but not others (Peiris et 
al., 1989; Van Gaal et al., 1989; Adams-Campbell et al., 
1990). WHR was not significantly correlated with SBP or DBP 
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in non obese males or obese females, in the studies by 
Gerber et al . (1990) and Kanai et al. (1990), respectively. 
WHR was not correlated with SBP or DBP in Nigerian females 
or in American females studied by Adams-Campbell et al. 
(1990). However, WHR was associated to SBP and DBP in 
several studies (Peiris et al., 1989; r=0.55 for SBP and 
r=0.45 for DBP; p<0.01 in 33 females; and Van Gaal et al., 
1989; SBP: 147 + 7 in AO vs. 128 + 11mm/Hg in GFO; DBP: 89 ± 
7 in AO vs. 81+6 mm/Hg in GFO, p<0.01). WHR was 
correlated with SBP (r=0.26; p<0.01), but not with DBP in 88 
white American females studied by Adams-Campbell et al. 
(1990). 
In this dissertation research, the SSF was 
significantly correlated with SBP in males (r=0.44; p=0.03) 
and females (r=0.44; p=0.06), and with DBP in males (r=0.58; 
p=0.004) and females (r=0.50; p=0.001). These findings 
suggest that the hypertension risk factors were associated 
with total body subcutaneous fat measured as SSF. 
In this dissertation research, BMI was significantly 
correlated with SBP (r=0.54; p=0.001) and DBP (r=0.47; 
p=0.004) in females, but not in males. BMI was 
significantly correlated with SBP (r=0.28; p<0.01) and DBP 
(r=0.33; p<0.01) in 135 males studied by Gerber et al. 
(1990); and in 93 American Black females (SBP: r=0.24; 
p<0.05), and 88 White American females (SBP: r=0.34; p<0.01; 
DBP: r=0.21; p<0.05) studied by Adams-Campbell et al. 
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(1990). However, BMI was not significantly correlated with 
SBP or DBP after adjusting for age in 124 Nigerian females 
(Adams-Campbell et al., 1990), or after adjusting for age 
and the visceral/subcutaneous fat area ratio, in 57 obese 
Japanese females studied by Kanai et al. (1990). 
In this dissertation research, the hypertension risk 
factors were more correlated with general obesity measured 
as SSF and BMI, than with body fat distribution measured as 
the WHR. The lack of significant correlations between the 
hypertension risk factors and WHR was not expected. The 
correlations between SBP or DBP and WHR in obese females 
reported by Kanai et al. (1990) were not significant. 
However, the ratio of intra-abdominal visceral fat area to 
subcutaneous fat area (V/S) measured by CT, was 
significantly correlated with SBP (r=0.59; p<0.001) and with 
DBP (r=0.52; p<0.001) after adjusting for age and BMI. The 
V/S ratio was not measured in this dissertation research, 
however, intra-abdominal fat accumulation may play an 
important role in the pathogenesis of hypertension in these 
subjects. A significant association may have been masked by 
our failure to differentiate between subcutaneous and intra­
abdominal fat. The location for measuring waist 
circumference was probably not a factor in our data analysis 
since other investigators found significant correlations 
using the same location (i.e., the umbilicus level) (Van 
Gaal et al., 1989; and, Adams-Campbell et al., 1990). The 
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small sample size in this dissertation research does not 
account for the lack of significant correlations between WHR 
and the hypertension risk factors. Significant correlations 
were found by other investigators with a similar sample size 
(n=33 females) (Peiris et al . , 1989). Other confounding 
factors not controlled in this research such as, 
socioeconomic status, occupational, psychosocial, genetic 
factors, cigarette smoking, and alcohol intake, may have 
affected the hypertension-body fat distribution 
relationship. Epidemiologic studies indicate that people 
who regularly consume two drinks or more of alcohol per day 
(>30 ml of ethanol), have higher mean blood pressure levels 
and a higher prevalence of hypertension than people who 
drink less (NRC, 1989). Cigarette smokers tend to be leaner 
than nonsmokers and tend to have lower BP than nonsmokers; 
smokers who quit gain several pounds of body fat (NRC, 
1989). In these subjects general body fat, and not body fat 
distribution, was associated with SBP and DBP. 
c. There is a positive correlation between WHR, SSF, 
and BMI and TC (Table 11). 
TC was the only dependent variable that was highly 
correlated with WHR for males (r=0.49; p=0.01) and females 
(r=0.44; p=0.004). TC has been positively correlated with 
WHR in other studies. In the study by Freedman et al. 
(1990) WHR was positively correlated with TC in 709 males 
(r=0.27; p<0.001) and 415 females (r=0.26; p<0.001). TC was 
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higher in females with AO than in females with GFO (absolute 
values were not reported; p<0.05) (Van Gaal et al., 1989). 
Terry et al. (1989) and Houmard et al. (1991) reported 
positive correlations between TC and WHR of 0.38 (p<0.001) 
and 0.29 (p<0.05), respectively, in males. TC levels were 
not significantly different between two groups of males with 
different WHR (Peeples et al . , 1989), nor was TC 
significantly correlated with WHR in 84 postmenopausal 
females (Soler et al., 1988). 
In this dissertation research, SSF was correlated with 
TC in females (r=0.28; p=0.05) but not males (Table 11). 
These findings are consistent with the study by Seidell et 
al. (1989) but not with other studies (Terry et al., 1989; 
and, Haffner et al., 1987). Subscapular SF, which is an 
estimate of upper body subcutaneous fat, was significantly 
correlated with TC in 85 Dutch females (r=0.36; p<0.001) and 
in 87 females from Verona (r=0.41; p<0.001) studied by 
Seidell et al . (1989). Percent BF estimated from 
hydrostatic weighing was correlated with TC (r=0.28; p<0.05) 
in 81 males studied by Terry et al. (1989). However, after 
adjusting for WHR and STR the correlation between TC and %BF 
was no longer significant. These results indicate that the 
relationship between XBF and TC was not independent of WHR 
and STR. 
BMI was not significantly correlated with TC in males 
or females in this dissertation research (Table 11). 
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These findings are consistent with some investigations 
(Houmard et al . , 1991; Soler et al., 1988) but not with 
others (Terry et al., 1989; Haffner et al., 1987; and 
Seidell et al., 1989). BMI was not significantly correlated 
with TC either in 46 nonobese males studied by Houmard et 
al . (1991), or in 84 nonobese postmenopausal females studied 
by Soler et al. (1988). BMI was significantly correlated 
with TC in 81 nonobese males (Terry et al., 1990: r=0.21; 
p<0.05), and in 284 obese males (Haffner et al., 1987: 
r=0.11; p<0.05). BMI was correlated with TC in females from 
Verona (r=0.45; p<0.001), but not in females in other 
populations (Seidell et al., 1989). 
In this dissertation research, a positive significant 
correlation was expected between TC and WHR, BMI, and SSF. 
The results obtained revealed that body fat distribution, 
measured as the WHR, was more highly correlated with TC than 
total body fat. 
d. There is a negative correlation between WHR, SSF, 
and BMI and each of the selected CHD risk factors: HDL-C, 
HDL2-C, and HDL3-C. 
WHR was not significantly correlated with HDL-C, HDL2-
C, or HDL3-C in this dissertation research. These findings 
are consistent with some investigations (Pouliot et al., 
1989; Ostlund et al., 1990) but not others (Freedman et al., 
1990; Houmard et al., 1991; Peiris et al., 1989; Ostlund et 
al . , 1990; Van Gaal et al., 1989; Terry et al., 1989; 
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Peeples et al.,1989; Meilahn et al., 1991; and, Despres, 
Moorjani et al., 1989). WHR was not significantly 
correlated with HDL-C, HDL2-C, or HDL3-C in 22 premenopausal 
nonobese females (Pouliot et al., 1989) nor with HDL3-C in 
77 males and 69 females 60-70 years of age (Ostlund et al., 
1990). 
WHR was significantly correlated with HDL-C in several 
other studies (Freedman et al., 1990: r=-0.22; p<0.001 in 
709 males, and r=-0.14; p<0.01 in 415 females; Houmard et 
al., 1991: r=-0.40; p<0.05 in 46 nonobese males; Peiris et 
al., 1989: r=-0.47; p<0.01 in 33 premenopausal obese 
females; Ostlund et al., 1990: r=-0.31; p<0.01 in 77 males, 
and r=-0.25; p<0.05 in 69 females; Terry et al., 1989: r=-
0.43; p<0.0001 in 73 males; Despres, Moorjani, et al., 1989: 
r=-0.47; p<0.001 in 52 premenopausal obese females; Van Gaal 
et al., 1989: males with AO had lower HDL-C levels (p<0.005) 
than males with GFO (absolute values were not reported); 
Peeples et al., 1989: males with AO had significantly lower 
HDL-C levels (38 + 4 mg/dl vs. 53 + 7; p<0.05) than males 
with GFO; and, Meilahn et al., 1991: females in the highest 
quintile of WHR had lower levels of HDL-C (t=14 mg/dl; 
p<0.01 ) than females in the lowest quintile. 
WHR was significantly correlated with HDLZ-C in several 
studies (Ostlund et al., 1990: r=-0.34; p<0.01 in 77 males 
and r=-0.37; p<0.01 in 69 females; Terry et al., 1989: r=-
0.52; p<0.0001 in males; Meilahn et al., 1991: females in 
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the highest quintile of WHR had lower levels of HDL2-C (10 
mg/dl; p<0.01) than females in the lowest quintile. Despres, 
Moorjani, et al. , 1989: r=-0.43; p<0.01 in obese females. 
WHR was also correlated with HDL3-C (r=-0.44; p<0.01) 
(Despres, Moorjani, et al., 1989). Females in the highest 
quintile of WHR had lower HDL3-C levels (t=4.4 mg/dl; 
p<0.01 ) than females in the lowest quintile (Meilahn et al., 
1991 ). 
The correlations between SSF and HDL-C, and HDL3-C were 
not significant in this dissertation research. The 
correlation between SSF and HDL2-C was significant for 
females (r=-0.32; p=0.03) but not for males. 
Subscapular SF which is an estimate of upper body 
subcutaneous fat was significantly correlated with HDL-C 
(r=-0.26; p<0.05) in males studied by Terry et al. (1989). 
HDL-C was significantly correlated with tricep SF in 
different female populations: Sweden (r=-0.31; p<0.01), 
Poland (r=-0.35; p<0.001); and, with subscapular SF in 
females from Sweden (r=-0.39; p<0.001), Poland (r=-0.33; 
p<0.01), and Verona (r=-0.32; p<0.01). These correlations 
were no longer significant after adjusting for BMI (Seidell 
et al., 1989). Subscapular and tricep SF were significantly 
correlated with HDL-C in 293 males (subscapular: r=-0.31; 
p<0.001; and triceps: r=-0.20; p<0.001) and in 441 females 
(subscapular: r=-0.24; p<0.001; and triceps: r=-0.14; 
p<0.01 ) studied by Haffner et al. (1987). These results 
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suggest that lipoproteins are highly related to upper body 
fat independent of total obesity. Abdominal subcutaneous 
fat measured by CT was not significantly correlated with 
HDL-C in premenopausal obese females (Despres, Ferland et 
al . , 1989); and, Despres, Moorjani et al., 1989), or in ncn 
obese females (Pouliot et al., 1989). Percent BF estimated 
from SSF was not significantly correlated with HDL-C in 
males or in females (Ostlund et al., 1990). 
Percent BF determined from SSF was significantly 
correlated with HDL2-C in males (r=-0.23; p<0.05) and 
females (r=-0.24; p<0.05) studied by Ostlund et al. (1990). 
Abdominal subcutaneous fat measured by CT was not 
significantly correlated with HDL2-C in obese females 
(Despres, Ferland et al., 1989; and, Despres, Moorjani et 
al. , 1989) or in nonobese females (Pouliot et al., 1989). 
HDLg-C was not correlated with abdominal subcutaneous fat 
measured by CT in obese females (Despres, Ferland et al., 
1989; and Despres, Moorjani et al., 1989) or in a group of 
nonobese females (Pouliot et al., 1989). Percent BF 
determined from SSF was not correlated with HDL3-C in 77 
males and 69 females studied by Ostlund et al. (1990). 
BMI was significantly correlated with HDL-C (r=-0.31; 
p=0.04) and with HDL2-C (r=-0.38; p=0.02) in females, but 
not in males in this dissertation research. BMI was not 
significantly correlated with HDL3-C in males or females. 
Other investigators found a significant correlation between 
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BMI and HDL-C. BMI was significantly correlated with HDL-C 
(r=-0.40; p<0.05) in 46 obese males studied by Houmard et 
al. (1991); in 73 males (r=-0.32; p<0.01) studied by Terry 
et al. (1989); and, in 284 males (r=-0.32; p<0.001) studied 
by Haffner et al. (1987). BMI was also correlated with HDL-
C in 52 obese females (r=-0.32; p<0.05) studied by Despres, 
Moorjani et al. (1989); in 84 postmenopausal females (r=-
0.24; p<0.05) studied by Soler et al. (1988); in Swedish and 
Polish females (r=-0.32; p<0.01) as well as in females (r=-
0.27; p<0.01) from Verona studied by Seidell et al . (1989); 
and, in 434 females (r=-0.26, p<0.001) studied by Haffner et 
al. (1987). BMI was not significantly correlated with HDL-
C either in Dutch or Neapolitan females studied by Seidell 
et al. (1989) or in elderly males or females studied by 
Ostlund et al. (1990). 
BMI was significantly correlated with HDL2-C in several 
other studies (Despres, Moorjani et al., 1989: r=-0.30; 
p<0.05; and, Terry et al., 1989: r=-0.31; p<0.01). However, 
BMI was not correlated with HDL2-C in a group of elderly 
males and females studied by Ostlund et al . (1990). 
BMI was significantly correlated with HDL3-C in obese 
females studied by Despres, Moorjani et al. (1989) (r=-
0.28; p<0.05), but not in 73 middle-aged males studied by 
Terry et al. (1989) or in elderly males or females studied 
by Ostlund et al. (1990). 
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In this dissertation research, HDL-C, HDLZ-C, and HDL3-
C were not significantly correlated with any of the 
measurements of body fat or body fat distribution in males. 
In females, BMI was significantly correlated with HDL-C and 
with HDLj-C, and SSF was significantly correlated with HDL2-
C. The lack of association between WHR and the lipoproteins 
in these subjects is not clearly interpretable. There are 
other factors (exercise habits before coming to the program, 
previous diets, alcohol intake, cigarette smoking, 
menopausal state, oral contraceptives use) that might affect 
the WHR-1ipoprotein association. According to Wood and 
Stefanick (1990) alcohol intake affects HDL-C and HDL-C 
subfraction concentrations. Cigarette smoking is associated 
with lower HDL-C levels. HDL-C increased with the cessation 
of smoking (Wood and Stefanick, 1990). In addition, 
variations in sex steroids represent an important factor for 
the association between intra-abdominal fat and HL activity. 
Steroids with androgenic activity increased the HL activity 
and reduced plasma HDLZ-C levels, while estrogenic steroids 
decreased HL activity and increased HDL2-C (Tikkanen & 
Nikkila, 1987). Distinctions according to menopausal state 
were not made in females in this study which may affect the 
WHR-1ipoprotein relationship. 
Hypotheses 2 and 3 were not considered in any of the 
studies previously cited as they were considered in this 
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research. In some of these studies, the multiple regression 
tests did not always control for the effects of age and WHR, 
or age and SSF. 
Hypotheses 2: 
Ha: After controlling for the effect of the 
variables age and WHR: 
a. the regression coefficient for SSF is greater than 
zero for each of the diabetes risk factors: insulin, 
glucose, and Hb A, (Table 12). 
The regression coefficients for the SSF were 
significantly greater than zero for insulin (males: 0.17 + 
0.05; p=0.002, and females: 0.18 + 0.04; p=0.0002), and 
glucose (males: 0.57 + 0.24; p=0.017, and females: 0.21 + 
0.09; p=0.015). The regression coefficient for SSF was 
significantly larger than zero for Hb A, in females (0.02 + 
0.01; p=0.009) but not males. 
SSF was not a significant predictor for the development 
of diabetes in 792, 54-years-old Swedish males after 
adjusting for BMI in a 13.5 years follow up study (Ohlson et 
al., 1985). According to Lohman et al. (1988), SF 
thicknesses are related to total body fatness through their 
association with total subcutaneous fat. Obesity is one of 
the most powerful risk factors for NIDDM (Kissebah et al. 
(1989). Therefore, a positive SSF regression coefficients 
for insulin, glucose, and Hb A, were expected. These 
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results suggest that insulin, glucose, and Hb A1 were 
related to general adiposity independent of body fat 
distribution and age. 
b. The regression coefficient for SSF is greater than 
zero for each of the hypertension risk factors: SBP and DBP. 
The regression coefficient for SSF was significantly 
greater than zero for SBP in males 0.18 + 0.07 (p=0.009) and 
in females 0.44 + 0.12 (p=0.0004), and significantly greater 
than zero for DBP in males 0.19 + 0.07 (p=0.006) and in 
females 0.16 + 0.07 (p=0.01). These results suggest that in 
this group of males and females, SBP and DBP were positively 
correlated with general adiposity measured as the SSF, and 
that the correlation remained significant after adjusting 
for the effects of age and body fat distribution. 
c. The regression coefficient for SSF is greater than 
zero for TC. 
For TC, the regression coefficient for the SSF was not 
different from zero for males or females. Consistent with 
the results from hypothesis 1, TC was positively correlated 
with WHR in males and females. TC was also positively 
correlated with SSF in females. However, the correlation 
between SSF and TC in females was no longer significant 
after adjusting for WHR and age. These results suggest that 
TC is not related to general obesity. Terry et al. (1989) 
found similar results. TC was significantly correlated with 
XBF estimated from body density (r=0.28; p<0.05) in 81 males 
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(Terry et al., 1989). However, the correlation was no 
longer significant after adjusting for WHR and 
subscapular/tricep ratio (STR). These results indicate that 
the relationship between XBF and TC was not independent of 
WHR and STR. Subscapular SF was significantly correlated 
with TC after adjusting for BMI in 140 nonobese Dutch 
females (r=0.28; p<0.001) studied by Seidell et al.(1989) 
which means that TC was associated with upper body 
subcutaneous fat independent of the effect of total body 
fat. 
d. The regression coefficient is less than 
zero for each of the CHD risk factors: HDL-C, HDL2-C, and 
HDL3-C. 
For HDL-C and HDL2-C, the regression coefficient for 
SSF was significantly less than zero for females (HDL-C: 
-0.14 + 0.08; p=0.06, and for HDL2-C: -0.10 + 0.05; p=0.04), 
but was not significant for males (Table 12). For HDL3-C, 
the regression coefficient for the SSF was significantly 
less than zero for males (-0.13 + 0.04; p=0.002) but not 
females. These results suggested that in females, HDL-C and 
HDL2-C were correlated with general obesity measured as SSF 
independently of the effects of age and WHR. In males, 
HDL3-C was correlated with SSF independent of the effects of 
age and WHR. These results suggested that in females 
general obesity is related with HDL-C and HDL2-C, while in 
males general obesity is associated with HDL3-C levels. The 
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lack of significant correlations in males between SSF and 
HDL-C and HDL2~C was probably because males tend to have 
less subcutaneous fat compared to females at the same degree 
of obesity. Significant negative correlations between SSF 
and HDL-C, HDL2-C, and HDL3-C were expected in this 
dissertation research. After adjusting for WHR and STR, the 
5KBF estimated by body density was not correlated with HDL-C 
in a group of 81 males studied by Terry et al. (1989). Upper 
body subcutaneous fat estimated by triceps and subscapular 
SF were not significantly correlated with HDL-C after 
adjusting for BMI in females from European countries studied 
by Seidell et al. (1989). 
Hypotheses 3: 
HA: After controlling for the effect of age and SSF: 
a. the regression coefficient for WHR is greater than 
zero for each of the diabetes risk factors: insulin, 
glucose, and Hb A1 (Table 13). 
For insulin, glucose, and Hb A,, the regression 
coefficient for WHR was not greater than zero for males or 
females. In addition to the simple correlation analysis 
results cited for hypothesis 1, no other studies have 
assessed the correlation between WHR and diabetes risk 
factors variables after adjusting for age and SSF. Ohlson 
et al. (1985) reported that after adjusting for BMI, WHR at 
baseline was a significant predictor for the development of 
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diabetes (statistical test value was not reported; 
p<0.0037). The results of this dissertation research 
suggest that general obesity estimated as SSF is correlated 
with the diabetes risk factors: insulin, glucose, and HbA, 
independent of age and body fat distribution measured as the 
WHR. 
b. The regression coefficient for WHR is greater than 
zero for each of the hypertension risk factors: SBP and DBP. 
For SBP and DBP the regression coefficient for WHR 
was not significantly greater than zero for males or 
females. SBP was significantly correlated (r=0.26; p<0.01) 
with WHR after adjusting for age in white American females 
studied by Adams-Campbell et al. (1990). In this same 
study, no significant correlations were found for Nigerians 
or for black American females. After adjusting for age, DBP 
was not correlated with WHR in any of the three ethnic 
groups. The results of this dissertation research suggest 
that SBP and DBP are significantly correlated with general 
obesity estimated by the SSF, independently of the effect of 
age and regional fat distribution measured as the WHR. 
c. The regression coefficient for WHR is greater than 
zero for TC. 
The regression coefficient was significantly greater 
than zero for TC in both males (90.53 + 40.84; p=0.02) and 
females (125.29 + 80.06; p=0.06). Thus, after controlling 
for the effect of age and SSF, the WHR was positively 
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correlated with TC. These results are consistent with the 
results from hypotheses 1 and 2. TC was more highly 
correlated with WHR and the correlation remained significant 
after adjusting for the effects of total subcutaneous fat 
(SSF) and age. In these subjects, TC levels were not 
related to total body subcutaneous fat. These results are 
consistent with the study by Anderson et al. (1988) in which 
TC and WHR were significantly correlated (r=0.17; p<0.001) 
after adjusting for age, BMI, smoking, alcohol intake, 
exercise, and oral contraceptive use in females, but not 
males. TC and WHR were significantly correlated (r=0.31; 
p<0.01) in 81 middle-aged males after adjusting for XBF and 
STR (Terry et al., 1989). TC and WHR were significantly 
correlated after adjusting for BMI (r=0.29; p<0.01) in 
nonobese Dutch females studied by Seidell et al. (1989). 
These results suggest that WHR varies with TC independent of 
overall fatness or STR. On the other hand, WHR and TC were 
not significantly correlated after adjusting for BMI, age, 
and physical activity in 84 postmenopausal females studied 
by Soler et al. (1988). The lack of significant association 
among the postmenopausal females studied by Soler et al. 
(1988) may be due to the fact that these females were not 
obese. Thus, high levels of total body fat (as a threshold 
effect) may need to be present in order to observe the 
negative effects of visceral fat on blood lipids. The 
results obtained in this research suggested that TC was 
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significantly correlated with body fat distribution 
independent of the effects of age and general obesity. 
d. The correlation coefficients are less than zero for 
each of the CHD risk factors: HDL-C, HDL2-C, and HDL3-C. 
For HDL-C, HDLZ-C, and HDL3-C the regression 
coefficients for WHR were not less than zero for males or 
females. These results suggest that HDL-C, HDL2-C, and 
HDLg-C are not related to body fat distribution but to 
general obesity or probably other factors such as alcohol 
intake and cigarette smoking that were not controlled for. 
WHR and HDL-C were not significantly correlated after 
adjusting for BMI, among females from different countries 
studied by Seidell et al. (1989). However, other 
investigations have found significant correlations between 
WHR and HDL-C. Anderson et al. (1988) reported a negative 
correlation between WHR and HDL-C (r=-0.13; p<0.001) after 
adjusting for BMI, age, smoking, alcohol intake, and 
exercise in males, but not in females. Terry et al. (1989) 
reported a significant negative correlation between WHR and 
HDL-C (r=-0.32; p<0.01) after adjusting for STR and %BF in 
males; Soler et al. (1988) found a negative correlation 
between WHR and HDL-C (regression coeff.=-72.5 + 16.5; 
p<0.001) after adjusting for BMI, ethanol intake, and 
physical activity. The correlations between WHR and HDLZ-
C, and HDL3-C after adjusting for other measures of general 
obesity were not considered in any of the previous cited 
studies. 
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Hypotheses 4: 
Ha: After adjusting for the SSF and age, an increase in 
WHR tertile from low to medium to high is associated with: 
a. an increase in the estimated means of each of the 
following diabetes risk factors: insulin, glucose, and Hb A1 
(Table 14). 
There was not a significant increase in insulin, 
glucose, or Hb A1, with an increase in WHR tertile in this 
dissertation research. Lundgren et al. (1989) reported a 
significant difference (p<0.01) in quintiles of WHR between 
41 females converted to diabetes and 319 nonconverted. In 
another study, the risk for diabetes in the upper 5% of the 
distribution of the WHR was 16.6 times higher than the risk 
in the lowest quintile (p<0.05) (Ohlson et al., 1985). Van 
Gaal et al. (1989) found that insulin was significantly 
higher (p<0.025) in females with high WHR (20.6 + 13.0) than 
in females with low WHR (14.3 + 4.5 uU/ml). In the same 
study, glucose was significantly higher (p<0.001) in females 
with high WHR (100.1 + 13.1) than in females with low WHR 
(88.9 + 7.6 mg/dl). The results from these studies suggest 
that insulin and glucose were related to body fat 
di st ri but ion i ndependent of general obesi ty. Fast ing 
insulin (p<0.05) and glucose (p<0.005) were significantly 
higher in obese females with high or low WHR (Landin et al., 
1989) which suggests that insulin and glucose are more 
related to overall fatness than to regional fat 
distribution. 
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In this dissertation research, when the analyses were 
done for males and females together, the p-values of the 
statistical tests were non-significant. However, p-values 
for glucose and for Hb A1 tended to be much lower when the 
analyses were combined for both males and females, compared 
to females alone. Females had a lower WHR than males (1.05 
+ 0.04 in males vs. 0.90 ± 0.01 in females). The lower WHR 
among females may suggest that at lower WHRs, the biological 
effect of WHR does not manifest itself (ie. significant 
relationships do not occur until some threshold for 
increased AO is achieved). In addition, the small sample 
size in each tertile reduced the statistical power. 
b. An increase in the estimated means of each of the 
following hypertension risk factors: SBP and DBP. 
There was not a significant increase in SBP or in 
DBP with an increase in WHR tertiles in this dissertation 
research. In males there were higher mean SBP and DBP in 
the highest WHR tertiles, but it was not significant. The 
large standard errors for each tertile could have masked any 
significant difference. Landin et al. (1989) found that SBP 
was about 30 mmHg higher in obese females with AO than in 
the non obese group (p<0.05) . No differences were found in 
SBP between high WHR and low WHR in nonobese females. DBP 
was about 15 mmHg higher in the obese females compared with 
lean females (p<0.01). No differences in DBP were found 
between the groups with different WHR, whether they were 
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obese or lean (Landin et al.. 1989). These results suggest 
that blood pressure is more dependent on total obesity than 
on regional obesity, and that obesity must be present for 
the WHR to have an effect. 
c. An increase in the estimated means of the CHD risk 
factor: TC. 
For females, there was a significant difference in the 
estimated mean for TC between tertiles (p-value=0.003) 
(Table 14). However, a dose response effect was not found. 
The group of females in the middle tertile had the lowest TC 
levels, while the females in the lowest and highest tertiles 
had similar TC levels (210.1 + 15.5 vs. 211.0 + 5.5). In 
males, there was an increase in the estimated mean TC with 
an increase in WHR tertile, but the difference was not 
statistically significant. When the test was performed for 
both genders together, the dose response relationship 
approached statistical significance (p=0.08). These results 
suggest that fat distribution may affect TC levels in both 
males and females. In this dissertation study, specific 
characteristics of the sample such as sample size, sample 
selection, large standard errors within each tertile and 
specific traits for females in the lowest tertile that are 
not clearly interpretable, may have affected the TC-WHR 
relationship. There is also the possibility of a threshold 
effect (i.e., WHR below a certain value may not affect TC). 
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These results are consistent with other investigations 
(Peeples et al ., 1989; and Soler et al., 1988). Peeples et 
al . (1989) did not find a significant difference in TC 
levels between males with high (185 + 13 mg/dl) or low WHR 
(171 + 3.9 mg/dl). Soler et al. (1988) reported a non­
significant increase in the estimated means for TC with an 
increase in WHR tertile in 83 females (low=219.7± 5.9, 
middle=226.0 + 7.1, high=233.5 + 6.6) after adjusting for 
BMI, age, and physical activity. 
Other investigators have found significant increases in 
TC levels with an increase in WHR tertiles (Anderson et 
al.,1988; and Van Gaal et al., 1989). Anderson et al. 
(1988) reported a significant increase in TC (+18 mg/dl) 
with an increase in WHR tertiles in 520 females after 
adjusting for age, smoking, alcohol intake, and oral 
contraceptives use (p<0.001), but the same relationship was 
not found in males. Van Gaal et al. (1989) found higher TC 
levels among 118 females with high WHR when compared with 30 
females with low WHR (absolute differences were not 
reported, p<0.05). No difference was found in males. 
d. After adjusting for SSF and age, an increase in WHR 
tertile from low to medium to high is associated with a 
decrease in the estimated means of each of the following 
dependent variables, CHD risk factors: HDL-C, HDLZ-C, and 
HDL3-C. 
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In males, HDL-C, HDLZ-C, and HDL3-C decreased with an 
increase in the WHR tertile, but only HDL3-C was 
statistically significant (p=0.01). In females, an increase 
in WHR was not associated with a decrease in any of these 
dependent variables in this dissertation research. It seems 
that lipoproteins are not related to body fat distribution 
in these subjects. There are several factors that could 
explain the lack of a dose-response effect for lipoproteins 
in females. Exercise habits before starting in the RESHAPE 
program, diet, alcohol intake, oral contraceptives use, 
estrogen replacement therapy, distinction menopausal state, 
cigarette smoking, history of weight loss, history of CHD, 
and NIDDM could have masked the WHR terti1e-1ipoprotein 
associations. There is the possibility that females in this 
research did not have enough visceral fat accumulation to 
observe the associations between deep abdominal fat 
accumulation and alterations in plasma lipids. In addition, 
the lower sample size in each tertile decreased the 
statistical power. Several investigators have reported a 
significant decrease in HDL-C with increases in the WHR 
tertiles: Anderson et al. (1988) reported a decrease of 
-4 mg/dl in males (p<0.01), but the decrease was not 
statistically significant in females. Soler et al. (1988) 
found a significant increase in HDL-C with a decrease in WHR 
tertile in females after adjusting for BMI, ethanol intake, 
and physical activity, (HDL-C for low tertile=66.5 + 2.4, 
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middle=59.1 + 2.3, and high= 52.6 + 2.5, p<0.01). Mean HDL-
C levels were about 14 mg/dl lower (p<0.01) in the highest 
quintiles of WHR in females when compared to females in the 
lowest quintile (Meilahn et al., 1991). 
Other investigators have found significantly lower 
values for HDL-C in males with high WHR when compared to 
males with low WHR. Van Gaal et al. (1989) reported higher 
HDL-C in males with low WHR than in males with high WHR 
(absolute values for HDL-C were not reported, p<0.005); 
however, the differences in females were not significant. 
Peeples et al. (1989) reported higher HDL-C (53 ± 7 vs. 38 + 
4 mg/dl; p<0.05) in 9 pairs of males with low WHR when 
compared to males with high WHR. HDL-C was higher among 10 
premenopausal obese females with low WHR (48.2 ± 7.0 vs. 
37.3 + 4.8; p<0.001) when compared to 10 females with high 
WHR (Despres, Moorjani et al., 1989). 
Two studies examined HDL2-C and HDL3-C and the 
relationships with WHR (Meilahn et al., 1991; and Despres, 
Moorjani et al . , 1989). HDL2-C was about 10 mg/dl lower 
(p<0.01) in females at the highest WHR quintile when 
compared to females in the lower quintile (Meilahn et al., 
1991). HDLZ-C was higher (p<0.001) in obese females with 
low WHR (19.8 + 4.0 mg/dl) when compared to females with 
high WHR (13.8 + 2.5 mg/dl) (Despres, Moorjani et al., 
1 9 8 9 ) .  
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HDL3-C was about 4.4 mg/dl lower (p<0.01) in females at 
the highest WHR quintile when compared to females in the 
lower quintile (Meilahn et al . , 1991). HDL3-C was higher 
(p<0.01) in obese females with low WHR (28.8 + 3.9 mg/dl) 
when compared to females with high WHR (23.6 + 3.0 mg/dl). 
Hypotheses 5: 
Ha: At the end of the 12-week RESHAPE program, each of 
the following dependent variables will: 
a. decrease: diabetes risk factors insulin, glucose, 
and Hb A,. 
Fasting insulin (males: -4.7 + 1.2 ulU/ml; p=0.002, 
females: -4.3 + 0.9 ulU/ml; p=0.0002), glucose (males: -
10.6 + 3.8 mg/dl; p=0.008, females: -5.1 ± 2.5 mg/dl; 
p=0. 03), and Hb A1 levels (males: -0.9 + 0.1%; p=0.04, 
females: -0.9 + 0.3%; p=0.003) decreased significantly by 
the end of the 12-week program. These results suggest that 
insulin sensitivity and glucose tolerance were increased in 
these subjects. None of the previous studies cited assessed 
changes in Hb A, after an exercise intervention program. 
However, a significant decrease in Hb A.C (from 8.8 ± 0.9 to 
8.0 + 0.6%; p<0.05) in adults with insulin-dependent 
diabetes, after a 12-week walking/jogging program was 
reported by Bazzarre and Izlar (1986). Hb A1, reflects the 
average blood sugar concentration for an extended time 
period (Gabbay et al., 1977). Hb A, remains unaffected by 
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the short term fluctuations in blood sugar levels (Sigma 
Diagnostics, P. 0. Box 14508, ST. Louis, MO 63178, 1984). 
Gabbay et al. (1977) reported that a single measurement of 
Hb A1 represents an integrated measure of the glucose levels 
seen by tissues over the preceding several months. Hb A, 
levels may reflect carbohydrate imbalance better than 
fasting glucose concentration or glucose tolerance tests. 
Lower levels of insulin, glucose, and Hb A, were expected at 
the end of the 12-week intervention program. Results from 
hypotheses 1, 2, and 3 are consistent in that the diabetes 
risk factors were significantly correlated with SSF, 
independent of the effects of WHR and age. The reductions 
in diabetes risk factors in these subjects parallel the 
reductions in SSF. 
Other investigators have found a decrease in fasting 
glucose after an exercise and/or diet intervention program: 
(Vansant et al., 1988: 9 premenopausal obese females with AO 
decreased fasting glucose by 0.80 + 0.49 mmol/1; p<0.05 
after an 8-week low calorie diet program; and Nieman et al., 
1990: fasting glucose decreased in 21 mildly obese females 
(5.2 ± 0.1 vs. 5.0 + 0.1 mmol/1; p<0.05) after a 5-week 
exercise and diet program). Other investigators did not 
find any significant changes in glucose levels after 
exercise or diet exercise programs. Glucose levels did not 
change significantly in 5 young males (BMI = 27.5 + 2.9) 
after 100 days of aerobic exercise program (Tremblay, Nadeau 
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et al ., 1990), or in obese females after a 12-week diet, 
walking program (Bjorkelund et al., 1991; and, Anderson et 
al., 1991), or in lean males (Anderson et al. , 1991). 
Changes in fasting insulin were assessed in two 
studies: insulin decreased (7.4 + 3.2 vs. 3.9 + 1.5 ull/ml ; 
p<0.01) after 100-day exercise training program in 5 males 
studied by Tremblay, Nadeau et al. (1990). Insulin 
decreased by 2.8 + 0.9 mll/1 (p<0.05) after a 12 week 
exercise program in 7 obese females studied by Anderson et 
al . (1991); however, insulin levels did not decreased 
significantly in males and leaner females. 
b. Decrease hypertension risk factors: SBP and DBP. 
SBP decreased significantly at the end of the 12-week 
program for males (-9.7 + 2.7 mm/Hg; p=0.002) and females (-
10.6 + 3.1 mm/Hg; p=0.001). DBP decreased significantly for 
males (-7.7 + 2.4 mm/Hg; p=0.003) but not females (-1.1 ± 
1.8 mm/Hg; p=0.27). The nonsignificant reductions in DBP in 
females could reflect the small, although significant, 
reductions in BMI and %BF. In this dissertation research, a 
decrease in SBP and DBP was expected at the end of the 
program. SBP and DBP were reduced significantly from 124 to 
114 and from 82 to 73 mm Hg, respectively, (p<0.001) in 
females studied by Bazzarre et al. (1985). SBP and DBP did 
not decrease after a 12-week exercise-diet program in 63 
obese females (Bjorkelund et al., 1991). The group of 
subjects in the Bjorkelund et al. (1991) study walked as a 
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group for only 1 hour every 2 weeks. It was not clear if 
subjects were encouraged to exercise on their own or if 
walking charts were filled by the subjects. Maybe, these 
subjects did not walk long enough to elicit changes in SBP 
or DBP in these subjects. The subjects in the RESHAPE study 
walked as a group three times per week for a maximum of an 
hour. In addition, subjects were encouraged to walk on 
their own during the rest of the week. 
c. Decrease CHD risk factor: TC. 
Males (-29.8 + 8.7 mg/dl; p=0.002) and females (-28.4 + 
6.8 mg/dl; p=0.0002) had significantly lower TC levels at 
the end of the 12-week program. A decrease in TC at the end 
of the 12-week program was expected. Decreased TC levels 
could also reflect diet intake modification since these 
subjects were encouraged to decreased calories, fat, and 
cholesterol intake. This result is consistent with some 
investigations (Blumenthal et al., 1991; Nieman et al., 
1990; Despres, Tremblay et al., 1990; Anderson et al., 
1991), but not others (Bjorkelund et al., 1991; and Marti et 
al . , 1990). 
TC decreased from 223 ± 40 to 217 ± 42 mg/dl (p=0.08) 
in premenopausal and postmenopausal nonobese females that 
exercised either aerobically or by strength exercise 
(Blumenthal et al., 1991), and from 5.28 + 0.22 to 4.61 + 
0.12 mmol/L (p<0.05) in obese females who followed either a 
low calorie vegetarian diet, or diet plus exercise (Nieman 
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et al . , 1990). After participating in a 12-week 
walking/jogging program, TC levels decreased from 198 + 35 
to 185 + 38 mg/dl; p<0.01 in females studied by Bazzarre et 
al . (1985). TC levels were reduced significantly after 25 
days of exercise training in males (p<0.05) and remained 
reduced until the completion of the study (Despres, Tremblay 
et al. , 1990; Anderson et al., 1991). Anderson et al. 
(1991) also found decreased TC in lean (-0.5 + 0.2; p<0.05) 
and obese females (-0.4 + 0.2; p<0.05) after 12-week 
exercise program. TC was not reduced either in 63 obese 
females (Bjorkelund et al., 1991), or in 39 males (Marti et 
al., 1990) after a jogging/walking program. In this 
dissertation research, reductions in TC were much larger 
than any other study cited. In other studies, modifications 
in diet were not emphasized while in the RESHAPE program, 
subjects were encouraged to decrease saturated fat, simple 
sugars, and cholesterol intake. The decreased dietary 
intakes based on the small number of food records returned 
at the end of the program do not conclusively demonstrate 
that all subjects achieved similar reductions in dietary 
intake. However, the decreased dietary intake is consistent 
with decreased TC in both males and females, and with 
clinical trials of diet on decreased TC. 
d. Other dependent variables will increase: CHD risk 
factors: HDL-C, HDL2-C, and HDL3-C. 
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HDL-C and HDL3-C levels were decreased instead of 
increasing in both males and females. HDL2-C levels were 
higher in males and females at the end of 12 weeks, but the 
increase was statistically significant for males only (-2.5 
+ 1.3 mg/dl; p=0.04). Since exercise training may improve 
the lipoprotein lipid profile, an increase in HDL-C, HDL2-
C, and HDL3-C was expected at the end of the exercise 
intervention program in this dissertation research study. 
Since HDL2-C increased and HDL3-C tended to decrease, the 
HDL-C did not change significantly. The failure to find 
significant increases in HDL-C after an exercise 
intervention program is consistent with several prospective 
studies (Blumenthal et al., 1991; Nieman et al., 1990; and, 
Vansant et al., 1988) that failed to demonstrate improved 
lipid profile among exercising females. 
HDL-C levels were decreased in females that 
participated either in aerobic exercises or in strength 
training exercises (Blumenthal et al., 1991). HDL-C levels 
decreased in a group of obese females after 2-weeks of 
following either a diet or diet plus exercise (Nieman et 
al . , 1990). By the 5th week, the exercise group increased 
HDL-C to baseline levels, while the "diet only" group did 
not. These results suggest that exercise training 
attenuated the decreased in HDL-C. Similarly, HDL-C did not 
increase in females with AO or GFO after an 8-week low cals 
diet program (Vansant et al., 1988). Other investigators 
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have reported higher HDL-C levels after an exercise 
intervention program (Marti et al., 1990; and Despres, 
Tremblay et al . , 1990). HDL-C increased in males by 0.12 
mmol/1 (p<0.028) after 16 weeks of jogging/walking program 
(Marti et al., 1990), and after 100 days of exercise 
training (p<0.05) in a group of males studied by Despres, 
Tremblay et al. (1990). 
Wood et al. (1984) cited by Despres, Tremblay et al. 
(1990) indicated that a substantial amount of aerobic 
exercise is needed in order to observe a significant 
increase in plasma HDL-C. Wood et al. (1984) also found 
that aerobic exercise and body fat loss were important 
determinants of HDL-C changes. Gidez and Eder (1984) 
reported that the increase in HDL-C after weight loss does 
not occur until months after weight reduction, and that 
measurements of HDL-C are meaningful only after weight has 
been maintained for this period. The increase in HDL-C 
after weight stabilization might be mediated by an increase 
in adipose tissue LPL. Therefore, subsequent maintenance of 
reduced weight appear to be an effective means of increasing 
HDL-C. A diet low in saturated fat may decrease VLDL, LDL-
C, and HDL-C (Gidez & Eder, 1984). The subjects in the 
RESHAPE program were encouraged to decrease fat intake, 
which may explain why HDL-C did not increase. Hepatic 
lipase (HL) which is increased in obese subjects, is 
positively correlated with deep abdominal fat independent of 
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total body fat (Despres, Ferland et al., 1989). HDL2-C is 
negatively correlated with HL activity. The increase in 
plasma HL activity observed in visceral obesity is partly 
responsible for reductions in HDL2-C. Subjects in the 
RESHAPE program walked for an hour from week 8 through 12, 
which probably was not long enough to elicit changes 
(decreased HL activity) in lipoprotein metabolism. WHR was 
not significantly reduced which probably accounts for the 
non-increase in lipoproteins. Hormonal effects may have 
also affected the lack of change in lipoproteins since both 
HDL2-C and HL activity are sensitive to sex steroids. 
None of the studies previously cited evaluated changes 
in HDL3-C. The metabolism of HDL is complex and specific 
associations between HDL-C subclasses and coronary 
atherosclerosis are still incompletely understood. Several 
investigators (Musliner & Krauss, 1988; and, Wallentin & 
Sundin, 1985) have compared concentrations of HDL subclasses 
(HDLZ-C and HDL3-C) in subjects with and without CHD. Most 
studies have shown that HDL2-C and HDL3-C concentrations are 
decreased in males with CHD. Wallentin and Sundin (1985) 
found lower levels of HDL-C (p<0.001), HDL2-C (p<0.001), and 
HDL3-C (p<0.003) in patients with coronary artery disease 
when compared with healthy controls after controlling for 
obesity, TG, and smoking. 
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Hypotheses 6: 
Ha: At the end of the 12-week program each of body 
weight (BW), BMI, SSF, percent body fat, waist circumference 
(VIC),  hip circumference (HC), and WHR will decrease (Table 
17). 
BW (males: -5.6 + 1.5 Kg; p=0.001; and, females: -2.2 + 
0.6 Kg; p=0.0006), BMI (males: -1.8 + 0.4; p=0.001; and, 
females: -0.9 + 0.2; p=0.001), SSF (males: -25.1 + 4.7mm; 
p=0.00005; and, females: -10.2 + 2.2mm; p=0.0001), %BF 
(males: -5.1 ± 0.8%; p=0.00005; and, females: -2.2 + 0.4; 
p=0.00005), waist circumference (WC) (males: -9.1 + 3.9 cm; 
p=0.017, and females: -3.6 + 1.2 cm; p=0.004), and hip 
circumference (HC) (males: -2.8 + 1.5 cm; p=0.04; and, 
females: -2.1 ± 0.9 cm; p=0.013) were significantly lower at 
the end of the RESHAPE program. Both males and females had 
a decrease in WHR which approached statistical significance 
(males: -0.07 + 0.14; p=0.09; and, females: -0.01 + 0.01; 
p=0.07). The decrease in WC was larger than the decrease in 
HC in both males and females, which theoretically would lead 
to a decrease in WHR. The findings of this research are 
consistent with previous results reported in the literature. 
BW decreased in males that participated in diet and/or 
exercise programs: (Anderson et al., 1991: -2.0 + 0.6 Kg; 
p<0.05; Bazzarre et al., 1985: from 200 + 18 to 191 + 19 lb; 
p<0.01; and, Bouchard et al., 1990: BW decreased from 86.7 
to 78.7 kg (p<0.01) after 100-days aerobic exercise. Other 
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investigators reported a decreased in BW in females after a 
diet/exercise program: BW decreased by a mean of 2.83 + 
2.46; p<0.001 in obese females with AO and by a mean of 3.98 
+ 3.92; p<0.05 in females with GFO studied by Bjorkelund et 
al . (1991). Obese females that followed a VLCD alone, 
behavior therapy alone, or combined treatment lost 10.4 + 
4.1, 10.8 + 6.3, and 15.2 + 7.6 kg, respectively, in the 
study by Wadden et al. (1988). When categorized according 
to body fat distribution, BW decreased by 10.0 % in obese 
females with AO, and by 12.3% in obese females with GFO 
(Wadden et al., 1988). BW decreased from 158 + 27 to 153 + 
25 lb; p<0.001 in females studied by Bazzarre et al., 1985; 
BW decreased by a mean of 3.5 + 0.8 kg (p<0.05) in obese 
premenopausal females studied by Krotkiewski et al. (1988); 
and, by a mean of 9.6 + 2.4 kg and 10.2 + 3.3 kg (p-values 
were not reported) in obese premenopausal females with GFO 
and AO, respectively, (Vansant et al., 1988). However, no 
difference in BW was found in males or in females according 
intensity of usual daily leisure-time activities (Tremblay, 
Despres et al., 1990), or in females with general obesity 
after a diet exercise program (Bjorkelund et al., 1991), or 
in leaner or obese females studied by Anderson et al. (1991) 
after an aerobic exercise program. 
Several investigators reported reductions in BMI after 
exercise/diet intervention programs: (Bouchard et al., 1990: 
BMI decreased from 27.5 to 25.0 kg/m2 (p<0.001), in 5-young 
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males; Bjorkelund et al. , 1991: BMI decreased by a mean of 
1.50 + 1.06 (p<0.05), and 1.03 + 0.95 (p<0.001) in females 
with GFO and AO, respectively; Vansant et al., 1988: BMI 
decreased significantly (p<0.05) from 31.6 + 1.7 to 28.1 + 
1.7, and from 33.9 + 4.3 to 30.2 + 4.2 in females with GFO 
and AO, respectively, after 8-week diet program; and, 
Tremblay, Despres et al., 1990: BMI was significantly higher 
(p<0.05) in females categorized in the lower intensity of 
daily leisure activities (less than 5 METS) when compared 
with females in higher categories (between 7 and 9 METS). 
BMI did not decrease significantly in males (Marti et 
al . , 1990) or in leaner or obese females (Anderson et al., 
1991), or in females with general obesity (Bjorkelund et 
al., 1991) after an exercise intervention program. BMI was 
not different among males categorized by intensity of usual 
daily leisure-time activities (Tremblay, Despres et al., 
1990). 
The sum of 10 SF measures, the sum of 5 SF in the trunk 
area, and the sum of 5 SF in the body extremities area 
decreased significantly (p<0.01) in a group of 5-males after 
an aerobic exercise program. Subcutaneous fat was reduced 
by 31% (p<0.001), and by 24% (p<0.001) in the trunk and the 
extremities, respectively, (Bouchard et al., 1990). Males 
and females in the highest category of daily leisure-time 
activities category had lower SSF measures (p<0.05) than 
males and females in the lowest category (Tremblay, Despres 
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et al . , 1990). SSF were reduced significantly from 85 + 19 
to 64 ± 16 mm; p<0.001 in males; and, from 106 + 37 to 82 + 
27 mm; p<0.001 in females studied by Bazzarre et al. (1985). 
Reductions in SSF were not statistically significant in 39-
males studied by Marti et al. (1990) after a 16-week 
walking/jogging program, probably because only 31% of the 
males jogged regularly for at least 90 minutes every week 
during the 4-month period. 
Several investigators reported a decrease in BF after 
an exercise and/or diet intervention program: (Anderson et 
al . , 1991: BF was reduced in males (-2.9 + 1.4Kg; p<0.05) 
and in obese females (-4.6 + 1.5Kg; p<0.05) after a 12-week 
aerobic exercise program; Bazzarre et al., 1985: %BF was 
reduced in males from 29 + 5 to 25 + 4%; p<0.001; and in 
females from 38 + 5 to 35 + 5%; p<0.001 after a 12-week 
walking/jogging program; Bouchard et al., 1990: %BF was 
significantly reduced from 18.7% to 12.5% (p<0.001) in 5-
males after aerobic exercise program; Vansant et al., 1988: 
%BF was reduced in females with AO from 45.0 + 3.5 to 41.2 + 
3.2% and from 46.2 + 6.0 to 42.0 + 6.8%, in females with GF0 
and AO, respectively, after a 8-week diet program; Wadden et 
al., 1988: females with AO and GFO decreased BF by 16%, and 
by 20.3%, respectively). 
Percent BF was not reduced in other studies: (Marti et 
al. , 1990: %BF did not decrease significantly in 61 males 
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after a walking/jogging program; and, Anderson et al . , 1991: 
BF was not reduced significantly in lean females. 
WC may decrease after exercise/diet intervention 
programs: Anderson et al., 1991: WC decreased in males (-
2.9 + 1.1 cm; p<0.05), and in leaner females (-3.2 + 1.1 cm; 
P,0.05), and obese females (-4.4 + 0.2 cm; p<0.001); 
Bjorkelund et al., 1991: WC was reduced significantly (-
3.42 + 3.04 cm; p<0.001) in females with AO; Vansant et al., 
1988: WC decreased in females with GFO by a mean of 7.3 + 
2.3 cm, and in females with AO by a mean of 9.1 + 1.9 cm (no 
p-value was reported); Wadden et al., 1988: WC was reduced 
by 7.7% in females with AO, and by 7.6% in females with GFO 
(no p-value was reported); Krotkiewsky et al., 1988: WC 
decreased by 8% in obese premenopausal females (p<0.001) 
after 2-weeks on a 544 kcal/day diet; Tremblay, Despres et 
al., 1990: males and females categorized in the highest 
activity-intensity group (METS<5), were characterized by 
reduced WC (p<0.05). The reduction in WC in the previously 
cited studies was similar to the reduction by the subjects 
in this dissertation research (Table 17). 
Several investigators reported a decrease in HC after 
exercise/diet intervention programs. HC decreased by 2.3 + 
0.8 cm; p<0.05, in males, by 2.7 + 0.8 cm; p<0.01, in leaner 
females, and by 2.7 + 1.1 cm; P<0.05, in obese females 
studied by Anderson et al. (1991); by 7.6 + 4.3 cm in obese 
premenopausal females with AO, and, by 9.5 + 5.9 cm in 
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females with GFO studied by Vansant et al. (1988) (no p-
value was reported). HC was reduced by 5.196 in obese 
females with AO, by 7.8% in obese females with GFO studied 
by Wadden et al. (1988) (no p-value was reported); by 4% 
(p<0.05) in obese premenopausal females after 2 weeks on a 
544 kcal/day diet (Krotkiewsky et al., 1988). However, HC 
was not different according activity-intensity group in 
males or females studied by Tremblay, Despres et al. (1990); 
or among obese females after participate in exercise/diet 
intervention program (Bjorkelund et al., 1991). 
WHR have been reported to decrease after exercise/diet 
intervention programs. Females with AO reduced WHR by 2.4-% 
(p<0.01) (Bjorkelund et al., 1991); from 0.85 + 0.04 to 0.82 
+ 0.02, p<0.01) (Vansant et al., 1988); and, by 2.7% (p-
value was not reported) (Wadden et al., 1988). WHR 
decreased by 3% (p<0.01) in premenopausal obese females 
studied by Krotkiewsky et al. (1988) after 2 weeks on 544 
kcal/day diet. WHR was lower in males and females 
categorized in the highest activity-intensity group 
(p<0.05). This difference was mainly due to WC differences 
since HC was not different among groups (Tremblay, Despres 
et al., 1990). WHR was reduced by 0.02 (p<0.001) in 61 
males studied by Marti et al. (1990) after participation in 
a walking/jogging program. 
Other investigators did not find a decrease in WHR. 
WHR was not reduced significantly in females with general 
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obesity or with GFO studied by Bjorkelund et al. (1991), or 
in females with GFO studied by Vansant et al. (1988). WHR 
increased by 0.1X in obese females with GFO studied by 
Wadden et al.,1988) (no p-value was reported). 
WHR was not altered by the weight and fat loss in a 
group of 5 males studied by Bouchard et al. (1990) that 
participated in aerobic exercise for 4-months, nor in males 
or females after an aerobic exercise intervention program 
(Anderson et al. , 1991). These previous cited 
investigations consistently showed that females with GFO are 
more resistant to changes in WHR. 
Both males and females in this dissertation research 
had a decrease in WHR which approached statistical 
significance (Table 17). The reduction in WC was larger 
than the reduction in HC leading to an average decrease in 
WHR. These results are consistent with the concept that 
adipocytes in the abdominal area are more lipolytic than 
adipocytes in the gluteofemoral area (Leibel et al . , 1989). 
Hypotheses 7: 
Hfl: CSA scale scores will increase and the STAI scale 
scores will decrease at the end of the 12-week program among 
the participants in the RESHAPE program (Table 18). 
Values for CSA were higher at the end of the 12-week 
program for both males and females, but the increase was 
significant only for males (3.9 ± 3.8; p=0.0002). Values 
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for STAI decreased for both males (3.2 + 1.9; p=0.06) and, 
females (3.1 + 2.0; p=0.07). In this dissertation research 
project, a decrease in the STAI scale and an increase in the 
CSA scale were expected. None of the studies previously 
cited, assessed the effect of an exercise program on stress 
management. WHR has been correlated with several 
psychological variables such as degree of mental disorder 
(p<0.001), feelings of stress (p<0.02), sleeplessness 
(p<0.01), nightmares (p<0.01), regular use of tranquilizers 
(p<0.007), regular use of antidepressants (p<0.02), number 
of accidents (p<0.03), and number of fractures (p<0.03) 
indicating accident proneness as well as mental disorders, 
in females (values for the correlations were not reported) 
(Lapidus et al., 1989). BMI was negatively associated to 
achievement, aggression, and dominance (p<0.02). Larsson et 
al. (1989) found a negative correlation between WHR and 
social class (p<0.009), and social group (p<0.03), and 
positive correlation with periods and duration of sickness 
(p<0.005) in 792 males after adjusting for BMI. According 
to Rosato (1986) aerobic exercise had successfully been used 
as therapy for relieving anxiety, mental depression, drug 
addiction, and schizophrenia. 
Hypotheses 8: 
Ha: At the end of the 12-week program subjects will 
have a lower calorie (cals), fat, and cholesterol intake, 
and a higher dietary fiber intake (Table 19). 
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Males and females decreased kcal and fat intake, but 
the decrease was significant only for kcal intake (332 + 100 
cals; p=0.04), and fat intake (35 + 9 g; p=0.03) in males. 
Cholesterol intake was not reduced significantly in any 
group. Dietary fiber intake was not increased significantly 
in any group, but it approached significance in females (5 + 
3 g; p=0.09). The number of subjects who returned food 
records at the end of the study was small (5 females and 3 
males). In addition, none of the subjects from the control 
group returned food records at the end of the program. 
Therefore, it was not possible to assess the effectiveness 
of the program for changes in nutrient-food intake by the 
participants. According to the food records returned at the 
end of the program, males and females decreased kcal, and 
fat, and increased dietary fiber. With a larger number of 
subjects returning food records at the end of the program, 
significant favorable changes in food intake variables 
should have occurred. 
From the studies previously cited, one (Anderson et 
al . , 1991) obtained a diet history from the participants at 
the beginning and at the end of the study. Specific results 
for different nutrients were not reported. However, the 
investigators stated that obese females decreased energy 
intake (329 ± 91 kcal; p<0.05) with training while leaner 
females and males did not. Others studies previously cited, 
(Bouchard et al., 1990; Vansant et al., 1988; Nieman et al., 
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1990; Wadden et al., 1988; and Bjorkelund et al., 1991) did 
not assess changes in nutrient-food intake before and after 
intervention programs, even when diet was included as part 
of the programs. 
Hypothesis 9: 
Hfl: The cardiovascular fitness of males and females 
will improve at the end of the 12-week program as measured 
by a decrease in the time taken to walk a mile (Table 20). 
The time taken to walk a mile was decreased 
significantly at the end of the 12-week program for males 
(-1.3 + 0.3 min; p=0.002) and females (-1.7 + 0.6 min; 
p=0.009) in this dissertation research. A decrease in the 
time for walking a mile was expected among the participants 
in the RESHAPE program. From the studies previously cited, 
no one included the 1-mile test as part of their evaluation. 
According to Rosato (1986) there are some beneficial 
effects that accompany long term aerobic exercise. Some of 
these effects are: a decrease in heart rate by 10 to 25 
beats/minute, an increase in stroke volume since the heart 
can pump more blood per beat, and an increase in blood flow. 
Exercise training may improve the aerobic capacity by 15 to 
20% in previously untrained healthy young adult. This 
improvement may be due to a combination of the physiological 
adaptations previously discussed. 
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Hypotheses 10: 
Ha: Favorable reductions in the SSF are positively 
correlated with changes in each of the: 
a. diabetes risk factors: insulin, glucose, and Hb A1 
(Table 21). 
A decrease in glucose and Hb A, were not correlated 
with a decrease in SSF in males or females. A decrease in 
insulin level was correlated with a decrease in SSF only for 
males (r=0.53; p=0.04). For the correlation between changes 
in insulin and changes in SSF, only 2 of the 12 females 
included in the analysis increased insulin levels. However, 
the correlation was not significant because there were 
females that reduced insulin levels without reducing SSF. In 
addition, there was one female that reduced about twice in 
SSF than the next female that reduced more SSF, that reduced 
the correlation between changes in insulin and changes in 
SSF. The 12 males included in the analysis decreased 
insulin levels which contributed to the significant 
correlation (p=0.04). For the correlation between changes 
in glucose and changes in SSF, only 5 of the 13 females, and 
3 of the 14 males included in the analysis increased glucose 
levels. For the correlation between changes in Hb An and 
changes in SSF, only 1 of the 13 females, and 3 of the 13 
males included in the analysis increased Hb An. For this 
analysis only subjects who reduced 6mm of SSF or more were 
included. This selection reduced the sample size further 
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(Table 21). It might be that significant correlations could 
be obtained with a larger sample size or by including all 
the subjects in the study since probably subjects who did 
not reduced SSF could have an increase in the diabetes risk 
factors. A positive correlation between changes in SSF and 
changes in the diabetes risk factor variables was expected 
in this dissertation research. None of the studies 
previously cited assessed changes in SSF with changes in the 
diabetes risk factor variables considered in this 
dissertation research. 
Lundgren et al. (1989) studied the correlations between 
increases in BMI, SSF, waist and hip circumference, and WHR 
with increases in serum glucose concentration during a 12-
year follow up period. The p-values for the correlations 
found were significant (p<0.001) for all anthropometric 
variables except WHR (p<0.192) (correlation values were not 
given). According to Lonnroth (1988) obesity is often 
associated with insulin resistance and type II diabetes 
(NIDDM). The risk for diabetes is increased for overweight 
Americans when compared to non-overweight Americans as 
revealed by NHANES II (NRC, 1989). As explained in the 
review of literature section, hyperinsulinemia accompanies 
obesity as a marker of the insulin resistance, and fasting 
plasma insulin levels are correlated with the degree of 
obesity (Kissebah and Peiris, 1989). Subjects in this study 
decreased SSF, XBF, and BMI significantly. Both males and 
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females also reduced insulin and Hb A,. Females also 
reduced fasting glucose levels significantly. However, not 
all the subjects who reduced SSF reduced insulin, glucose or 
Hb A, levels. Thus, the correlation coefficients, although 
positive for insulin and glucose were nonsignificant. With 
a larger sample size, significant correlations between 
changes in SSF and changes in diabetes risk factor variables 
would probably be observed. 
b. Hypertension risk factors: SBP and DBP (Table 21). 
A decrease in SBP was not correlated with a decrease 
in SSF in males or females. Reductions in DBP were 
significantly correlated with reductions in SSF for males 
(r=0.49; p=0.03) and females (r=0.42; p=0.06). These 
results suggest that subjects who reduced subcutaneous fat, 
tended to reduce DBP. Hypertension can usually be 
controlled with medication, diet, weight loss, and exercise. 
Therefore, in this dissertation research, a positive 
correlation between changes in SSF and changes in SBP and 
DBP was expected. The correlation between changes in DBP 
and changes in SSF was higher and more significant for males 
than females probably because males lost more SSF and 
reduced DBP more than females. None of the studies cited 
before assessed this specific hypothesis. In the Framingham 
study (Kannel et al., 1967), the risk of developing 
hypertension increased with increased BW. In the most obese 
group, 46% were hypertensive. MacMahon et al. (1987) found 
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that approximately one-third of the prevalence of 
hypertension was attributable to obesity in males and 
females aged 25 to 64 years. 
c. CHD risk factor: TC. 
Changes in TC were not correlated with changes in SSF. 
In this dissertation research, a positive correlation 
between changes in SSF and changes in TC was expected. In 
the general population, subjects who are more active usually 
do not have lower cholesterol levels when compared to less 
active subjects. More active subjects usually have 
increased HDL2-C and decreased LDL-C leading to a small net 
change in TC (Wood & Stefanick, 1990). Both males and 
females decreased TC and SSF significantly in this 
dissertation research. However, the decrease in TC was not 
significantly correlated to the decrease in SSF. For the 
correlation between changes in TC and changes in SSF, 12 of 
the 14 females, and 12 of the 16 males included in the 
analysis decreased TC levels. For this analysis only 
subjects who reduced 6.0 mm of SSF or more were included. 
This selection reduced the sample size further (Table 21). 
It might be that significant correlation would be obtained 
with a larger sample size. 
d. Favorable reductions in the SSF are negatively 
correlated with changes in each of the CHD risk factors: 
HDL-C, HDL2-C, and HDL3-C (Table 22). 
205 
A decrease in SSF was correlated with an increase in 
HDL2-C (r=-0.71; p=0.003) in females, but not in males. A 
decrease in SSF was not correlated with an increase in HDL-
C, or HDL3-C for males or females. These results are 
consistent with some investigations. Changes in SSF were 
significantly correlated (r=-0.39; p<0.001) with changes in 
HDLZ-C in males studied by Marti et al. (1990). The 
correlation was negative (-0.11) for HDL-C but did not 
approach statistical significance. No significant 
correlation was found for HDL3-C. Marti et al. estimated 
that a decrease in SSF by 18 mm would have raised the HDL2-
C concentration by 0.15 mmol/1. In this dissertation 
research, for the correlation between changes in HDL-C and 
changes in SSF, only 5 of the 14 females, and 8 of the 16 
males included in the analysis increased HDL-C levels. For 
the correlation between changes in HDL2-C and changes in 
SSF, 10 of the 13 females, and 10 of the 16 males included 
in the analysis increased HDL2-C levels. For the 
correlation between changes in HDL3-C and changes in SSF, 
only 2 of the 14 females, and 6 of the 16 males included in 
the analysis increased HDL3-C levels. For this analysis 
only subjects who reduced 6.0mm of SSF or more were 
included. This selection reduced the sample size further 
(Table 22). A significant correlation might be obtained 
with a larger sample size. 
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Hypotheses 11: 
Ha: Favorable reductions in the WHR are positively 
correlated with changes in each of: 
a. diabetes risk factors: insulin, glucose, Hb A, 
(Table 23). 
A decrease in WHR was not correlated with a decrease 
in insulin, glucose, or Hb A, in males or females. A 
positive correlation between changes in WHR and changes in 
diabetes risk factor variables was expected in this study. 
The correlations between changes in diabetes risk factor 
variables and changes in WHR were not significant in this 
study probably because WHR was not reduced significantly 
after the 12-week program. In addition, for the correlation 
between changes in insulin and changes in WHR, 2 of the 7 
females increased insulin levels, while the 7 males included 
in the analysis decreased insulin levels. For the 
correlation between changes in glucose and changes in WHR, 3 
of the 8 females increased glucose levels, while the 9 males 
included in the analysis decreased glucose levels. For the 
correlation between changes in Hb A, and changes in WHR, the 
8 females included in the analysis decreased Hb A,, while 
only 1 of the 9 males included in the analysis increased Hb 
A, levels. 
Subjects who lost WHR by 0.03 or more were included in 
this analysis which reduced the sample size further. The 
magnitude in WHR reduction was small (females: 0.01 + 0.01 
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and males: 0.07 + 0.14) compared with the magnitude in 
insulin reduction (females: 4.3 + 0.9 and males: 4.7 + 
1.2uIU/ml), glucose (females: 5.1 + 2.5 and males: 10.6 ± 
3.8 mg/dl), and Hb A1 (females: 0.09 + 0.3 and males: 0.9 + 
0.1X) which may affect the value and significance of the 
correlations. Again, with a larger sample size, significant 
correlations might be found. None of the previous studies 
cited addressed this hypothesis. Lundgren et al. (1989) 
evaluated the correlation between increases in WHR and 
increases in serum glucose in a group of females during a 
12-year follow up study. The correlation found between 
changes in these two variables was not significant 
(p=0.192). 
b. Hypertension risk factors: SBP and DBP. 
Changes in SBP or DBP were not significantly correlated 
with changes in WHR. A decrease in WHR was expected to 
correlate with decreases in SBP and DBP in this study. For 
the correlation between changes in SBP and changes in WHR, 7 
of the 9 females decreased SBP, while the 9 males included 
in the analysis decreased SBP. However, the correlation was 
not significant in males or females probably because of the 
reduced sample size and because these subjects reduced SBP 
without reducing WHR significantly. For the correlation 
between changes in DBP and changes in WHR, only 4 of the 9 
females decreased DBP, while 2 of the 9 males included in 
the analysis increased DBP. Neither the decrease in DBP or 
in WHR was significant in females. 
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c. CHD risk factor: TC. 
Decreased WHR was positively correlated with decreased 
in TC in males (r=0.68; p=0.02) but not in females. When 
both males and females were analyzed together, the 
correlation was positive and significant (r=0.43; p=0.04) 
probably because of a higher statistical power. The ranges 
in WC, HC, and WHR were higher in males than in females 
which may contribute to the significant correlation in males 
and the lack of significant correlation in females. 
d. Favorable reductions in the WHR are negatively 
correlated with changes in each of the CHD risk factors: 
HDL-C, HDL2-C, and HDL3-C (Table 24). 
A decrease in WHR was not correlated with an increase 
in HDL-C, HDL2-C, or HDL3-C, in males or females. These 
results are consistent with the study by Marti et al. 
(1990). Marti et al. found no correlation between changes 
in WHR and changes in HDL-C, HDL2-C, and HDL3-C in males 
after a 16-week aerobic exercise program. However, changes 
in WHR were significantly and inversely related to changes 
in total physical activity (r=-0.27; p<0.05). In this 
dissertation research, for the correlation between changes 
in HDL-C and changes in WHR, 4 of the 8 females decreased 
HDL-C, while 5 of the 9 males included in the analysis 
decreased HDL-C. For the correlation between changes in 
HDLZ-C and changes in WHR, 2 of the 8 females decreased 
HDL2-C, while 4 of the 9 males included in the analysis 
209 
decreased HDL2-C. For the correlation between changes in 
HDLg-C and changes in WHR, 6 of the 8 females decreased 
HDLg-C, while 6 of the 9 males included in the analysis 
decreased HDL3-C. The lack of consistency and statistical 
power influenced the correlation analysis. Measurement 
error may have contributed to the lack of significant 
statistical findings. According to Marti et al. (1989) the 
proportion of total variance due to measurement errors is 
much larger for change data than for cross sectional data, 
since measurement error contributes twice to the total 
variance for change data. 
Hypotheses 12: 
Ha: Favorable reductions in BW are positively 
correlated with changes in each of: 
a. Diabetes risk factors: insulin, glucose, Hb A1 
(Table 25). 
A decrease in BW was not correlated with a decrease in 
insulin, glucose, or Hb A1. These hypotheses were not 
considered in any of the studies previously cited. BW 
includes not only body fat but also fat free mass and water. 
Changes in BW are not a good indicator of changes in BF 
because the measurement do not distinguish between fat mass 
and fat free mass (McArdle et al., 1986). Lundgren et al. 
(1989) found a positive and significant correlation 
(p<0.001) between increase in BMI and an increase in glucose 
levels in females after a 12-year follow up. 
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b. Hypertension risk factors: SBP and DBP. 
A decrease in BW was positively correlated 
with a decrease in DBP (r=0.46; p=0.06) in females. Changes 
in SBP were not correlated with changes in BW in males or 
females. Since the risk of developing hypertension 
increases with an increase in BW, positive correlations were 
expected between changes in BW and changes in SBP and DBP. 
c. CHD risk factor: TC, 
Decreased BW was correlated with decreased TC (r=0.73; 
p=0.002) in females, but not in males. Nieman et al. (1990) 
found that a decrease in BW accounted for approximately 40% 
of the change in TC in females. A positive correlation was 
expected between changes in BW and changes in TC. 
d. Favorable reductions in BW are negatively correlated 
with changes in each of the CHD risk factors: HDL-C, HDLZ-
C, and HDL3-C (Table 26). 
Changes in BW were not correlated with changes in HDL-
C, HDL2-C, or HDL3-C in males or females. These findings 
are consistent with the study by Marti et al. (1990), who 
did not find a significant correlation between changes in 
BMI and changes in HDL-C, HDL2-C, or HDL3-C in males after 
four months of aerobic exercise. Thus, one important factor 
in evaluating the results of this study is that none of the 
other investigators calculated correlations between changes 
in BW and changes in lipoproteins. 
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General Limitations 
1. Use of volunteers: volunteers represent a group of 
self-motivated and health conscious people. They may not 
have been representative of the general population of 
overweight or obese people. 
2. Use of free living subjects: because subjects were 
free living it was difficult to control food intake and 
physical expenditure on a daily basis. However, subjects 
were encouraged to walk and to control their food intake as 
part of their lifestyle, which could also be an advantage. 
3. Sample size: at the end of the program 5 of 20 males 
and 14 of 31 females were not available for final 
evaluation. The sample size was similar to many other 
studies, but ideally should have been much larger in order 
to increase the statistical power. 
4. Food records: only 8 subjects returned food records 
at the end of the program. This lack of compliance made it 
impossible to generalize about these results for the entire 
RESHAPE population. A greater number of food records should 
have indicated if the dietary habits significantly affected 
the decrease in fasting glucose, insulin, Hb A,, and lipid 
levels. 
5. Although the subjects served as their own controls, 
the use of a control group would have strengthened the 
evaluation of the effectiveness of the intervention program 
on the variables. 
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6. Not all the participants were obese. Thus, future 
studies may want to categorize subjects as "lean", 
moderately overweight and obese. See the study by Anderson 
et al . (1991) as an example. 
7. Smoking and alcohol intake were not controlled for 
in this study. However, few subjects smoked and many 
subjects reported that they seldom or never drank alcoholic 
beverages. These factors could have affected the blood 
lipids and blood pressure. 
8. No distinction was made regarding the menopausal 
status of females which could have affected the diabetes and 
CHD risk factors. 
9. WHR measurement: The WHR was calculated from a 
waist circumference measured at the level of the umbilicus, 
and a hip circumference measured at the widest part between 
hip and buttocks. In other studies, different body 
landmarks have been used to measure the waist and hip 
circumference. Thus, differences in the findings reported 
among studies may at least partially reflect differences in 
the methods used to assess body fat distribution as well as 
unique anthropometric characteristics of some of the 
populations that have been studied. For example, 
significant differences in anthropometric profiles exist 
among whites, blacks, hispanics, and oriental populations. 
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Recommendations For Future Research 
There are several factors that should be considered 
when doing research similar to that presented. Future 
research on body fat distribution should include a large 
sample size, as well as matching for confounding variables 
such as age, gender, and SSF. More accurate methods for 
measuring intra-abdominal fat versus subcutaneous fat such 
as the CT should be used to evaluate the body fat 
distribution-disease relationships assuming facilities and 
costs are not problems. Additionally, the procedures for 
measuring hip and waist circumferences should be 
standardized. The development of methods that differentiate 
between subcutaneous and deep abdominal fat are needed. 
Such methods should be both practical and cost effective 
because of the large number of subjects recruited for such 
investigations. Reference values for measurements like 
waist, hip, WHR based on age, gender, and ethnic groups are 
also needed. Repeated measurements of waist and hip 
circumferences and WHR should be taken several times during 
the research period to evaluate changes in patterns of fat 
di st ri but i on. 
In addition, there are many areas that could be 
explored regarding body fat distribution-disease 
relationships. Longitudinal studies should be carried out 
to evaluate: changes in body fat distribution from childhood 
to adulthood and the relationship with chronic diseases; 
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differences in fat distribution among people from different 
ethnic backgrounds and the relationship with chronic 
diseases; body fat distribution in chronic users of oral 
contraceptives since hormonal effects may affect body fat 
distribution; body fat distribution in postmenopausal 
females receiving estrogen replacement therapy; the effect 
of alpha-2 adrenergic receptor antagonists or beta 
adrenergic receptor agonists on body fat distribution as 
well as on abdominal versus gluteofemoral fat cell size and 
number; the effect of "sensible" low calorie, low fat diets 
with and without aerobic exercise on body fat distribution 
in different population subgroups such as adolescents, adult 
females, adult males, and postmenopausal females; the effect 
of a long term "sensible" low calorie, low fat diet upon 
diabetes risk factors, hypertension risk factors, and CHD 
risk factors; and, the effects of reducing WHR or changing 
body fat topography on the risk of developing NIDDM, since 
an excess mobilization of free fatty acids from the intra­
abdominal fat depots can impair the insulin hepatic 
ext ract ion. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
This dissertation research specifically focused on 
determining if body fat distribution exhibited a higher 
correlation with chronic disease risk factors (diabetes, 
hypertension, and CHD) than overall measures of general 
obesity such as the SSF and BMI. The specific objectives of 
this research were directed at the measurement of food 
intake, %BF, cardiovascular fitness and stress as well as 
selected risk factors for diabetes, hypertension, and CHD in 
a group of overweight/obese males and females. The selected 
nutrient variables of interest were: energy intake (cals), 
fat, protein and carbohydrate (grams per day, and as a 
percent of total kcal intake), cholesterol, dietary fiber, 
zinc and copper. Measures of body fat included body weight, 
the Quetelet index or BMI, SSF (triceps, biceps, subscapular 
and suprailiac), estimated %BF, and the WHR. Cardiovascular 
fitness was measured by the amount of time required to walk 
one mile. Measures of stress included the Personal Stress 
Assessment and the State-Trait Anxiety Inventory. 
The relative risk of developing CHD was based on the 
measurement of TC, HDL-C, HDL2-C, and HDI_3-C. The relative 
risk of developing hypertension was based on the measurement 
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of SBP and DBP. The relative risk of developing diabetes 
was based on measuring fasting glucose, insulin, and Hb A1. 
Twenty male subjects and 35 female subjects were 
evaluated at baseline for the cross-sectional study. 
Fifteen male subjects and 21 female subjects were evaluated 
at week 0 and at week 12 for the longitudinal component of 
this research. Statistical analyses conducted included 
descriptive statistics (means and standard errors of the 
means), Pearson product moment correlation coefficients, 
multiple regression analyses, paired-difference t-tests, and 
analysis of covariance. 
The following are the results obtained from the cross 
sectional study. TC was the only dependent variable 
associated with WHR in males and females after adjusting for 
age and SSF. TC was not correlated with SSF either in males 
or females after adjusting for age and WHR. Thus, TC was 
highly associated with body fat distribution independent of 
general obesity. Insulin, glucose, SBP, and DBP were 
correlated with SSF in males and females even after 
adjusting for age and WHR. These variables were more 
associated with general obesity independent of body fat 
distribution. Hb A,, HDL-C, and HDLZ-C were correlated with 
SSF independent of WHR and age in females but not in males. 
These results suggest that Hb A,, HDL-C, and HDLZ-C were 
associated with general obesity independent of body fat 
distribution in females. HDL3-C was correlated with SSF 
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after adjusting for age and WHR in males, but not in 
females. The lack of significant correlations between SSF 
and lipoproteins in males was probably because males tend to 
have less subcutaneous fat compared to females at the same 
degree of obesity. 
BMI was significantly correlated with insulin and SBP 
in males and females, and negatively correlated with HDL-C 
and HDL2-C in females but not males. BMI may not adequately 
reflect variations in body fat (Garn et al., 1986). Height 
is one of the component of BMI, and BMI may be stature 
dependent over at least part of the age range. BMI like 
weight itself may reflect both lean and fat tissue to a 
comparable degree which may explain the lack of significant 
correlations between BMI and the diabetes, hypertension, and 
CHD risk factors in comparison with SSF. 
The increase in WHR tertile from low to medium to high 
was associated with a non statistically significant increase 
in glucose, Hb A,, SBP, DBP, and TC in males. The increase 
in WHR was associated with a non statistically significant 
decrease in HDL-C and HDL2-C in males. The reduction in 
HDLg-C levels with increments in WHR was significant 
(p=0.01) in males. A larger sample size would increase the 
statistical power of these analysis. In females, the 
estimated means for TC in each tertile were significantly 
different, but there was no dose response effect. Increased 
WHR tertiles were not associated with increases in any of 
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the diabetes risk factors, hypertension risk factors or TC, 
or with decreases in HDL-C or HDL3-C in females. The 
increase in WHR was associated with a non statistically 
significant decrease in HDL2-C in females. The lack of 
associations between these variables and the WHR tertiles in 
females suggests that gender differences in WHR may account 
for differences in these relationships. There is the 
possibility that females in this research did not have 
enough visceral fat accumulation to observe the associations 
between deep abdominal fat accumulation and alterations in 
diabetes, hypertension, and CHD risk factors. In addition, 
exercise and dietary habits, history of weight loss, alcohol 
intake, cigarette smoking, oral contraceptive use, estrogen 
replacement in the postmenopausal women, menopausal state, 
genetic predisposition to hypertension, NIDDM and CHD 
represent confounding factors not controlled in this 
research that may have affected the association between WHR 
and dependent risk factors in females. Alterations in 
estrogen production may alter the effect of lipoprotein 
lipase activity on HDL-C, HDL2-C, and HDL3-C levels 
(Tikkanen & Nikkila, 1987). Because WHR was lower in 
females than males, there may be a threshold effect of WHR 
below which AO does not elevate risk factors. 
The following are the results from the longitudinal 
study. Body weight, BMI, SSF, %BF, WC, and HC decreased 
significantly in males and females. Even when the reduction 
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in waist circumference was larger than the reduction in hip 
circumference, the decrease in WHR was not significant. 
Fasting insulin, glucose, Hb A,, SBP, and TC were reduced 
significantly in both males and females. DBP decreased 
significantly in males but not females. In general, HDL-C, 
HDL2-C, and HDL3-C were not altered during the 12-week 
program in males or females. HDL2-C increased significantly 
(p=0.04) in males. As noted previously, cigarette smoking, 
alcohol intake, and dietary habits could have masked the 
exercise-1ipoprotein relationships. Changes in alcohol 
intake with changes in exercise habits might potentially 
affect the interpretation of the exercise influence on 
lipoprotein levels. A diet low in saturated fat may 
decrease VLDL, LDL-C, and HDL-C. The subjects in the 
RESHAPE program were encouraged to decrease fat and 
cholesterol intake, which may explain why HDL-C did not 
increase. In addition, these subjects walked for an hour 
from week 0 through week 12, which probably was not long 
enough to elicit changes (decreased HL activity and or 
increased LPL activity) in lipoprotein metabolism. WHR was 
not significantly reduced which probably accounts for the 
non-increase in lipoproteins. Hormonal effects may have 
also affected the lack of change in lipoproteins since both 
HDL2-C and HL activity are sensitive to sex steroids. 
Stress and anxiety improved after the 12-week program. 
Mean STAI scores decreased while mean CSA scores increased. 
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The increase in CSA scale was not significant in females. 
Fat and calorie intake decreased significantly in 
males. Dietary fiber intake increased while cholesterol 
intake decreased in males and females but these changes were 
not significant. These results cannot be generalized to the 
RESHAPE population since only eight food records were 
returned at week 12. Cardiovascular fitness significantly 
improved as measured by the amount of time required to walk 
a mile. Changes in SSF were correlated with changes in 
insulin and DBP in males. Changes in SSF were not 
associated with changes in glucose, Hb A1, SBP, TC, HDL-C, 
HDL2-C, or HDL3-C in males. Changes in SSF were associated 
with changes in HDL2-C in females. 
Changes in WHR were positively correlated with changes 
in TC in males. However, changes in WHR were not 
significantly correlated with any of the other dependent 
variables in males. Changes in WHR were not correlated with 
changes in any of the dependent variables in females. 
Changes in body weight were positively correlated with 
changes in TC in females, but not with any of the other 
dependent variables in females, or with any dependent 
variable in males. The lack of correlation between changes 
in the anthropometric variables and the dependent variables 
might be explained by the fact that not every subject who 
reduced SSF, WHR, or body weight, had a decrease in the 
diabetes risk factors, hypertension risk factors, TC, or an 
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increase in HDL-C, HDL2-C, or HDL3-C. There were large 
differences among subjects regarding changes in SSF, WHR, 
and body weight. The differences between responders and 
"non-responders" probably affected these relationships. 
Additionally, the sample size was reduced for the last three 
hypotheses, because only subjects who reduced each 
anthropometric variable by at least a certain amount were 
considered. The decrease in statistical power reduced the 
probability of finding significant results. 
Overall, the most important findings from this 
dissertation research were that the diabetes risk factors, 
hypertension risk factors, and lipoprotein were more related 
to the overall degree of obesity than to body fat 
distribution. TC was associated with body fat distribution 
measured as the WHR independent of the effects of age and 
body subcutaneous fat measured as the SSF. BW, XBF, BMI as 
well as waist and hip circumference were on the average 
significantly reduced at the end of the 12-week RESHAPE 
program for both males and females. Cardiovascular fitness 
increased as measured by the significant decrease in the 
time taken to walk a mile. 
Although more research is needed on the effects of 
abdominal body fat on chronic disease risk factors, 
educational and therapeutic guidelines should be directed 
toward males and females with abdominal fat distribution. 
Research on adolescents is also needed because obese 
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children frequently become obese adults. Exercise of long 
duration and high intensity such as "fast" walking combined 
with a low fat diet should be encouraged as a therapeutic 
and a preventive strategy for obesity, hypertension, NIDDM, 
and CHD. 
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APPENDIX A 
Relationship Between Abdominal Fat Distribution, 
Diabetes, Hypertension, and Coronary 
Heart Disease Risk Factors. 
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Diagram Explanation 
In AO, there is an increase in the size of the 
adipocytes or fat cells. In females, a normal distribution 
of adipose tissue includes a specific accumulation of body 
fat in the gluteo-femoral regions, mediated by stimulation 
of LPL activity, progesterone and estrogen. In females with 
irregular ovulations, there is an inadequate production of 
progesterone, affecting the accumulation of excess fat depot 
in the gluteo-femoral region. An elevation of free 
testosterone and a decrease in SHBG is observed in these 
females, and in females with AO indicating an increase in 
androgenic activity. In these females, as well as in males 
who do not have functioning gluteo-femoral adipose tissue, 
the excess is stored in other regions such as the abdomen. 
Androgens and corticosteroids probably facilitate fat 
storage in the abdomen directly. 
Steroids with androgenic activity increase HL activity 
leading to a decrease in HDL2-C. HL activity has a key role 
in the degradation of HDLZ molecules. Estrogens elevate HDL 
by suppressing HL activity and by increasing Apo A1 
synthesis, which is the protein backbone of the HDL 
molecule. HDL concentration are determined by: 1) synthetic 
rate of Apo A1, 2) activity of LPL which regulates the 
lipolytic degradation of TG-rich lipoproteins increasing 
HDL2-C, and 3) the activity of HL. 
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Human adipose tissue is an important site of HDL 
interaction and metabolism by the binding capacities of HDL 
to human adipocytes with high affinity and specificity. HDL 
binding is enhanced with increasing cell size as occurs in 
AO. These effects may contribute to lower HDL-C in AO. 
The intra-abdominal omental fat cells have a higher 
lipolytic sensitivity presumably due to an increase in the 
ratio of beta 1 to alpha 2 adrenergic activities and to 
diminished sensitivity to the action of insulin which is an 
anti-1ipolytic hormone. Insulin is going to have a less 
pronounced effect on abdominal adipose tissue, perhaps due 
to a small number of insulin receptors. Due to the above, 
abdominal adipose tissue is easily mobilized, and when 
enlarged will cause elevations of FFA in the portal vein. 
Increased circulating FFA inhibit glucose transport causing 
hyperinsulinemia or high insulin levels and eventually 
insulin resistance. FFA from abdominal adipocytes may lead 
to an increased hepatic VLDL-TG secretion and a subsequent 
decrease in HDL-C levels triggered by hyperinsulinemia. 
High concentrations of portal FFA may regulate the 
hepatic insulin uptake and lead to insulin resistance. 
Pancreatic Beta-cells secrete insulin, insulin passes 
through the portal circulation, and a major part is normally 
taken up by the liver. Therefore, a decrease in hepatic 
insulin uptake contributes to the hyperinsulinemia in AO, 
and is probably an important cause of the higher insulin 
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levels and associated complications. FFA could also lead to 
peripheral insulin insensitivity and decreased hepatic 
extraction, triggered by androgenic activity. These effects 
will further enhance hyperinsulinemia resulting in insulin 
resistance. 
Elevated insulin levels are most likely to be the key 
intermediary factor which connects upper body fat to lipid 
disturbances, probably enhanced by high FFA levels released 
from the visceral compartment. Insulin can enhance renal 
sodium retention directly, through its effect on renal 
tubules, and indirectly, through stimulation of the 
sympathetic nervous system and increase of aldosterone 
secretion. In addition, insulin can increase NE leading to 
an increase in BP via sympathetic nervous system 
st imulat i on. 
Insulin has a direct effect on the arterial walls that 
could be atherogenic: inhibition of lipolysis, stimulation 
of cholesterol, phospholipids, and TG synthesis; and, a 
mitogenic effect resulting in stimulation of smooth muscle 
proliferation leading to increased in BP and CHD. A high 
WHR may also influence levels of circulating clotting 
factors so as to increase the coagulability of blood in the 
coronary arteries and cerebral vessels, thus, leading to an 
increased risk of heart attacks. 
Relationship Between Abdominal Obesity, Diabetes, Hypertension, and Coronary Heart 
Disease Risk Factors. 
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APPENDIX B 
Consent Form 
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THE UNIVERSITY OF NORTH CAROLINA 
AT GREENSBORO 
SCHOOL OF HUMAN ENVIRONMENTAL SCIENCES 
Dtpartmmt cffood-Nutrition-Faed Strviet Managtwunt 
(919) 3344332; 3313 
CONSENT FORM 
I agree to participate in the study "Nutritional Status, 
Energy Expenditure and Chronic Disease Risk Factors Among Reshape 
participants of Spring 1990 which is being directed by Dr. Terry 
Bazzarre, and two doctoral students (Rita Sigmon and Lizette 
Sanchez). 
EXPLANATION OF STUDY 
I understand that the purpose of this study is to measure food 
intake, physical activity, stress, blood pressure and the levels 
of various constituents such as cholesterol, iron, zinc, vitamin 
C, and immunoglobulins present in the blood. I understand that the 
above measurements will enable Dr. Bazzarre and his colleagues to 
study the relationships of diet and physical activity to health 
and to disease problems such as cardiovascular heart disease, high 
blood pressure and diabetes. I understand that I will need to 
complete a questionnaire about my personal and familial medical 
health in order for Dr. Bazzarre to conduct his study. 
METHODS 
. I understand that a 4-day food record which I will complete 
at home will be "used to estimate my intake of 25 nutrients. I 
understand that a 4-day activity record that I will complete at 
home will be used to measure my energy expenditure for physical 
activity. I understand that questionnaires will be used to collect 
information about my personal and family medical histories as well 
as to assess the amount of. stress I have experienced in my l'ife 
during the past year. I understand that these questionnaires will 
be reviewed and completed at my first visit. The food records and 
activity records will be explained to me at visit I. 
I understand that my blood pressure will be measured using a 
standard blood pressure cuff. I understand that about 30 ml (5 
tablespoons) of blood will be collected to measure the cholesterol, 
iron, zinc, immunoglobulin, insulin, glucose and vitamin C in my 
blood. I understand that the risks of having by blood drawn 
include fainting, bruising, air emboli, puncture of an artery 
instead of a vein and compression of a nerve. I understand that 
CIIINIIOIO, NOITR C A Jt O L 1 N A I 174!t-lt»l 
THX UNIYUSITr or NOKTH OUtOUNA it ttnf—i 4 lU item fmUU uwUr latHlwH—t ia Ntrtk CarWfu 
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Dr. Bazzarre will draw blood following appropriate blood drawing 
techniques and will make every effort to avoid causing any of the 
above risks. I understand that my blood pressure will be measured 
and that the blood sample will be collected at visit II. I 
understand that I will return the food record and activity record 
at visit II. I understand that skinfold thickness measurements will 
be taking at four body sites. 
CONFIDENTIALITY 
I understand that, a code number rather than my name will be 
used to identify the information I provide to the researchers, and 
that my name and code number will be linked only on raw data forms. 
These forms will be kept securely in a file cabinet. * I also 
understand that I may withdraw from the study at any time of my 
choosing without prejudice form any of the investigators. 
EXPLANATION OF BENEFITS 
The benefits I may gain form participating in this -study 
include: evaluation of my risk of developing heart disease, 
hypertension, or nutrition problems; evaluation of my stress 
levels, resistance to diseases, and measurements of my body fat-. 
I will also receive a written report containing all my measurements 
upon the completion of the study. X understand that the benefits 
of participating in this research outweigh the potential risks 
which are not likely to occur. 
I understand that Dr. Bazzarre or his designee will be able 
to answer any questions I have. They can be reached at 919-334-
5332 during the weekdays. All of my immediate questions have been 
answered. 
SIGNATURE (FULL LEGAL NAME) Date 
SIGNATURE OF RESHAPE STAFF MEMBER 
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APPENDIX C 
Physician's Clearance Forms 
ATTACHMENT I 
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(Date) 
Dr. Terry I. Bazzarre 
RESHAPE 
School of Home Economics 
UNC-Greensboro 
Greensboro, NC 27412 
Dear Dr. Bazzarre, 
I have reviewed the medical records cf 
(name ot reshape participant; 
and reached the following opinion. 
Check as appropriate: 
May participate in the RESHAPE program without any known medical 
risk 
May participate in the RESHAPE program only after the fallowing 
tests have been satisfactorily completed 
(1) exercise stress test scheduled for the following 
date 
Month Day 7ear 
(2) Other tests: (please specify) 
May not participate in the RESHAPE program because of the following 
medicaI problems: 
Sincerely, 
(Signature; 
(Office Telephone Number) 
THE UNIVERSITY OF NORTH CAROLINA 
AT (JRKKNSBORO 
Sthuol «f Horn* Etontmitt 
Dear 
(Physician's Name) 
is being screened for participation in 
(Participant's Name; 
the RESHAPE program sponsored by the departments of Nutrition, Physical 
Education, and Psychology at-UNC-Greensboro. Part of our screening 
procedures require that we individually contact the physician of al! 
participants over 35 years of'age, and any participant who has known 
medical risk factors (e.g. high blood pressure, elevated fasting 
cholesterol, angina, etc.) before they begin the program. 
We would like you to review the aedlcal records of the above 
participant, conduct any necessary tests, and complete the attached form. 
Please nail the completed form to: 
Or. Terry I. Bazzarre, Director 
RESHAPE 
School of Home Economics 
UNC-Greensboro 
Greensboro, fiC 27412 
You can contact Dr. Bazzarre or members of the RESHAPE staff by 
calling 3TI-5332. 
Ue have also attached, for your Information, a letter which 
briefly explains the RESHAPE program. Ue have been approved as a ser­
vice provider for weight reduction by the State Hedical Director of 
Vocational Rehabilitation. 
Thank you for your assistance. 
Sincerely, 
Terry(l. Bazzarre, Fh.D. 
Associate Professor 
TlB:.ur 
Enclosure: 
Cllt.lSIOIO. KOITH CUOll!H/IMI! 
THC CKrVUtSnr t ' **QftT)t Carolina « »/ III m Mmik cmdma 
— i» 0mfi*i*» 
MEOICAL INFORMATION 
Dr. Terry t. Bazzarre Date 
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NAME 
RESHAPE 
Address 
R _ _ Telephone No(s): Home -
1 5 6 7 8 Year Work -
I.D. No. Session 1 « rail 2 * Spring 3 * Summer 4 » Private Client 
Sex: 1 3 Male Female 
Race: 1 1 Black 2 » White Other 
Physician's Clearance: (PHYSCL) 
If client is over 35 years 
of age or has CHD, diabetes 
or hypertension, give the 
client, the physician's 
clearance forms. 
Maine of physician 
10 
0 » Not approved _ 
1 * Approved 11 
2 • Approved w/ exercise stress test performed 
3 * Approved for walking only 
_ 4 « Other (Specify): 
_ 3 » iio-; Applicable (i.e. client is under 
35 years of age with no medical nistory 
of CHO, hypertension or diabetes) 
Occupation: (OCCU) 
Ask client to describe 
their current occupation. 
If retired, ask client to 
describe their occupation 
prior to retirement. 
01 
02 
03 
04 -
05 -
06 * 
1)7 » 
08 * 
09 -
10 » 
11 -
Housewife 
Student 12 13 
Health professional 
(e.g., MO, RN, RO, dentist, psychologist) 
Administrator/' Lawyer 
Secretary/ Clerical 
31ue Collar (e.g., mechanic, aarisnsr) 
Sales/' Service (e.g., social worker} 
Farmer 
Teacher/ Educator 
Technical/ Engineer/ Computer Programmer 
Other (Specify): 
Marital Status: (MARITAL) 1 • Married 
2 » Single 
3 » Divorced/ Separated 
14 
AGE: (AGE) years (Ask client for datj of birth: / / ) 
15 16 
MEDICAL INFORMATION 
Page 2 Date 
NAME (I.O. NO. R 
H«»1ght: (HEIGHT) record 1n inches 
1/4- - .3 in 
1/2" - .5 in 
3/4M « .8 in 
17 20 
GoaIs: 
(1) 
( 2 )  
(3) 
(4) 
(GOALS) 
Please ask client to 
describe his/ her goals:-
1 » Weight loss gT 
2 =• Fitness 
3 - Oiet 
4 • Stress Management 
5 > Weight loss + Fitness (1 & 2) 
6 * Weight loss + Oiet (1 & 3) 
7 - 1,2 & 3 
8 - 1,2,3 & 4 
9 * Other (Specify) 
Goals for Weight Loss: (GLWTLOSS) 
If the client plans to lose wt during the program, 
write the number of pounds s/he plans to lose during 
the program. If the subject does not plan to lose 
any weight, write " 0C0 " 1n columns 22 - 24. 
Children: (CHILDREN) Write down the number of children. 
Write down the age of the oldest child. 
Write down the age of the youngest child. 
List names, ages and sex of all chilaren. 
22 24 
25 
26 27 
28 29 
MEDICAL INFORMATION 
Page 3 . 
NAME U.O. NO. R ) 
PERSONAL MEDICAL HISTORY 
For each of the following chronic diseases mark: 1 * present 
2 3 absent 
3 * unknown 
Coronary Heart Disease (PCHD) 
Hypertension (PHYP) 
Diabetes (PDIA) 
Obesity (POBESITY) 
Ask the client 1f s/he has any other major medical problems. _ 
Please list: 0 » None 34 
(POTHER) _________ 1 * Cancer 
2 = Mental Health 
(e.g. depression) 
3 * Arthritis 
4 * Gastro-Intestinal 
5 » Endocrine 
6 * Respiratory (e.g. astraa, allergies 
7 * Dennatological 
8 * Other 
Smoking History: (SMOKE) 0 « Never 
1 • Stopped 35 
2 * Yes 
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UafS 
30 
31 
32 
33 
if tne individual stopoed smoking, how many years ago dia they stop? 
(YRSAGC) 35 37 
If the individual currently smokes, how many packs/ day does s/he siaoke? _ 
(PKSDAY) 38 
If the individual currently smokes, hew many years has s/he siscked? 
(YRSSMOKED) 7n 
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MEDICAL INFORMATION 
Page 4 DTEe" 
NAME ( I.O. NO. R 
Alcohol Intake: (ALCOHOL) 0 • Never 
1 » Yes 41 
If yes, describe the amount of the following beverages consumed. 
Beer (No. of 12 oz cans/ week) 
Wine (No. of 3 oz glasses/ week) 
Mixed Orinks (No. of 2 oz servings/ week) 
(SEER) 
(WINE) 
(MIXED) 
Note: Use 0 if they-never consume any of the above category 
of alcoholic beverages. Use 1 If s/he consumes the 
beverage between once/ year and once/ week. 
History of Obesity: 
Ask client if s/he considers herself or himself overweight? 
1 « yes 
2 • no 
If s/he considers herself or himself overweight, ask client 
how many pounds s/he is overweight? ARO 
how many years s/he has been overweight? 
42 43 
44 45 
46 47 
48 
(OVWT) 
- - - (XTRAWT) 
49 50 51 
52 53 
(yrsovwt: 
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NAME: 
RESHAPE 
(1.0. NO. R 
T 
INITIAL DATA : 
VARIABLE : 
Body Weight 
(pounds) 
Waist (inches) 
WEEK 0 
5*' 
64 
72 
10 
18 ~ 
26 
34 
42 
Thigh (inches) 
Biceps (mm) 
Triceps (mm} 
Subscapular(mm) 
Suprailiac (mm) 
Sum of 4 Skinfolds 
X Body Fat 
Blood Pressure: 
Systolic (urn Hg) 
Diastolic (inn Hg) 
Total Cholesterol (mgS) 
HOL-Cholesterol (mgS) 
Hematocrit (%) 
Exercise Heart Rate (8PM) 
Resting Heart Rate (BPM) 
58 
67 
* 
I 
75 79 
13 . 
21 
29 
37 
46 
52 55 
60 62 
66 68 
72 74 
6 8 
12 13 
15 77 
23 71 
WEEK 12 
59" "53 
68 7l 
6 ~~ 9 
14 17 
22 25 
30 33 
38 41 
47 51 
56 ~ 59 
63 65 
69 71 
75 ~ 77 
9 ~Tl 
14 15 
15 T9 
22 73 
Date: 
FOLLOW-UP DATA: 9 
(.* Wks p ^ogram! 
35" 17 
38' 
2 
79 
43 
47 
5~ 
5l 
5l 
63 
67 
42 
(THRWT! 
(THRWAIS7) 
46 
(THRTHICH! 
EC 
(THRBICE?; 
54 
(THR73ICP) 
58 
(THRSU3SC) 
62 
(THRSUPRA) 
66 
(THRSKIN) 
70 
(THRPBFAT) 
71 74 
12 Minute Walk/Run (Miles) . 
2* ~ 76 27 "79 
Activity Sessions Attended: Workshops Attended: 
30 71 it' 
(THRSYSBP) 
(THRDIABP) 
(THRTCi 
I 
(THRHDLC) 
I 
(THRHTC) 
(THRXHR) 
3 
(THRRHR) 
JTHRMILSS) 
21" " "23 
4 (END LINE i 
75 77 
6 3 
9 11
12 14
15 15 
1 r 18
APPENDIX D 
Percent Body Fat Tab! 
254 
Table 9. The equivalent fat content, as a percentage of body-weight, for a range of values 
for the sum of four skinfolds (biceps, triceps, subscapular and supra-iliac) of males and 
females of different ages 
Males (age in yean) Females (age in years) 
Skinfolds 
(mm) 17-29 30-39 40-49 50+ 16-29 30-39 40-49 50+ 
*5 4-8 —- — — 10-5 — — — 
30 81 I2'2 12*2 12-6 14-1 17*0 19'8 at-4 
»S xo-s *4-2 XJO IS-6 x6-8 19*4 22*2 34-0 
30 12-9 16-2 *77 186 19-5 21*8 34-S 36-6 
35 *4*7 177 19-6 ao-8 2X-5 33'7 26-4 38-5 
40 16-4 19-2 21-4 22*9 23-4 •25*5 28*2 303 
45 *7-7 ao'4 23-0 24-7 25-0 26-9 29-6 319 
50 19-0 21-5 34-6 26-5 26-5 282 31-0 33-4 
55 20*1 22*5 25-9 27-9 278 39*4 32-t 34-6 
60 21-2 *3*5 37*1 29-2 29-1 30-6 33-a 35-7 
«5 22-2 24-3 28-2 30-4 30-2 3 *'6 34*1 367 
70 23-1 25-1 29'3 31-6 31-2 3-'S 350 37-7 
75 24-0 25-9 30-3 32-7 32-2 33-4 3S'9 38-7 
80 248 26-6 31-2 33-8 33"» 34*3 36-7 396 
85 *55 27-2 32-t 34*8 34-0 35-t 37*5 40-4 
90 26-2 27-8 33-0 35*8 34-8 35*8 38-3 41-2 
95 26-9 28-4 33-7 36-6 35-6 36-5 390 41-9 
zoo 27-6 2Q'0 34-4 37-4 36-4 37-2 39-7 43-6 
xos 28-2 29'6 3S't 382 37't 37*9 40-4 43-3 
no 288 30*1 35-8 390 37-8 386 41-0 43-9 
"5 29-4 30-6 36-4 39*7 38-4 39-1 41-5 44-5 
120 30-0 31-1 37-0 40-4 390 396 4—'O 45-* 
125 30-5 3'-5 376 41-x 39-6 40*1 42*5 45-7 
130 31-0 31-9 38-2 41-8 40-2 40-6 430 46-2 
*35 3'*5 3a'3 38-7 4="4 40-8 41-1 43'S 467 
140 32-0 3-7 39-2 • 43'° 4«"3 4t-6 440 47-2 
*45 32-5 33-* 397 43-6 4«-8 42-t 44*5 47*7 
150 32-9 33-5 40-2 44' 42-3 42-6 4jo 48-3 
*55 33*3 33-9 407 44-6 42-8 43'« 45-4 487 
160 33*7 34*3 4 i'S 45"« 43-3 43-6 4 5 8  49-3 
165 34*« 34-6 41-6 4J-6 43-7 44*0 4 6 2  4 9 6  
170 34-5 34-8 42-0 46-. 44** 44-4 46-6 50-0 
*75 34*9 — — — — 44*8 4 7 0  504 
280 35*3 — — — — 45*1 47*4 50-8 
*85 35-6 — — — — 45-6 47-8 51-2 
*90 35*9 — — — — 45*9 48-2 St-6  
*95 — — — — — 46-2 485 5 2 0  
200 — — — — — 46-5 4 8 S  5*4 
205 — — — — — — 49-1 5®-7 
210 — — — — — — 494 53-0 
In two-thirds of the instances the error was within ± 3-5% °f 'lie Iwily-wcight as fat for ilic women 
and ±5% for the men. 
Reference: Durnin, J. V., & Womersley, J. (1974). Body 
fat assessed from total body density and its 
estimation from skinfold thickness: 
Measurements on 481 men and women aged.from 
16-72 years. British Journal of Nutrition. 
22., 77—96. 
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INSTRUCTIONS FOR FOOD RECORDS 
These instructions will help you in recording the food 
that you eat. Please read this instructions carefully. 
Please feel free to call the Department of Food and 
Nutrition at The University of North Carolina at Greensboro 
at 919 334-5313. 
1. Measure e 
1/2 cup, 1/4 
teaspoon, 
" ach item using household measurements (1 cup, 
I cup, tablespoon, teaspoon, 3/4 teaspoon, 1/2 
etc.). Abbreviations can be used. 
2. For items that are not measured such as fresh 
eggs, write the number of items eaten and whether 
1arge or smal1. 
Examples: 
1 large egg 
1 small banana 
Additional information about the size 
diameter, length, width, thickness or 
Examples: 
3" carrot 
1 brownie with walnuts, wedge 2" 
1- 12 oz. can coke 
Pizza with mushrooms, green peppers 
12" pizza 
1 apple - 2 1/2" diameter 
of t he 
ounces 
fruits or 
they are 
food such as 
is he!pful. 
by 2" by 1" high. 
and cheese - 1/8 of 
3. If you do not eat all the food you have served on your 
plate, try to measure the amount of each item you did not 
eat and subtract that amount from what was served. 
Example: If you are served a peanut butter sandwich with two 
slices of bread an 2 T peanut butter and you eat 3/4 of the 
sandwich, you have eaten 1 1/2 slices of bread and 1 1/2 T 
of peanut butter. 
4. Describe the food eaten as exactly as possible. 
a. For meat, fish, poultry, and eggs specify the cut or 
type of meat or fish (chuck or bass), whether you ate or 
trimmed off the fat, whether you ate the skin (poultry), 
percent fat (hamburger), and whether the fish was oil pack 
or water pack (tuna). 
b. For breads, cereal, cakes, cookies, etc. state 
whether the food is made from white flour or whole grain and 
whether the food was homemade or bought. Specify the brand 
names whenever possible. 
c. For margarine state the brand name, whether the 
margarine comes as a stick, soft or liquid, whether it is 
diet or regular, and whether it is whipped or not. 
d. For oils and shortening state the brand name, the 
major oil(s) (if known) and whether the fat is solid fat or 
oil. 
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e. For salad dressings specify whether it is homemade, 
commercial or restaurant, the type of oil or brand name, 
creamy or clear, and additional ingredients such as cheese 
or bacon bites. 
f. For dairy products indicate the percent fat, the 
brand name or relative price and whether it is a true dairy 
product or a nondairy product. 
g. For bakery items state whether they are homemade, 
restaurant or commercial, the brand, the principal fat, 
toppings or frostings, yeast or cake and type of grain. For 
pies indicate whether it is a single or double crust. 
h. For sauces and gravies indicate the type of fat, the 
meat fat, and what kind of milk added (if any). 
i. For recipes and mixed dishes indicate whether it is 
homemade, commercial or restaurant, the brand name, cooking 
method, and all the ingredients used. Submit a recipe if 
possi ble. 
j. For fruits and juices indicate whether they are 
fresh, frozen, canned, cooked, or dried; and whether the 
food is sweetened or unsweetened. 
k. For vegetables state whether they are cooked or raw, 
the kind of fat added if any, sauces added, the method 
cooked and any seasoning added. Specify how mashed potatoes 
were prepared. 
1. For soups specify whether they are homemade or 
canned, cream soups or clear soups and the water or kind of 
milk or stock added. 
m. For beverages and cereals, indicate whether they are 
sweetened or unsweetened, the brand, decaffeinated (coffee 
or tea), and whether it is cola or not. 
n. For crackers, snacks, candy bars indicate the brand, 
weight, type or size. If you are in doubt as to whether the 
information is needed or not, include the information. 
5. Record accompaniments such as gravies, sauces, salad 
dressings, mayonnaise, ketchup, mustard, seasonings, 
garnishes, etc. separately. Do not forget to record sugar, 
lemon, cream, non-dairy creamers, or flavorings that you may 
add to drinks such as coffee, tea, or milk. If you drink 
any liquid other than water, measure the amount in a liquid 
(pyrex) measuring cup. 
6. Describe how the food was prepared, including any 
additional fat, sugar or condiments that may be added. 
Example: 
sauteed in butter 
basted with garlic butter 
boi1ed in water 
deep fat fried in peanut oil 
simmered in wine 
7. Do not forget to record snacks. If you eat a snack away 
from home carry the wrapping home with you as a reminder. 
APPENDIX F 
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Laboratory Procedure for Cholesterol Analysis 
The reagents and materials necessary for this analysis 
were obtained from Sigma Diagnostics. The Cholesterol 
Reagent obtained from Sigma was Catalog No. 351-20, the 
cholesterol equilibrator was Catalog No. C 0284, and the 
Cholesterol Decolorizing Reagent was Catalog No. 350-10. 
The analyses conducted followed the guidelines for procedure 
established by Sigma Chemical Company (1986). 
Micro Method for Total Cholesterol 
1. To a test tube labeled blank, 0.01 ml of water was added. 
To a test tube labeled standard, 0.01 ml of Cholesterol 
Calibrator, Catalog No. C 0284 was added. To a test tube 
labeled test, for the sample plasma to be analyzed, 0.01 ml 
plasma was added. 
2. To each tube, 1.0 ml Cholesterol assay Solution was 
added. The test tubes were placed on the vortex for several 
seconds to ensure that the plasma and Cholesterol calibrator 
was mixed. 
3. The test tubes were incubated at 37°C in a waterbath for 
10 minutes. 
4. Once the solutions were placed in cuvets, the absorbance 
was read and recorded. The absorbance of the standard and 
the tests vs the blank as reference at 500 ± 15 nm were read 
within 30 minutes. 
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5. The total cholesterol was calculated as follows: 
Total Cholesterol (mg/dl) = (A test/ A standard) * 200 
200 is the concentration (mg/dl) of the Cholesterol 
Calibrator, Catalog No. C 0284. 
Micro Method for HDL Cholesterol 
1. To a small container (2 ml with top), 0.4 ml plasma and 
0.05 ml HDL Precipitating Reagent, Catalog No. 350-3, were 
placed and mixed throughly by the vortex. 
2. Samples were centifuged for 5-10 minutes to obtain clear 
supernat ant. 
3. To a test tube labeled blank, 0.05 water was added. To a 
test tube labeled standard, 0.05 ml Cholesterol Calibrator, 
Catalog No. C 9908, was added. To a test tube labeled test, 
0.05 ml supernatant (HDL fraction) from step 2 was added. 
4. To each test tube 1.0 ml Cholesterol Assay Solution was 
added. 
5. The test tubes were incubated at 37°C for 10-minutes. 
6. Once the solutions were placed in cuvets, the absorbance 
was read and recorded. The absorbance of the standard and 
the tests vs the blank as reference at 500 + 15 nm were read 
within 30 minutes. 
7. The HDL cholesterol was calculated as follows: 
HDL-C (mg/dl) = (A test/A standard) * 50 * 1.125 
Where: 50 = Concentration (mg/dl) of Cholesterol 
Calibrator, Catalog No. C9908. 
1.125 = Factor to correct for the dilution of the 
plasma during the isolation of the HDL fraction (step 1). 
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Assay Procedures for G1vcohemoglobin (Hb An) 
This procedure is described in the Sigma Diagnostics 
Instruction Booklet (Procedure No. 440, Quantitative Column 
Technique for Whole Blood at 415 nm) P.O. Box 14508, St. 
Louis, MO 63178, 1989. According to the Sigma procedure, an 
aliquot of hemolysate, prepared by mixing measured volumes 
of blood and hemolyzing solution, is introduced onto the 
resin column. Hb A, and other hemoglobins are absorbed onto 
the ion-exchange material. Subsequent addition of a known 
volume of eluting solution to the column removes only Hb A1. 
Measurement of the absorbance of this eluate and of the 
original hemolysate (diluted) at 415 nm permits quantitation 
of the Hb A1 fraction. 
Reagents 
Hemolyzing solution Catalog No. 440-2 
Hb A1 column Catalog No. 440-4 
Eluting solution Catalog No. 440-3 
Gycohemoglobin control-N Catalog No. G2012 
Procedure 
1. To one or more test tubes corresponding to the number of 
samples to be determined, add 0.5 mL Hemilyzing Solution, 
and 0.1 mL test sample. Mix contents well to obtain 
hemolyzate. 
2. Prepare Hb A1 Columns by shaking until the resin material 
above the column plug is resuspended. 
3. Place the column upright on the column stand. 
a) Remove first the top cap and then the bottom cap. 
b) Allow the liquid in the column to completely drain and 
proceed quickly to the next step. 
4. Add to the column carefully so as not to disturb the 
resin 0.050 ml hemolysate from Step 1. 
5. Place a clean test tube marked E beneath the column 
outlet. Carefully add 5.0 mL volumetric of Eluting Solution 
to the column using a 5.0-mL pipet. Add slowly with the tip 
of the pipet against the side of the column so that minimal 
disturbance of the resin bed occurs. 
6. Allow the column to drain completely into the tube marked 
E and mix tube contents. 
7. While the column is draining, mark a second test tube T 
and add 10.0 mL Eluting Solution, and 0.02 ml hemolysate 
from Step 1. Mix well. 
8. Transfer portions of tubes E and T to cuvets and read 
absorbance of each at 415 nm vs water as reference. 
Hb A 1  ( % )  =  Absorbance of Tube E * 20 
Absorbance of Tube T 
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Assay Procedure for Insulin Analysis 
The reagents and materials necessary for this analysis 
were obtained from Diagnostic Products Corporation 5700 West 
97th St. Los Angeles, CA 90045. The Coat-A-Count Insulin 
is a solid-phase 125I radioimmunoassay designed for the 
quantitative measurement of insulin in serum. It is 
intended strictly for in vi t ro diagnostic use as an aid in 
clinical diagnosis. In the Coat-A-count Insulin procedure, 
1Z5I-labeled insulin competes with insulin in the patient 
sample for sites on insulin-specific antibody immobilized to 
the wall of a polypropylene tube. After incubation, 
isolation of the antibody-bound fraction is achieved by 
decanting the supernatant. The tube is then counted in a 
gamma counter, the counts being inversely related to the 
amount of insulin present in the patient sample. The 
quantity of insulin in the sample is then determined by 
comparing the counts to a standard curve. 
Reagents: 
1. Insulin Antibody-coated tubes 
2. Buffered (125I) Insulin 
3. Insulin calibrators, the reconstituted calibrators 
contain respectively 0, 5, 15, 20, 100, 200, and 400 micro-
International Units of insulin per milliliter in processed 
human serum. 
Radioimmunoassay Procedure 
All components must be at normal temperature before 
use. 
1. Plain tubes: Label four plain (uncoated) 12x75mm 
polypropylene tubes T (total counts) and NSB (nonspecific 
binding) in duplicate. 
Coated tubes: Label fourteen Insulin Antibody-Coated Tubes A 
(maximum binding) and B through G in duplicate. Label 
additional antibody-coated tubes, also in duplicate, for 
controls and patient samples. 
2. Pipet 200 ul of the zero calibrator A into the NSB and A 
tubes, and 200 ul of each remaining calibrator, control and 
patient sample into the tubes prepared. Pipet directly to 
the bottom. 
3. Add 1.0 ml of Buffered [125I] Insulin to every tube. 
Vortex. Samples should not be left in the tubes for 
extended periods of time. Following step 2 (sample 
addition), step 3 (tracer addition) should be completed with 
minimal delay, with no more than 40 minutes elapsing between 
the addition of the first sample and the completion of 
tracer addition. Set the T tubes aside for counting (at 
step 6). 
4. Incubate for 18-24 hours at room temperature. 
5. Decant thoroughly. Removing all visible moisture will 
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enhance precision. Using a foam decanting rack, decant the 
contents of all tubes (except T tubes) and allow them to 
drain for 2 or 3 minutes. Then strike the tubes sharply on 
absorbent paper to shake off all residual droplets. 
6. Count for 1-minute in ia gamma counter. 
Calculation of Results: 
To calculate insulin concentrations from a logit-log 
representation of the calibration curve, first calculate for 
each pair of tubes the average NSB-corrected counts per 
minute: 
Net Counts = Average CPM - Average NSB CPM 
Determine the binding of each pair of tubes as a percent of 
maximum binding (MB), with the NSB-corrected counts of the A 
tubes taken as 100%: 
Percent Bound = Net Counts 
Net MB Counts * 100 
Using logit-log graph paper plot Percent Bound on the 
vertical axis against Concentration on the horizontal axis 
for each of the calibrators B through G, and draw a straight 
line approximating the path of these six points. Insulin 
concentrations for the unknowns may then be estimated from 
the line by interpolation. 
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Assay Procedures for Plasma Glucose 
This procedure is described in the Sigma Diagnostics 
Instruction Booklet (Procedure No. 16-UV, Quantitative, 
Enzymatic [Hexokinase] Determination of glucose in plasma at 
340 nm) P.O. Box 14508, St. Louis, MO 63178, 1988. The 
enzymatic reaction involved in the assay begins when glucose 
is phosphorylated by adenosine triphosphate (ATP), in the 
reaction catalyzed by hexokinase (HK). The glucose-6-
phosphate (G-6-P) formed is then oxidized to 6-
phosphogluconate (6-PG) in the presence of nicotinamide 
adenine dinucleotide (NAD). This reaction is catalized by 
glucose-6-phosphate dehydrogenase (G-6-PDH). During this 
oxidation, an equimolar amount of NAD is reduced to NADH. 
The consequent increase in absorbance at 340 nm is directly 
proportional to glucose concentration. 
Reagents: The Glucose (HK) reagent, when reconstituted 
according to the directions, contains approximately the 
following concentrations of active ingredients: 
NAD 1.5 mmol/L 
ATP 1 .0 mmol/L 
Hexokinase(yeast) 1000 units/L 
G-6-PDH (L.m.) 1000 units/L 
Magnesium ions 2.1 mmol/L 
Buffer pH 7.5 ± 0.1 
Procedure: 
1. Prepare Glucose (HK) reagent according to the 
i nst ruct i ons. 
2. Warm reagent to ambient temperature. 
3. Add 1.5 ml of Glucose (HK) reagent to a labeled cuvet. 
4. Read and record absorbance (A) at 340 nm vs water as 
reference. This is INITIAL A. 
5. Add 0.01 mL (10uL) of sample. Mix by gentle inversion. 
6. Incubate cuvets for 5-min. Read and record the absorbance 
(A) at 340 nm vs water as reference. This is FINAL A. 
Following completion of reaction, FINAL A remains constant 
for 60 minutes. 
7. Subtract INITIAL A from FINAL A to obtain change in 
absorbance (change A). 
8. To calculate glucose concentration (mg/dL), multiply the 
change A by factor 437 when sample to reagent ratio is 1:150 
and by factor 293 when sample to reagent ratio is 1:100. 
Example: 
The following absorbance values were obtained using a 
cuvet with a 1-cm lightpath. 
Sample to reagent ratio = 1:150 
INITIAL A = 0.106 
FINAL A = 0.296 
change A = 0.296 - 0.106 = 0.190 
Glucose Concentration of sample = 0.190 * 437 = 83 mg/dL 
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Name 
I.D. Number F S 1 
01 02 03 04 05 06 07 
Date: / / 
08 09 10 11 12 13 
Current Self Appraisal 
Between the following pairs of words select the space that best describes 
the way you feel today and nark it with an X. For example: If you are feeling 
very depressed mark the first space. 
depressed X joyous 
If you are very joyous mark the fifth space. If you are moderately depressed 
the 2nd space, etc. 
Please read each set of words carefully. 
1 2 3 4 5 
rested tired 
rich poor 
well _____ ill 
happy sad 
stressed relaxed 
lonely supported 
angry calm 
blah perky 
14 
IT 
IT 
rr 
18" 
TT 
20" 
21~ 
accepted unaccepted 
(l'iked by others) 22 
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APPENDIX H 
State-Trait Anxiety Inventory 
Self-Evaluation Questionnaire 
PLEASE NOTE 
Copyrighted materials in this document have 
not been filmed at the request of the author. 
They are available for consultation, however, 
in the author's university library. 
268 
University Microfilms International 
